https://timmermanreport.com/2015/02/third-rocks-obesity-hopeful-ember-therapeutics-closes/2015-02-04T18:05:34+00:00http://timmermanreport.com/wp-content/uploads/2015/02/kstarr.pnghttps://timmermanreport.com/2015/02/seattle-genetics-commercial-boss-leaves-president-gig-bristol-myers/2015-02-04T22:37:39+00:00https://timmermanreport.com/wp-content/uploads/2015/02/cboerner.jpghttps://timmermanreport.com/2015/02/former-dendreon-ceo-lures-ex-amgen-scientists-immunotherapy-startup/2015-02-06T01:28:20+00:00http://timmermanreport.com/wp-content/uploads/2015/02/mgold.jpghttps://timmermanreport.com/2015/02/qa-affymetrix-founder-stephen-fodor-resurfaces-cellular-research/2015-02-06T20:07:36+00:00http://timmermanreport.com/wp-content/uploads/2015/02/fodor.pnghttps://timmermanreport.com/2015/02/cellular-dynamics-tracks-superdonors-cell-therapy-foray/2015-02-09T13:16:19+00:00http://timmermanreport.com/wp-content/uploads/2015/02/ianwilmut.pnghttps://timmermanreport.com/2015/02/intelligent-mdx-maker-of-molecular-diagnostics-that-raised-40m-shuts-down/2015-02-11T23:01:26+00:00https://timmermanreport.com/2015/02/faqs-timmerman-report/2015-02-12T19:43:41+00:00https://timmermanreport.com/wp-content/uploads/2015/02/2014-07-13-21.05.06.jpghttps://timmermanreport.com/2015/02/video-alnylams-john-maraganore-canaans-julie-papanek-bio-ceo/2015-02-12T21:37:11+00:00https://timmermanreport.com/wp-content/uploads/2015/02/jm.pnghttps://timmermanreport.com/2015/02/frazier-versant-find-heart-drug-bet-laguna/2015-02-17T15:10:28+00:00http://timmermanreport.com/wp-content/uploads/2015/02/james\_bio.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/2015-02-18T20:39:40+00:00http://timmermanreport.com/wp-content/uploads/2015/02/hans-bishop.jpghttp://timmermanreport.com/wp-content/uploads/2015/02/adeleneperkins.jpghttps://timmermanreport.com/wp-content/uploads/2015/02/carolgallagher.jpghttps://timmermanreport.com/wp-content/uploads/2015/02/saumitrarahatekar.jpghttps://timmermanreport.com/wp-content/uploads/2015/02/ethanperlstein.jpghttp://timmermanreport.com/wp-content/uploads/2015/02/barbarayates.jpghttps://timmermanreport.com/wp-content/uploads/2015/02/Atul-Butte2\_0.jpghttps://timmermanreport.com/2015/02/global-blood-zeroes-sickle-cell-potentially-big-touchy-opportunity/2015-02-20T05:31:57+00:00http://timmermanreport.com/wp-content/uploads/2015/02/Ted-Love-Headshot.jpghttps://timmermanreport.com/2015/02/five-things-watch-next-weeks-big-genomics-show/2015-02-23T05:12:57+00:00http://timmermanreport.com/wp-content/uploads/2015/02/dgmacarthur\_bw2.jpghttps://timmermanreport.com/2015/02/tularik-alumni-now/2015-03-02T17:07:56+00:00https://timmermanreport.com/2015/03/margaret-hamburg-one-time-great-fda-commissioners/2015-03-02T18:36:48+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttp://timmermanreport.com/wp-content/uploads/2015/02/hamburg.pnghttps://timmermanreport.com/2015/03/esperion-jockeys-place-statins-next-big-class-heart-drugs/2015-03-06T18:33:49+00:00http://timmermanreport.com/wp-content/uploads/2015/03/esperion-bio-tim-mayleben.jpghttps://timmermanreport.com/2015/03/2015-power-rankings-biotech-investment-banks/2015-03-09T10:00:09+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/03/ember-therapeutics-after-shutting-down-pools-ip-with-mariel/2015-03-13T15:57:01+00:00https://timmermanreport.com/2015/03/the-top-20-early-stage-biotech-investors-and-2-resuscitated-by-the-boom/2015-03-16T10:00:05+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-3.pnghttps://timmermanreport.com/2015/03/third-rocks-revolution-medicines-tears-apart-antifungals-atom-by-atom/2015-03-18T10:00:33+00:00http://timmermanreport.com/wp-content/uploads/2015/03/mgoldsmith.pnghttps://timmermanreport.com/2015/03/nash-is-the-next-monster-pharmaceutical-market-here-are-the-players/2015-03-20T17:01:51+00:00https://timmermanreport.com/2015/03/salaries-are-inching-up-in-the-biotech-boom-not-booming/2015-03-23T10:00:14+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttp://timmermanreport.com/wp-content/uploads/2015/03/radfordsurvey.pnghttps://timmermanreport.com/2015/03/antibiotic-rd-getting-attention-whos/2015-03-24T04:35:51+00:00http://timmermanreport.com/wp-content/uploads/2015/03/Ankit\_Mahadevia\_Small\_b-e1426115612339.jpghttps://timmermanreport.com/2015/04/sareptas-controversial-ceo-is-out-but-duchenne-muscular-dystrophy-rd-is-rising/2015-04-03T18:13:46+00:00https://timmermanreport.com/wp-content/uploads/2015/04/chamberlain11-e1428022646618.jpghttps://timmermanreport.com/2015/04/striking-a-balance-between-government-and-business-support-for-research/2015-04-04T15:33:36+00:00https://timmermanreport.com/2015/04/baseball-and-biotech-where-hope-springs-eternal/2015-04-06T18:57:21+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/04/which-big-public-investors-are-crossing-over-into-the-private-arena/2015-04-09T11:00:31+00:00http://timmermanreport.com/wp-content/uploads/2015/04/pitchbook2014B.pnghttp://timmermanreport.com/wp-content/uploads/2015/04/pitchbook2014c1.pnghttp://timmermanreport.com/wp-content/uploads/2015/04/pitchbook2014D.pnghttps://timmermanreport.com/2015/04/the-big-boys-love-cambridge-lets-hope-they-dont-squeeze-the-life-out-of-it/2015-04-13T22:15:02+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttp://timmermanreport.com/wp-content/uploads/2015/04/mgilman1-e1428962932988.jpghttps://timmermanreport.com/wp-content/uploads/2015/04/dfambrough.jpghttps://timmermanreport.com/2015/03/company-subscriptions-to-timmerman-report-you-asked-and-you-get/2015-04-14T15:45:07+00:00https://timmermanreport.com/2015/04/who-should-biotech-and-pharma-industry-pros-follow-on-twitter/2015-04-15T13:14:05+00:00https://timmermanreport.com/2015/04/aacr-conference-preview-five-themes-to-watch-in-immunotherapy/2015-04-16T12:56:04+00:00http://timmermanreport.com/wp-content/uploads/2015/04/jodonnelltormey-e1429111352888.jpghttps://timmermanreport.com/2015/04/academic-paternalism-has-got-to-go-its-time-to-re-invent-biotech-student-life/2015-04-27T18:27:34+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttp://timmermanreport.com/wp-content/uploads/2015/04/dougcrawford.jpghttps://timmermanreport.com/wp-content/uploads/2015/01/Thong-Le-e1452374194718.jpghttps://timmermanreport.com/2015/04/qa-with-illumina-ceo-jay-flatley-on-building-a-genome-sequencing-powerhouse/2015-04-29T17:49:35+00:00http://timmermanreport.com/wp-content/uploads/2015/04/jayflatley.jpghttps://timmermanreport.com/2015/05/whats-real-and-whats-not-in-digital-health/2015-05-05T16:35:56+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/05/jpapanek.pnghttps://timmermanreport.com/2015/05/gates-foundation-vc-portfolio-where-is-the-global-health-investment-going/2015-05-07T11:20:09+00:00https://timmermanreport.com/2015/05/baseball-regression-to-the-mean-and-avoiding-potential-clinical-trial-biases/2015-05-14T16:56:23+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2015/05/more-than-moderna-whos-who-in-mrna-therapeutics/2015-05-18T21:30:38+00:00http://timmermanreport.com/wp-content/uploads/2015/05/SBancel-moderna-2.jpghttps://timmermanreport.com/2015/05/zigging-away-from-the-herd-lillys-road-less-traveled-rd-strategy/2015-05-18T21:44:28+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttp://timmermanreport.com/wp-content/uploads/2015/05/adahlem.jpghttps://timmermanreport.com/2015/05/why-a-pfizer-rd-exec-joined-little-synlogic-to-make-therapeutic-synthetic-life/2015-05-21T14:43:36+00:00http://timmermanreport.com/wp-content/uploads/2015/05/jcgr.pnghttps://timmermanreport.com/2015/05/long-term-relationships-may-not-pay-in-many-businesses-but-they-still-do-in-biotech/2015-05-26T14:54:34+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/05/bio-mark-levin-sm-e1432329834267.jpghttps://timmermanreport.com/2015/05/how-vcs-split-the-pie-who-gets-what/2015-05-27T18:48:54+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/01/mikepowell.jpghttps://timmermanreport.com/2015/05/cancer-immunotherapys-four-year-run-a-timeline-of-major-events/2015-05-29T15:58:03+00:00https://timmermanreport.com/2015/06/cancer-is-hot-diabetes-is-not-watch-for-safety-and-costs-at-next-medical-meeting/2015-06-05T13:22:56+00:00https://timmermanreport.com/wp-content/uploads/2015/06/dbradbury.jpghttps://timmermanreport.com/2015/06/bristol-myers-should-drop-the-bully-act-non-competes-are-bad-for-biotech/2015-06-08T11:25:06+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/06/BruceMontgomery-1-sm1.jpghttps://timmermanreport.com/2015/06/nea-polaris-bet-22m-on-startup-xtuit-to-break-down-tumor-microenvironment/2015-06-11T11:00:13+00:00https://timmermanreport.com/2015/06/big-pharma-talent-is-flocking-to-biotech-startups-nobodys-saying-are-you-nuts/2015-06-11T04:24:51+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/05/cwilson.pnghttps://timmermanreport.com/2015/06/its-time-to-re-think-some-assumptions-about-cancer-rd/2015-06-15T21:13:00+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttp://timmermanreport.com/wp-content/uploads/2015/06/disis.jpghttp://timmermanreport.com/wp-content/uploads/2015/06/cheever.jpghttps://timmermanreport.com/2015/06/like-the-tr-tell-a-friend-to-subscribe-and-enter-to-win-a-t-shirt/2015-06-19T17:49:06+00:00https://timmermanreport.com/wp-content/uploads/2015/06/timmerman-launch-20mar15-332-e1434735450858.jpghttps://timmermanreport.com/2015/06/a-small-dose-of-hope-for-our-old-fashioned-drug-safety-surveillance-system/2015-06-23T15:07:35+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/06/jsegal-e1434760765682.jpghttps://timmermanreport.com/2015/02/biotech-poised-go-public-2015-isnt/2015-06-26T15:18:19+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/06/linkedin-is-woven-into-the-fabric-of-biotech-but-some-top-people-still-dont-get-it/2015-07-01T23:48:12+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/06/BG-photo-Oct-2014.jpghttp://timmermanreport.com/wp-content/uploads/2015/06/Flemming-Ornskov-e1435526336338.pnghttps://timmermanreport.com/2015/07/qa-with-shire-ceo-flemming-ornskov-on-becoming-more-biotech-like/2015-07-02T15:54:13+00:00http://timmermanreport.com/wp-content/uploads/2015/06/Flemming-Ornskov-e1435526336338.pnghttps://timmermanreport.com/2015/07/pay-cut-thats-ok-wall-street-veterans-find-new-purpose-in-biotech-life/2015-07-07T10:15:18+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttp://timmermanreport.com/wp-content/uploads/2015/07/lorence-kim-v2-157x210.jpghttps://timmermanreport.com/2015/07/happy-belated-independence-day-timmerman-report-is-here-to-stay/2015-07-09T10:45:08+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_19.jpghttps://timmermanreport.com/2015/07/forget-price-controls-value-based-pricing-is-the-new-threat-to-drug-development/2015-07-17T07:45:38+00:00https://timmermanreport.com/wp-content/uploads/2015/07/twilson.jpghttps://timmermanreport.com/2015/07/how-are-biotech-vcs-performing-in-the-boom-youd-be-surprised-part-ii/2015-07-21T07:45:17+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/07/the-non-compete-chill-has-passed-bristol-myers-medimmune-settle-over-i-o-star/2015-07-21T21:21:36+00:00https://timmermanreport.com/wp-content/uploads/2015/07/David-Berman-225.jpghttps://timmermanreport.com/2015/07/bad-behaviors-creeping-into-biotech-during-the-boom/2015-07-27T21:37:21+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/07/data-from-texas-vcs-letting-winners-ride-stock-market-wave/2015-07-29T14:47:47+00:00https://timmermanreport.com/2015/07/join-me-for-tr-subscriber-meetup-aug-5-in-kendall-square/2015-07-31T07:45:37+00:00https://timmermanreport.com/wp-content/uploads/2015/07/timmerman\_67.jpghttps://timmermanreport.com/2015/08/molecular-information-companies-one-way-or-another-find-value-in-genomics/2015-08-04T07:42:20+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/07/michael-pellini.jpghttps://timmermanreport.com/2015/07/the-amgen-seattle-alumni-where-are-they-now/2015-08-05T12:45:00+00:00https://timmermanreport.com/2015/08/making-biotech-drugs-people-can-afford-kuow-radio-segment/2015-08-07T05:05:26+00:00https://timmermanreport.com/wp-content/uploads/2015/08/JIm-Thomas-e1438856112533.jpghttps://timmermanreport.com/2015/08/pharmaphobia-makes-important-counterargument-but-falls-short/2015-08-10T18:39:56+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-3.pnghttp://timmermanreport.com/wp-content/uploads/2015/08/tstossel.jpghttps://timmermanreport.com/2015/08/important-note-for-tr-subscribers-please-re-register/2015-08-12T23:38:40+00:00https://timmermanreport.com/2015/08/amarin-vs-the-fda-on-free-speech-a-careful-what-you-wish-for-moment/2015-08-18T15:21:14+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/08/phutt.jpghttps://timmermanreport.com/2015/06/the-cubist-alumni-where-are-they-now/2015-08-19T17:10:28+00:00https://timmermanreport.com/2015/08/not-just-research-not-just-diagnostics-adaptive-veers-into-t-cell-drug-discovery/2015-08-19T18:07:34+00:00https://timmermanreport.com/wp-content/uploads/2015/01/harlan-robins\_2.jpghttps://timmermanreport.com/2015/08/a-day-in-the-life-of-a-biotech-building-1616-eastlake/2015-08-21T10:45:35+00:00https://timmermanreport.com/wp-content/uploads/2015/08/1616.jpghttps://timmermanreport.com/wp-content/uploads/2015/08/cpaya.pnghttps://timmermanreport.com/wp-content/uploads/2015/01/Thong-Le-e1452374194718.jpghttps://timmermanreport.com/wp-content/uploads/2015/08/tfoy.pnghttps://timmermanreport.com/2015/08/how-to-get-corporategroup-subscriptions-to-timmerman-report-its-easy/2015-08-26T00:42:58+00:00https://timmermanreport.com/2015/08/informed-consent-isnt-working-sage-apple-just-might-be-onto-something/2015-08-26T16:12:33+00:00https://timmermanreport.com/wp-content/uploads/2015/08/jwilbanks.jpghttps://timmermanreport.com/wp-content/uploads/2015/08/mmeyer.pnghttps://timmermanreport.com/2015/08/insider-stock-sales-at-biotechs-big-six-see-whos-cashing-out-the-most/2015-08-28T08:12:32+00:00https://timmermanreport.com/2015/09/insider-selling-at-biotechs-highflying-ipos-after-the-lockup/2015-09-04T09:44:46+00:00https://timmermanreport.com/2015/08/what-happens-after-the-hype-a-few-survive-the-trough/2015-09-04T04:49:17+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/08/alny5year.pnghttps://timmermanreport.com/wp-content/uploads/2015/08/andrewhirsch.jpghttps://timmermanreport.com/2015/09/medical-device-innovation-is-on-life-support-what-will-revive-it/2015-09-08T08:20:57+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/09/nimesh-shah.jpghttps://timmermanreport.com/wp-content/uploads/2015/09/medtechpwc.pnghttps://timmermanreport.com/wp-content/uploads/2015/09/tclement.jpghttps://timmermanreport.com/2015/05/the-genentech-alumni-where-are-they-now/2015-09-08T15:44:23+00:00http://timmermanreport.com/wp-content/uploads/2015/05/arthur-levinson-e1432251389665.jpghttps://timmermanreport.com/2015/02/merck-exodus-talented-people-going/2015-09-11T18:43:18+00:00http://timmermanreport.com/wp-content/uploads/2015/01/mikepowell.jpghttps://timmermanreport.com/2015/09/more-than-just-science-relationships-between-vcs-and-pharma-drive-deals/2015-09-14T19:06:39+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/01/bryanroberts.jpghttps://timmermanreport.com/wp-content/uploads/2015/01/bobmore.jpghttps://timmermanreport.com/2015/09/new-fda-commish-lillys-diabetes-stunner-and-a-dust-up-over-immortality/2015-09-18T19:00:16+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/wp-content/uploads/2015/09/llyjardiance-e1442582995744.pnghttps://timmermanreport.com/2015/09/just-snags-15m-from-merck-lilly-arch-for-low-cost-biotech-drugs/2015-09-18T21:23:22+00:00https://timmermanreport.com/wp-content/uploads/2015/08/JIm-Thomas-e1438856112533.jpghttps://timmermanreport.com/2015/09/the-mckinsey-alumni-where-are-they-wielding-influence/2015-09-22T12:59:59+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/09/mikepearson.jpghttps://timmermanreport.com/2015/09/seattle-subscribers-come-talk-journalism-sports-and-biotech-at-the-tr-meetup/2015-09-23T12:41:57+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-153.jpghttps://timmermanreport.com/2015/09/a-timeline-of-the-turing-pharma-pricing-controversy/2015-09-23T19:06:52+00:00https://timmermanreport.com/wp-content/uploads/2015/09/drugspending-e1443033351701.pnghttps://timmermanreport.com/2015/09/the-mother-of-all-drug-pricing-controversies-slingshots-at-fda-nominee-and-nobel-handicapping/2015-09-25T08:47:35+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/09/pharma-gouging-got-everyones-attention-now-its-time-to-re-imagine-fair-pricing/2015-09-28T08:45:06+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/09/praveen.pnghttps://timmermanreport.com/2015/03/cancer-combos-are-the-way-forward-will-drugmakers-put-patients-first/2015-10-01T03:37:57+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttp://timmermanreport.com/wp-content/uploads/2015/03/portrait-david-schenkein.jpghttp://timmermanreport.com/wp-content/uploads/2015/03/adeleneperkins.jpghttps://timmermanreport.com/2015/10/the-immune-system-as-a-metaphor-for-the-turing-pharma-mess/2015-10-02T11:57:38+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2015/10/fallout-from-the-drug-pricing-fiasco-the-new-thing-in-genome-editing-more/2015-10-02T19:48:46+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/10/glaxosmithkline-a-bunch-of-numbskulls-or-crazy-like-a-fox/2015-10-05T08:13:56+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/10/sir-andrew-witty.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/gskvsmrkvspfe-e1443826526156.jpghttps://timmermanreport.com/2015/10/who-deserves-to-be-called-a-founder-and-who-doesnt/2015-10-13T03:26:07+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/10/vertex-takes-heat-valeant-takes-more-heat-express-scripts-cuts-a-pcsk9-deal-more/2015-10-13T18:18:12+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/10/introducing-signal-the-stat-podcast-im-co-hosting-with-meg-tirrell/2015-10-14T19:36:02+00:00https://timmermanreport.com/wp-content/uploads/2015/10/signalimage.jpghttps://timmermanreport.com/2015/10/theranos-exposed-lilly-cholesterol-drug-flops-23andme-raises-more-dough/2015-10-16T16:32:52+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/04/hungry-for-cash-academia-grabs-for-a-bigger-piece-of-biotech-action/2015-10-16T18:47:59+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttp://timmermanreport.com/wp-content/uploads/2015/04/robert\_nelsen2.jpghttp://timmermanreport.com/wp-content/uploads/2015/04/jeffrey-d-marrazzo.jpghttps://timmermanreport.com/2015/10/playing-hardball-academia-looks-to-even-the-score-with-vcs-big-pharma/2015-10-19T17:59:27+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/10/investors-shouldnt-nitpick-old-data-bluebirds-new-gene-therapy-vector-makes-a-difference/2015-10-23T10:45:31+00:00https://timmermanreport.com/wp-content/uploads/2015/10/zackfink.pnghttps://timmermanreport.com/wp-content/uploads/2015/10/fink1-e1445562575741.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/fink2-e1445562711720.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/fink3.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/fink4-e1445562869765.jpghttps://timmermanreport.com/2015/10/valeants-takedown-fda-black-boxes-the-cancer-vaccine-pig-pile/2015-10-23T23:32:25+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/10/biotech-and-pharma-need-to-find-more-on-ramps-for-young-people/2015-10-26T17:06:32+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/10/mgladstone.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/2015-10-27T16:54:34+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-186.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-200.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-196.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-193.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-183.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-167.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-162.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-160.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-125.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-123.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-117.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-111.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-093.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-084.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-083.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-077.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-076.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-074.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-068.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-067.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-063.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-062.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-046.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-015.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-011.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-009.jpghttps://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-008.jpghttps://timmermanreport.com/2015/10/pfizers-new-megamerger-target-valeant-squirms-amgens-cancer-advance/2015-10-30T22:05:11+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/wp-content/uploads/2015/10/loncarft.jpghttps://timmermanreport.com/2015/11/d-c-crosshairs-on-pharma-ash-roller-coaster-an-ipo-cooldown/2015-11-06T13:31:17+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/wp-content/uploads/2014/12/fastercuresRichardPops.jpghttps://timmermanreport.com/2015/11/raiding-the-talent-at-pfizer-where-might-the-rd-brains-go/2015-11-09T16:49:59+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/11/the-100m-club-see-who-makes-the-cut-in-sf-boston-and-beyond/2015-11-10T15:39:07+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/11/science-on-the-red-carpet-crispr-in-the-spotlight-more-bad-behavior/2015-11-13T12:01:03+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/11/a-new-social-contract-in-pharma-qa-with-alnylams-john-maraganore/2015-11-16T10:48:50+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/11/jm.pnghttps://timmermanreport.com/2015/11/a16z-digs-biotech-clovis-crashes-fda-crackdown-on-supplements/2015-11-21T02:03:16+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/11/reimaging-the-scientific-enterprise-qa-with-mits-bob-langer/2015-11-23T21:48:03+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/11/p\_faculty\_r\_langer.jpghttps://timmermanreport.com/2015/11/updated-commentary-on-the-fda-duchenne-panel-with-meg-tirrell/2015-11-25T17:46:29+00:00https://timmermanreport.com/2015/11/free-speech-in-pharma-should-be-for-rd-people-too-not-just-sales-marketing/2015-11-30T09:28:00+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/11/Derek-Lowe1-e1435835132452.jpghttps://timmermanreport.com/2015/12/pfizergan-stirs-the-pot-boston-pharma-starts-with-600m-bang-hepc-drug-pricing-back-in-the-news/2015-12-04T14:58:35+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/12/carters-immunotherapy-success-wu-tang-biopharma-a-gut-brain-startup/2015-12-11T10:45:08+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/12/why-im-not-buying-any-consumer-genetic-tests-this-holiday-season/2015-12-14T15:28:37+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/12/brooksdyad7.jpghttps://timmermanreport.com/2015/12/shkreli-gets-pinched-cruz-tries-to-kneecap-fda-woodfords-nutty-investment/2015-12-18T13:17:08+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/12/what-technologies-were-hyped-and-which-came-down-a-notch-in-2015/2015-12-21T13:53:04+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/12/GartnerHype.jpghttps://timmermanreport.com/wp-content/uploads/2015/12/dzohar.jpghttps://timmermanreport.com/wp-content/uploads/2015/12/pacb.jpghttps://timmermanreport.com/2015/12/orbimed-reloads-bayers-crispr-foray-some-good-longreads/2015-12-24T09:43:32+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/12/editors-picks-the-best-of-tr-from-2015/2015-12-28T10:42:53+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2016/01/competition-by-itself-isnt-enough-to-corral-drug-prices/2016-01-07T05:56:08+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/12/roger-longman.jpghttps://timmermanreport.com/2016/01/all-the-biotech-deals-and-financings-you-can-grok-before-jp-morgan-2016/2016-01-08T09:43:22+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/wp-content/uploads/2016/01/loncarsecondarydiscounts.jpghttps://timmermanreport.com/wp-content/uploads/2016/01/meggileadprices.jpghttps://timmermanreport.com/2016/01/illumina-arch-bezos-bet-100m-on-deep-sequencing-for-early-cancer-detection/2016-01-10T22:55:58+00:00https://timmermanreport.com/wp-content/uploads/2015/04/jayflatley.jpghttps://timmermanreport.com/2016/01/go-go-years-have-been-good-for-biotech-but-service-providers-are-feeling-the-strain/2016-01-11T12:03:56+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/01/Thong-Le-e1452374194718.jpghttps://timmermanreport.com/wp-content/uploads/2016/01/gg.pnghttps://timmermanreport.com/wp-content/uploads/2016/01/sg.pnghttps://timmermanreport.com/wp-content/uploads/2016/01/aj.pnghttps://timmermanreport.com/2016/01/post-jpm-perspective-fda-shoots-down-dmd-drug-illuminas-audacity/2016-01-15T10:30:16+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2016/01/a-clinical-disaster-in-france-alkermes-whiffs-and-the-dmd-anti-climax/2016-01-22T09:55:03+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2016/01/big-pharma-may-be-a-dinosaur-but-it-can-move-fast-when-it-wants/2016-01-25T17:28:16+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/01/avaishnaw.jpghttps://timmermanreport.com/2016/01/mercks-hcv-contender-red-tickers-and-research-parasites/2016-01-29T10:32:13+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2016/02/a-short-history-of-cures-for-hepatitis-c/2016-02-01T14:12:25+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2016/01/time-to-renew-your-tr-subscription/2016-02-02T02:02:34+00:00https://timmermanreport.com/2016/02/as-the-smirk-turns-fdas-opioid-control-and-a-gene-editing-ipo/2016-02-05T18:14:10+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2016/02/zika-fear-stock-jitters-and-soul-searching-on-drug-prices/2016-02-12T14:23:45+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2016/02/drugmakers-are-lousy-at-communicating-heres-how-to-improve/2016-02-16T14:07:57+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/02/ddunsire.jpghttps://timmermanreport.com/wp-content/uploads/2016/02/jm.pnghttps://timmermanreport.com/wp-content/uploads/2016/02/tcoles.jpghttps://timmermanreport.com/2016/02/intercept-rumors-alnylams-200m-factory-and-some-precious-ebola-antibodies/2016-02-19T10:55:43+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/wp-content/uploads/2016/02/drewtweet1.jpghttps://timmermanreport.com/2016/02/actives-vs-zombies-dysfunctional-boards-are-haunting-biotech-and-messing-with-ma/2016-02-22T14:03:20+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/02/oded.jpghttps://timmermanreport.com/wp-content/uploads/2016/02/janderson.jpghttps://timmermanreport.com/2015/09/post-labor-day-hangovers-ipi-nivo-combo-data-the-pcsk9-pricing-debate/2016-02-23T19:26:08+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/12/family-offices-a-quiet-emerging-force-in-biotech-investing/2016-02-25T04:21:04+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2016/02/califf-confirmed-obama-elevates-precision-med-and-lab-made-sperm/2016-02-26T18:45:16+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2016/02/merck-nanostring-seek-to-identify-i-o-responders-in-rich-companion-dx-deal/2016-02-29T21:00:44+00:00https://timmermanreport.com/wp-content/uploads/2016/02/bgray.jpghttps://timmermanreport.com/2016/03/trumps-so-called-healthcare-plan-valeant-boss-returns-and-gileads-good-week/2016-03-04T18:17:10+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/03/subscribers-come-celebrate-at-the-tr-one-year-anniversary-party/2016-03-08T10:23:52+00:00https://timmermanreport.com/wp-content/uploads/2016/03/timmerman\_46.jpghttps://timmermanreport.com/2016/03/draft-joe-biden-and-roy-vagelos-for-a-fair-deal-on-drug-pricing/2016-03-07T19:28:24+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/03/vp\_portrait\_lores-e1457218213907.jpeghttps://timmermanreport.com/wp-content/uploads/2016/03/pattymurray-e1457219138698.jpghttps://timmermanreport.com/wp-content/uploads/2016/03/Susan\_Desmond\_Hellmann\_227x154.jpghttps://timmermanreport.com/wp-content/uploads/2016/03/kenfrazier-e1457218843995.jpghttps://timmermanreport.com/wp-content/uploads/2016/03/steve\_ubl.jpghttps://timmermanreport.com/2016/03/learn-or-die/2016-03-10T17:42:03+00:00https://timmermanreport.com/wp-content/uploads/2016/02/lisasuennen.jpghttps://timmermanreport.com/wp-content/uploads/2016/03/joinordie.jpghttps://timmermanreport.com/wp-content/uploads/2016/03/jocelyn.jpghttps://timmermanreport.com/wp-content/uploads/2016/03/jennymccarthy.jpghttps://timmermanreport.com/2016/02/one-way-to-improve-clinical-trials-a-yelp-style-rating-system/2016-03-10T18:07:28+00:00https://timmermanreport.com/wp-content/uploads/2015/01/kyleserikawa.jpghttps://timmermanreport.com/wp-content/uploads/2016/02/happyemoji.pnghttps://timmermanreport.com/wp-content/uploads/2016/02/sademoji.pnghttps://timmermanreport.com/2016/02/no-crispr-cas-wont-save-the-day-for-agbio-a-twist-on-the-gmo-debate-might/2016-03-10T18:07:43+00:00https://timmermanreport.com/wp-content/uploads/2015/01/kyleserikawa.jpghttps://timmermanreport.com/2016/02/are-you-ready-for-some-football-maybe-yes-maybe-no/2016-03-10T18:07:58+00:00https://timmermanreport.com/wp-content/uploads/2016/02/lisasuennen.jpghttps://timmermanreport.com/2016/01/should-basic-lab-experiments-be-blinded-to-chip-away-at-the-reproducibility-problem/2016-03-10T18:08:34+00:00https://timmermanreport.com/wp-content/uploads/2015/01/kyleserikawa.jpghttps://timmermanreport.com/2015/11/google-knows-whats-in-your-inbox-but-it-shouldnt-get-your-genome-without-consent/2016-03-10T18:08:53+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2016/03/medicares-bombshell-celldex-cancer-vaccine-crashes-illumina-passes-torch/2016-03-11T10:09:02+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/03/medicare-swings-the-machete-against-a-broken-payment-model-for-doctors/2016-03-14T09:45:31+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2016/03/sanofi-bets-50m-on-dice-a-directed-evolution-twist-on-drug-discovery/2016-03-16T06:00:03+00:00https://timmermanreport.com/wp-content/uploads/2015/01/kjudice2.pnghttps://timmermanreport.com/wp-content/uploads/2016/03/photo\_katherine-bowdish.jpghttps://timmermanreport.com/2016/03/qa-drug-pricing-gileads-gregg-alton-outtakes-signal/2016-03-17T09:35:22+00:00https://timmermanreport.com/wp-content/uploads/2016/03/Alton.jpghttps://timmermanreport.com/2016/03/valeant-finally-collapses-carl-junes-curious-omission-wittys-swan-song/2016-03-18T13:32:14+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/03/celator.jpghttps://timmermanreport.com/2016/03/no-peanuts-tweeds-merck-rightly-pays-harvard-20m-cancer-drug/2016-03-21T13:18:04+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/03/IsaacSmall\_146\_146\_all\_-72\_c1.pnghttps://timmermanreport.com/2016/03/merck-beats-gilead-court-bms-locks-padlock-paul-allens-100m-biotech-bet/2016-03-25T10:16:14+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/03/make-sense-acqui-hire-biotech/2016-03-28T10:22:53+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/01/John-Mendlein.jpghttps://timmermanreport.com/2016/04/medivation-microscope-obamas-opioid-control-plan-burrills-ban/2016-04-01T10:07:12+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/04/can-migraine-drugmakers-avoid-pcsk9-headwinds/2016-04-04T13:20:42+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/12/roger-longman.jpghttps://timmermanreport.com/2016/04/seattleites-join-chad-harlan-robins-interview-tr-party-apr-25/2016-04-07T10:37:48+00:00https://timmermanreport.com/wp-content/uploads/2015/01/harlan-robins\_2.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/Chad\_Robins\_CEO\_2015a-e1459985386206.jpghttps://timmermanreport.com/2016/04/12-vcs-matter-never-read/2016-04-11T10:54:47+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/04/kristina\_burow2.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/albert\_cha.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/kim-kamdar.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/Larry\_Lasky\_LRG-e1460148867823.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/anand.jpghttps://timmermanreport.com/2016/04/medivation-stiffs-sanofi-ims-drug-spending-billionaire-worship/2016-04-15T15:53:12+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/2016-04-19T21:27:37+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0360-1.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/bostonmarathon2016.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0418.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0412.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0403.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0396.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0393.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0386.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0375.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0356.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0350.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0349.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0342.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0331.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0328-e1461078415190.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0322.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0307.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0294.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0290-e1461078380928.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0271.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0253.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0251.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0250.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0237.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0236.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0230.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0229.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0225.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0217.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0207.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0205.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0195.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0191.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0187.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0182.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0172.jpghttps://timmermanreport.com/2016/04/sarepta-lions-den-theranos-hits-bottom-pharmas-microbiome-foray/2016-04-22T09:59:10+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2016/04/less-disruption-please/2016-04-23T13:06:23+00:00https://timmermanreport.com/wp-content/uploads/2016/02/lisasuennen.jpghttps://timmermanreport.com/2016/04/fantasy-drug-development-leagues-baseball-geeks-fun/2016-04-23T13:06:43+00:00https://timmermanreport.com/wp-content/uploads/2015/01/kyleserikawa.jpghttps://timmermanreport.com/2016/04/theranos-trigger-event-just-might-bring-order-diagnostic-wild-west/2016-04-25T14:04:34+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/09/bijan-salehizadeh@2x.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/bonnie.jpghttps://timmermanreport.com/2016/04/congress-slaughters-valeant-hogs-sarepta-smackdown-soon-shiongs-9-figure-payday/2016-04-29T10:40:47+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/05/much-drug-pricing-scrutiny-biopharma-facing-not-much-might-think/2016-05-04T03:03:40+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2016/05/prince-puts-face-opioid-problem-ims-merges-quintiles-sarepta-gone-wild/2016-05-06T18:54:03+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/05/bull-market-bubble-see-chat-biotech-leaders-milken-global/2016-05-09T10:20:45+00:00https://timmermanreport.com/2016/05/distributed-rd-spark-entrepreneurship-biopharma/2016-05-11T10:34:22+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2016/05/olivers-rant-science-reporting-sid-mukherjee-tempest-clovis-mea-culpa/2016-05-13T15:25:59+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/04/pfizergan-unravels-gilead-gets-nash-drug-verily-self-dealing/2016-05-14T16:52:10+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/04/vrtxchart.jpghttps://timmermanreport.com/2016/05/genentech-enters-pd-l1-arena-theranos-ashes-asco-pr-machine-shifts-high-gear/2016-05-20T09:39:50+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/05/immuno-oncology-whos-part-2/2016-05-20T18:16:46+00:00https://timmermanreport.com/wp-content/uploads/2016/05/krieg.jpghttps://timmermanreport.com/2016/05/sexism-biotech-need-aware-stay-vigilant/2016-05-23T17:01:36+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/10/the-next-macro-phage-thing-in-immuno-oncology/2016-05-23T19:32:57+00:00https://timmermanreport.com/wp-content/uploads/2015/09/VitoPalombella.jpghttps://timmermanreport.com/2016/05/immuno-oncology-whos-part-1/2016-05-25T15:36:54+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2016/05/regeneron-supports-youth-science-minerva-nails-schizophrenia-trial-sarepta-waits/2016-05-27T09:40:36+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/05/jain.jpghttps://timmermanreport.com/2016/06/fantasy-drug-development-fleshing-cool-way-test-wits-biopharma-game/2016-06-02T09:41:09+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2016/06/asco-preview-biomarins-monster-dmd-write-superbug-wakeup-call/2016-06-03T09:15:47+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/wp-content/uploads/2016/06/flex.jpghttps://timmermanreport.com/2016/06/bigger-better-biotech-venture-capital/2016-06-06T09:24:16+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/06/Schwab-175x197.pnghttps://timmermanreport.com/wp-content/uploads/2014/12/Thong-Le.jpghttps://timmermanreport.com/2016/06/silicon-valley-joins-drug-device-discovery-party/2016-06-07T09:03:30+00:00https://timmermanreport.com/wp-content/uploads/2016/02/lisasuennen.jpghttps://timmermanreport.com/2016/06/bio-jabs-payers-jennifer-l-merck-buys-afferent/2016-06-10T14:15:33+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/06/bls.pnghttps://timmermanreport.com/2016/06/the-schreiberians-where-are-they-now/2016-06-14T09:21:59+00:00https://timmermanreport.com/wp-content/uploads/2016/06/stuart\_schreiber.jpghttps://timmermanreport.com/2016/06/7003/2016-06-17T09:02:30+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/06/jeb.pnghttps://timmermanreport.com/2016/06/going-public-crummy-valuations-crossover-hangover/2016-06-20T11:36:05+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/06/BG-photo-Oct-2014.jpghttps://timmermanreport.com/wp-content/uploads/2015/01/oleg1.pnghttps://timmermanreport.com/2016/06/obama-toys-precision-med-job-gates-shines-light-superbugs-parker-angles-crispr-trial/2016-06-24T18:20:42+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/06/nihalzheimers.pnghttps://timmermanreport.com/2016/06/vp-calling-advice-cancer-tell-go-dc/2016-06-27T19:39:52+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/06/vp\_portrait-e1466795097383.jpeghttps://timmermanreport.com/2016/06/pfizer-gsk-abbvie-join-51-5m-bet-computer-drug-discovery-shop-morphic-therapeutic/2016-06-30T11:30:19+00:00https://timmermanreport.com/wp-content/uploads/2015/09/praveen.pnghttps://timmermanreport.com/2016/07/impressions-moonshot-gileads-new-hcv-drug-tesaros-parp-winner/2016-07-01T22:24:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/07/brexit-changed-way-look-biopharmas-reputation-problem/2016-07-07T09:39:10+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2016/07/want-help-biopharmas-reputation-problem-tackle-poverty/2016-07-18T09:48:42+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2016/07/juno-deaths-amgen-aims-humira-obamas-1m-citizen-scientist-dream/2016-07-08T15:52:00+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/07/nelsentweet.pnghttps://timmermanreport.com/wp-content/uploads/2016/07/brennantweet.pnghttps://timmermanreport.com/wp-content/uploads/2016/07/suetweet.pnghttps://timmermanreport.com/2016/07/high-powered-peter-schultz-lab-alumni-see-now/2016-07-09T18:19:12+00:00https://timmermanreport.com/wp-content/uploads/2016/07/pete-schultz-wide-e1467401156622.jpghttps://timmermanreport.com/2016/07/best-boring-companies-biotech/2016-07-11T16:40:14+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/07/irwdchart.pnghttps://timmermanreport.com/wp-content/uploads/2016/07/seagenchart.pnghttps://timmermanreport.com/2016/07/scangos-exits-relypsa-gets-bought-jounce-snags-261m-celgene/2016-07-22T18:23:28+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/07/another-alzheimers-whiff-biomarin-nails-gene-therapy-hemophilia-seres-meltdown/2016-07-29T18:25:40+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/07/bradhcv.pnghttps://timmermanreport.com/2016/08/donating-personal-data-giving-pay-play-whole-new-meaning/2016-08-03T16:56:10+00:00https://timmermanreport.com/wp-content/uploads/2016/02/lisasuennen.jpghttps://timmermanreport.com/2016/08/7139/2016-08-05T18:57:30+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/08/biibtakeover.pnghttps://timmermanreport.com/2016/08/watching-watchdog-icer-determine-fair-prices-drugs/2016-08-15T10:02:18+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2016/08/zika-advances-biogens-hemophilia-spinout-postdocs-get-raise/2016-08-12T09:40:39+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/08/illumina-takeout-ha-portola-stumbles-nyts-biotech-dean-moves/2016-08-19T17:41:01+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/08/andypollack.jpghttps://timmermanreport.com/wp-content/uploads/2016/08/ilmnaug18.jpghttps://timmermanreport.com/2016/08/epipen-pricing-fury-pfizers-14b-megabid-medivation-denali-grabs-130m/2016-08-27T02:45:35+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/08/dagros.pnghttps://timmermanreport.com/2016/08/7218/2016-08-29T09:54:28+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/08/roncohen.jpghttps://timmermanreport.com/2016/09/reflections-health-national-parks-epipens-foul-aftermath-saunders-steps/2016-09-09T17:22:49+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/09/rockoff.pnghttps://timmermanreport.com/2016/09/saunders-delivers-powerful-reminder-industry-purpose-others-listening/2016-09-13T01:05:41+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/09/saunders.jpghttps://timmermanreport.com/2016/09/phil-sharps-review-hard-hitting-hood-biography-boston-book-launch-tour/2016-09-13T09:01:20+00:00https://timmermanreport.com/wp-content/uploads/2016/09/hooduniv.jpghttps://timmermanreport.com/2016/09/sareptas-controversial-victory-allergans-buying-spree-gsks-history-making-ceo/2016-09-22T13:11:24+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/09/crisprsalaries.pnghttps://timmermanreport.com/2016/09/much-novel-antibiotic-help-hillary-cempra-experiments-fair-price/2016-09-26T14:40:15+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/09/prabha.pnghttps://timmermanreport.com/2016/09/former-google-translate-star-leaves-venters-human-longevity-join-illuminas-grail/2016-09-29T21:28:04+00:00https://timmermanreport.com/wp-content/uploads/2016/09/franz.jpghttps://timmermanreport.com/2016/09/gileads-bloom-fades-grail-poaches-data-star-kite-passes-big-car-t-trial/2016-09-30T09:17:35+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/09/Heroin-Fentanyl-vials-NHSPFL-1600x900.jpghttps://timmermanreport.com/wp-content/uploads/2016/09/gp2016.jpghttps://timmermanreport.com/2016/10/biotech-pr-boom-good-pr-business-not-good-industry-credibility/2016-10-03T17:28:05+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/10/clindenboom.jpghttps://timmermanreport.com/2016/10/alnylams-crash-theranos-strings-em-along-sareptas-deal-spree/2016-10-07T14:10:25+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/10/kaisergraphic.jpghttps://timmermanreport.com/wp-content/uploads/2016/10/ctic.pnghttps://timmermanreport.com/2016/10/value-frameworks-can-provide-value-patients/2016-10-17T09:28:17+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2016/10/bcg-alumni-wielding-influence-biotech-pharma/2016-10-13T00:31:48+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/10/hannahchang.jpghttps://timmermanreport.com/wp-content/uploads/2016/10/bcgfired.jpghttps://timmermanreport.com/2016/10/esmo-recap-illuminas-revenue-miss-mylans-monster-465m-medicaid-settlement/2016-10-14T09:18:33+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/10/bernie-fumes-ariad-overreach-alkermes-depression-drug-rebounds-ashg-notes/2016-10-21T21:30:15+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/10/ariadtweet.pnghttps://timmermanreport.com/wp-content/uploads/2016/10/illuminatweet.pnghttps://timmermanreport.com/wp-content/uploads/2016/10/nordtweet.pnghttps://timmermanreport.com/2016/10/next-voice-hear-doctors-office-will/2016-10-25T09:45:58+00:00https://timmermanreport.com/wp-content/uploads/2016/02/lisasuennen.jpghttps://timmermanreport.com/2016/10/amgen-banks-price-increases-humana-puts-sarepta-box-mit-starts-150m-engine/2016-10-28T09:53:06+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/10/cohentweet.jpghttps://timmermanreport.com/2016/10/resilience-biotech-leaders-create-culture-can-bounce-back/2016-11-01T02:31:15+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/02/tcoles.jpghttps://timmermanreport.com/wp-content/uploads/2015/01/mikepowell.jpghttps://timmermanreport.com/2016/11/pfizer-kills-psck9-drug-cempra-whiffs-calif-voters-take-aim-drug-prices/2016-11-04T09:40:52+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/11/bernielilly.pnghttps://timmermanreport.com/wp-content/uploads/2016/11/berniepeople.pnghttps://timmermanreport.com/wp-content/uploads/2016/11/novolilly1.pnghttps://timmermanreport.com/wp-content/uploads/2016/11/jacob.pnghttps://timmermanreport.com/wp-content/uploads/2016/11/harlan.pnghttps://timmermanreport.com/2016/11/valeant-anthem-chirping-crickets-suggest-saunders-social-contract-doomed/2016-11-07T10:21:33+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2016/11/time-take-crystal-ball-figure-trump-will-healthcare/2016-11-10T20:14:06+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2016/06/bio-shows-newt-love-backdoor-influence-trump-administration/2016-11-11T00:01:48+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/06/Greenwood\_Jim\_3163\_crop.jpghttps://timmermanreport.com/2016/11/7438/2016-11-11T11:20:32+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/11/dealing-megawatt-scientists-big-talkers-control-freaks-demigods/2016-11-14T10:39:36+00:00https://timmermanreport.com/wp-content/uploads/2016/11/ninetypesPIs.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/kristina\_burow2.jpghttps://timmermanreport.com/2016/11/7464/2016-11-18T11:20:53+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/11/collinsplenary.jpghttps://timmermanreport.com/2016/11/sounding-alarm-brexit-uk-biotech-struggles-cope-isolationism/2016-11-18T17:35:33+00:00https://timmermanreport.com/wp-content/uploads/2016/11/sdickman.jpghttps://timmermanreport.com/2016/11/lillys-alzheimers-strikeout-junos-double-whammy-sanofi-yanks-bladder-cancer-drug/2016-11-25T19:43:46+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/11/gift-employees-clients-kids-signed-copies-hood/2016-11-28T18:58:15+00:00https://timmermanreport.com/wp-content/uploads/2016/09/hooduniv.jpghttps://timmermanreport.com/2016/11/pursuing-autism-gut-brain-axis-startup-axial-raises-19m/2016-11-30T15:05:22+00:00https://timmermanreport.com/wp-content/uploads/2016/11/David\_Donabedian.jpghttps://timmermanreport.com/wp-content/uploads/2016/11/Michelle\_Dipp-165.jpghttps://timmermanreport.com/2016/12/21st-century-cures-rolls-thru-house-price-poised-gut-obamacare-bluebird-soars/2016-12-02T17:28:42+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/forbeshealth.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/nisen.pnghttps://timmermanreport.com/2016/12/tom-prices-doctor-centered-approach-healthcare/2016-12-06T12:11:16+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2016/12/13-young-people-bucking-odds-finding-paths-break-biotech/2016-12-08T20:45:02+00:00https://timmermanreport.com/wp-content/uploads/2016/12/armonsharei.jpghttps://timmermanreport.com/wp-content/uploads/2016/12/hannahchang.jpghttps://timmermanreport.com/wp-content/uploads/2016/12/sebastiankraves.jpghttps://timmermanreport.com/wp-content/uploads/2016/12/AnasuyaMandal.jpghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/2016-12-16T11:01:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/approvals.jpghttps://timmermanreport.com/wp-content/uploads/2016/12/mdanderson.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/opht.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/sidforbes.jpghttps://timmermanreport.com/wp-content/uploads/2016/12/americandream.pnghttps://timmermanreport.com/2016/12/unfashionable-science-daring-model-alzheimers-without-vcs/2016-12-22T10:51:21+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/johnalam.pnghttps://timmermanreport.com/2016/12/senators-dial-heat-overblown-crispr-case-biogens-new-ceo/2016-12-23T11:14:26+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/hank.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/denali.jpghttps://timmermanreport.com/2016/12/big-rna-day-spinraza-cempra-stumbles-intarcia-rakes-loot/2016-12-30T11:45:10+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/burkenusi.pnghttps://timmermanreport.com/wp-content/uploads/2016/12/cnbc12282016.pnghttps://timmermanreport.com/2015/06/whos-exploring-dna-dark-matter-for-drug-discovery/2017-01-04T22:13:39+00:00https://timmermanreport.com/wp-content/uploads/2015/06/jstam4.jpghttps://timmermanreport.com/2017/01/neon-therapeutics-gets-70m-push-neoantigen-cancer-vaccines/2017-01-05T05:01:02+00:00https://timmermanreport.com/wp-content/uploads/2017/01/hughodowd.jpghttps://timmermanreport.com/2017/01/amgen-wins-pcsk9-duel-jenkins-parting-shot-obamacares-last-stand/2017-01-06T17:41:13+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/amgen.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/sherkow1.jpghttps://timmermanreport.com/wp-content/uploads/2017/01/alexion.pnghttps://timmermanreport.com/2017/01/time-biopharma-push-public-health/2017-01-09T10:57:54+00:00https://timmermanreport.com/2017/01/brace-pharma-trumps-coming/2017-01-12T19:14:13+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2017/01/takeda-takes-ariad-illumina-plants-100-genome-stake-anti-vaxxer-nuzzles-trump/2017-01-13T20:04:29+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/mental.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/celgprices.pnghttps://timmermanreport.com/2017/01/takes-two-universities-industry-can-work-together-fix-phd-job-market/2017-01-23T11:20:52+00:00https://timmermanreport.com/wp-content/uploads/2017/01/Boaz-Vilozny\_Headshot\_w500p.pnghttps://timmermanreport.com/2017/01/takeda-leans-little-guy-ovid-therapeutics-go-distance-epilepsy-drug/2017-01-18T20:23:56+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/jeremy-levin.pnghttps://timmermanreport.com/wp-content/uploads/2015/05/jpapanek.pnghttps://timmermanreport.com/2017/01/whos-trumps-health-team-bms-cedes-ground-merck-cre-superbugs-move/2017-01-20T11:20:59+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/vyastweet.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/humiraprice.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/funds.pnghttps://timmermanreport.com/2017/02/canadian-biotech-breakaway/2017-02-06T11:01:24+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AM-head-shot.jpghttps://timmermanreport.com/wp-content/uploads/2017/01/canadavc.pnghttps://timmermanreport.com/2017/02/now-ever-need-personalized-medicine-immuno-oncology/2017-02-13T11:02:25+00:00https://timmermanreport.com/wp-content/uploads/2017/01/SW-Lower-Res.jpghttps://timmermanreport.com/wp-content/uploads/2017/01/AC-Headshot.jpghttps://timmermanreport.com/2017/01/women-making-progress-slowly-biotech-boards-report-says/2017-01-24T14:01:29+00:00https://timmermanreport.com/wp-content/uploads/2016/02/ddunsire.jpghttps://timmermanreport.com/wp-content/uploads/2017/01/fig3.pnghttps://timmermanreport.com/2017/01/drug-delivery-devices-tantalize-promise-adherence-local-delivery-personalization/2017-01-30T11:02:26+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/kurtgraves.jpghttps://timmermanreport.com/2017/01/interview-steve-miller-express-scripts-part-1/2017-01-25T11:23:40+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2017/01/conversation-steve-miller-evolving-relationship-pbms-biopharma-part-2/2017-01-26T11:22:05+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2017/02/pulse-check-patient-centricity-7-vital-signs/2017-02-10T11:30:04+00:00https://timmermanreport.com/wp-content/uploads/2017/02/Kim-McCleary.jpghttps://timmermanreport.com/2017/02/every-biopharma-lab-3d-printer-laser-cutter/2017-02-21T11:30:42+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2017/02/changing-small-molecule-exclusivity-rules-long-term-drug-price-policy/2017-02-08T11:25:44+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2017/01/jj-reels-actelion-30b-celgene-snaps-delinia-ipo-flurry/2017-01-27T20:06:52+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/gorsky.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/megjj.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/skorney.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/biohack.pnghttps://timmermanreport.com/2017/02/join-bio-europe-spring-mar-21-barcelona-talk-eu-entrepreneurship/2017-02-07T11:25:46+00:00https://timmermanreport.com/wp-content/uploads/2017/01/mayweg.jpghttps://timmermanreport.com/2017/02/road-not-traveled-journey-phd-biotech-business-finance-industry/2017-02-16T11:28:37+00:00https://timmermanreport.com/wp-content/uploads/2017/01/lukelee-page.jpghttps://timmermanreport.com/2017/02/hiring-women-execs-biotech-vc-firms-moneyball-play-part-2/2017-02-21T17:44:08+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2017/02/bms-block-maybe-sarepta-sells-golden-ticket-gilead-summit-pic/2017-02-24T11:39:52+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/02/frazier.pnghttps://timmermanreport.com/wp-content/uploads/2017/02/bijanjuno.pnghttps://timmermanreport.com/wp-content/uploads/2017/02/teamsummit.jpghttps://timmermanreport.com/wp-content/uploads/2017/02/houston.jpghttps://timmermanreport.com/2017/03/dunsire-joins-xtuit-fight-microenvironment-spero-gets-51-7m-antibiotics/2017-03-08T13:30:59+00:00https://timmermanreport.com/wp-content/uploads/2016/02/ddunsire.jpghttps://timmermanreport.com/wp-content/uploads/2015/03/Ankit\_Mahadevia\_Small\_b-e1426115612339.jpghttps://timmermanreport.com/2017/03/really-need-international-womens-artificial-intelligence-day/2017-03-13T10:42:00+00:00https://timmermanreport.com/wp-content/uploads/2016/02/lisasuennen.jpghttps://timmermanreport.com/2017/03/gottlieb-deck-fda-editing-human-embryos-gilead-exec-rips-pbms/2017-03-10T19:56:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/03/kliff.jpghttps://timmermanreport.com/wp-content/uploads/2017/03/mediascience.pnghttps://timmermanreport.com/wp-content/uploads/2017/03/bolle.pnghttps://timmermanreport.com/2017/03/biomatics-run-gates-vets-raises-200m-genomics-healthcare-startups/2017-03-15T19:28:33+00:00https://timmermanreport.com/wp-content/uploads/2017/03/JulieSunderland.jpghttps://timmermanreport.com/2017/03/egenesis-snags-38m-make-crispr-modified-pigs-organ-transplantation/2017-03-16T04:01:00+00:00https://timmermanreport.com/wp-content/uploads/2017/03/luhanyang.pnghttps://timmermanreport.com/2017/03/white-house-wants-whack-nih-allergans-crispr-foray-new-vcs-sprout/2017-03-17T10:14:46+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/03/phrmastatement.pnghttps://timmermanreport.com/2017/03/opioid-crisis-needs-help-biotech-nektar-drug-half-step/2017-03-20T13:33:23+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/03/Steve\_Doberstein\_C8W0101-2.jpghttps://timmermanreport.com/wp-content/uploads/2017/03/nktrsummit.pnghttps://timmermanreport.com/2017/03/amgens-pcsk9-mixed-bag-regeneron-gsks-genomics-bet-healthcare-vote-stalls/2017-03-24T10:05:14+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/03/califftweet.pnghttps://timmermanreport.com/wp-content/uploads/2017/03/begleytweet.pnghttps://timmermanreport.com/2017/03/trump-policy-checklist-things-stand-7-big-biopharma-issues/2017-03-29T16:54:00+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2017/03/third-rocks-tango-gets-55m-crispr-enabled-synthetic-lethal-cancer-combos/2017-03-30T11:00:44+00:00https://timmermanreport.com/wp-content/uploads/2017/03/bweber.jpghttps://timmermanreport.com/2017/03/fda-commish-scrutiny-string-big-approvals-regeneron-tesaro-genentech/2017-03-31T11:15:41+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2017/04/six-clues-show-academic-institution-serious-entrepreneurship/2017-04-03T10:56:58+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/IssiRozen.jpghttps://timmermanreport.com/wp-content/uploads/2015/05/jpapanek.pnghttps://timmermanreport.com/2017/04/allens-100m-cell-biology-resource-cool-idea-long-way-go-scientists-say/2017-04-05T07:01:03+00:00https://timmermanreport.com/wp-content/uploads/2017/04/rickhorwitz\_web\_bg-2.jpg\_\_148x148\_q85\_crop\_subsampling-2.pnghttps://timmermanreport.com/2017/04/aacr-reflections-genomics-adapts-o-world-scientists-stand-re-thinking-fight-early-stage-cancer/2017-04-06T19:13:05+00:00https://timmermanreport.com/wp-content/uploads/2017/04/sblackman.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/samtweet1.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/samtweet2.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/samtweet3.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/samtweet4.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/samtweet5.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/samtweet6.pnghttps://timmermanreport.com/2017/04/gottlieb-nails-senate-hearing-23andme-back-fdas-good-grace-aacr-reflections/2017-04-07T09:46:38+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/karlin-smith.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/rattner.pnghttps://timmermanreport.com/2017/04/boston-biotech-see-tr-anniversary-party-thursday-afternoon/2017-04-12T15:53:56+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0396.jpghttps://timmermanreport.com/2017/04/sec-busts-paid-stock-pumpers-neurocrine-scores-fda-ok-bms-unloads-two-assets/2017-04-14T13:23:47+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/shaywitztweet.pnghttps://timmermanreport.com/2017/04/time-human-knockout-project-advance-drug-discovery/2017-04-17T10:22:45+00:00https://timmermanreport.com/wp-content/uploads/2017/04/plenge.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/2017-04-19T19:38:12+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0081-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0055.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0083.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0084.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0099.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170413\_16\_54\_55\_Pro.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170413\_16\_42\_04\_Pro.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170413\_17\_59\_32\_Pro.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170413\_18\_00\_41\_Pro.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170415\_007.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/BostonMarathon2017fullsize.jpghttps://timmermanreport.com/2017/04/lessons-pcsk9-know-go-drug-discovery/2017-04-20T10:33:42+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2017/04/verily-verily-everywhere-tesaros-cheaper-parp-not-really-juno-exec-shakeup/2017-04-21T12:10:00+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/sektweet.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/andyzejula.pnghttps://timmermanreport.com/2017/04/steve-holtzman-biotech-stand-science/2017-04-22T18:30:00+00:00https://timmermanreport.com/wp-content/uploads/2017/04/sholtzman.jpghttps://timmermanreport.com/2017/04/biotech-execs-going-white-house-nash-buzz-zuckerberg-bankrolls-preprint-movement/2017-04-28T17:09:57+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/hopkins.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/cohennbc.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/leonid.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/cong.pnghttps://timmermanreport.com/2017/05/whos-long-read-linked-read-dna-sequencing/2017-05-01T10:35:40+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/shendure.jpghttps://timmermanreport.com/2017/05/house-passes-trumpcare-alzheimers-drug-shenanigans-ipo-flurry/2017-05-05T10:38:00+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/rockoffphrma.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/cummings.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/process.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/simpsons.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/milkenglobal2017.jpghttps://timmermanreport.com/2017/05/seattle-biotech-see-tr-2nd-anniversary-party-tuesday-adaptive/2017-05-08T11:37:22+00:00https://timmermanreport.com/wp-content/uploads/2017/03/TRseattleLauchPhoto.jpghttps://timmermanreport.com/2017/05/palpitations-pd-1pd-l1-land-mystery-als-drug-approval-car-t-scare/2017-05-12T09:50:07+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/gottliebtweet.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/physicianstweet.pnghttps://timmermanreport.com/2017/05/biotech-people-care-can-industry-make-difference/2017-05-16T10:34:26+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/robperez.jpghttps://timmermanreport.com/wp-content/uploads/2017/05/sarahmacdonald.jpghttps://timmermanreport.com/2017/05/former-lieutenants-tribute-henri-termeer/2017-05-18T15:36:48+00:00https://timmermanreport.com/wp-content/uploads/2017/05/chris\_rivera\_headshot\_resized.jpghttps://timmermanreport.com/2017/05/biotech-pioneer-leaves-us-verily-hires-ex-fda-commish-amazon-prowling-pharma/2017-05-19T10:39:00+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/termeertweet.pnghttps://timmermanreport.com/2017/05/12-vcs-matter-never-read-2/2017-05-25T10:06:37+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/garheng.jpghttps://timmermanreport.com/wp-content/uploads/2017/05/BenAuspitz\_2-12-2016-319x319.jpghttps://timmermanreport.com/wp-content/uploads/2017/05/JeanGeorge.jpghttps://timmermanreport.com/2017/05/alexion-expose-historic-first-fda-pumas-come-behind-victory/2017-05-30T14:42:01+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/suetweet.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/popsgottlieb.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/pumachart.pnghttps://timmermanreport.com/2017/05/parting-thoughts-genzyme-ceo-david-meeker/2017-05-31T10:18:20+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/wp-content/uploads/2017/05/meeker.jpghttps://timmermanreport.com/2017/06/atlas-venture-lures-rising-star-kevin-bitterman-away-polaris/2017-06-01T11:00:22+00:00https://timmermanreport.com/wp-content/uploads/2017/05/bittermanmug.jpghttps://timmermanreport.com/2017/06/state-ags-pull-knives-pharma-grail-grows-acquisition-crispr-jitters/2017-06-02T17:05:49+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/crisprjitters.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/adhd.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/tsro.pnghttps://timmermanreport.com/2017/06/asco-notebook-observations-cancer-rd-foundation-medicine-halozyme-blueprint-nektar/2017-06-05T21:41:59+00:00https://timmermanreport.com/wp-content/uploads/2017/06/troycox.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/jonathanz.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/jeffalbers.jpghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-1/2017-06-08T10:47:31+00:00https://timmermanreport.com/wp-content/uploads/2017/06/socialcitizen.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/bluesafety.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/gskkeiper.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/incystock.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/loncarmellman.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/incyloncar1.pnghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-2/2017-06-09T10:04:17+00:00https://timmermanreport.com/wp-content/uploads/2017/06/loxochart.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/baselga.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/westalex.pnghttps://timmermanreport.com/2017/06/fda-drops-opioid-hammer-collins-stays-nih-pfizers-relentless-ratcheting/2017-06-09T11:38:15+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/collinsrenew.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/umerjazz.pnghttps://timmermanreport.com/2017/06/long-distance-relationships-biotech-startups-make-work/2017-06-12T10:34:29+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/eriklundh.jpeghttps://timmermanreport.com/wp-content/uploads/2017/06/team-j-owens-v4.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/aallen.jpghttps://timmermanreport.com/2017/04/foreword-hood-trailblazer-genomics-age-david-baltimore/2017-06-13T21:30:23+00:00https://timmermanreport.com/wp-content/uploads/2017/04/Baltimore-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/hoodscreenshot.jpghttps://timmermanreport.com/2017/06/dos-donts-startup-boards/2017-06-15T10:46:58+00:00https://timmermanreport.com/wp-content/uploads/2017/06/bobmore-e1497476431914.jpghttps://timmermanreport.com/2017/06/supreme-court-speeds-biosimilars-clancys-lucrative-switch-apple-sniffs-around-health-records/2017-06-17T01:19:06+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/darkweb.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/tesarofiveday.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/alexionstock.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/granttweet.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/gatestweet.pnghttps://timmermanreport.com/2017/06/american-sickness-skillful-deconvolution-u-s-healthcare/2017-06-19T10:44:30+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/americansickness.jpghttps://timmermanreport.com/2017/06/plants-space-might-trying-tell-us-something-cautionary-precision-medicine/2017-06-20T10:05:04+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2017/06/rubius-snags-120m-engineer-red-blood-cell-therapies-off-shelf/2017-06-21T04:01:36+00:00https://timmermanreport.com/wp-content/uploads/2017/06/torsten1.pnghttps://timmermanreport.com/2017/06/repare-secures-68m-series-discover-synthetic-lethal-cancer-drugs/2017-06-22T09:00:25+00:00https://timmermanreport.com/wp-content/uploads/2017/06/lsegal.jpghttps://timmermanreport.com/2017/06/secret-senate-healthcare-overhaul-advances-novartis-nails-cv-study-clovis-cashes-parp-win/2017-06-23T10:34:49+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/biostatementsenate.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/caroline.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/schwabnvca.pnghttps://timmermanreport.com/2017/06/watershed-moments-celgene-bristol-myers-squibb-became-deal-winners/2017-06-26T14:39:38+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/jeremy-levin.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/bassil.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/jdm.jpghttps://timmermanreport.com/2017/06/find-biotech-startup-cash-without-traditional-vcs/2017-06-29T10:43:24+00:00https://timmermanreport.com/wp-content/uploads/2017/06/CHubbert-e1498678944331.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/briangallagher.jpghttps://timmermanreport.com/2017/06/mercks-cv-surprise-fda-clamors-generics-amgen-illuminas-precision-medicine-win/2017-06-30T09:45:05+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/sachs.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/datadiarrhea.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/andycara.pnghttps://timmermanreport.com/wp-content/uploads/2017/06/keytrudatweet.pnghttps://timmermanreport.com/2017/07/think-drug-best-class-world-changes/2017-07-05T10:40:54+00:00https://timmermanreport.com/wp-content/uploads/2017/07/Nagesh.jpghttps://timmermanreport.com/2017/07/konicas-precision-medicine-power-play-endo-yanks-opioid-celgenes-pd-1-foray/2017-07-07T10:24:26+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2017/07/allergan-ceo-brent-saunders-reflects-year-business-social-contract/2017-07-10T10:30:08+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/09/saunders.jpghttps://timmermanreport.com/2017/07/single-cloned-microbe-orchestrate-immune-system-evelo-gets-50m-test-concept/2017-07-11T04:01:38+00:00https://timmermanreport.com/wp-content/uploads/2017/07/simba.pnghttps://timmermanreport.com/wp-content/uploads/2017/07/krishna-yeshwant.jpghttps://timmermanreport.com/2017/07/novartis-big-car-t-moment-amicus-exits-fda-penalty-box-evelos-bold-50m-microbiome-play/2017-07-14T16:51:15+00:00https://timmermanreport.com/wp-content/uploads/2017/07/rtntweets.pnghttps://timmermanreport.com/wp-content/uploads/2017/07/gottliebgenerics.pnghttps://timmermanreport.com/2017/07/whither-experts-review-death-expertise-thoughts-biopharma/2017-07-31T10:26:31+00:00https://timmermanreport.com/wp-content/uploads/2017/07/deathofexpertise.jpghttps://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2017/07/macarthurtweet.pnghttps://timmermanreport.com/2017/07/family-offices-quietly-putting-money-work-biotech-startups/2017-07-19T19:42:59+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2017/07/vertexs-grand-slam-cf-puma-stretches-price-sarepta-biomarin-bury-hatchet/2017-07-21T09:56:17+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/07/shorts.pnghttps://timmermanreport.com/wp-content/uploads/2017/07/geniuses.pnghttps://timmermanreport.com/wp-content/uploads/2017/07/pumatweets.jpghttps://timmermanreport.com/2017/07/agios-neurocrine-striving-mature-hold-onto-souls/2017-07-24T10:15:04+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/07/schenkein.jpghttps://timmermanreport.com/2017/08/grail-plucks-low-hanging-fruit-egenesis-creates-perv-free-pigs-roivant-raises-1b/2017-08-11T10:09:44+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/brookings.jpghttps://timmermanreport.com/2017/08/manage-biotech-information-think-widely-deeply/2017-08-17T18:17:30+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2016/02/tcoles.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/team-j-owens-v4.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/vix.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/Bruce-Booth-Web-Bio.jpghttps://timmermanreport.com/2017/08/price-seat-table/2017-08-17T19:28:17+00:00https://timmermanreport.com/wp-content/uploads/2017/04/sholtzman.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/jeremy-levin.pnghttps://timmermanreport.com/2017/08/8680/2017-08-18T10:27:27+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/mrkstatement.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/colestweet.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/chartweets.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/2017-08-21T10:39:12+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottcollins.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/fdatwitter.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottslavitt.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottsharfstein.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottsharpless.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottcompound.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottcures.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottcaliff.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottprice.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottsharf.jpghttps://timmermanreport.com/wp-content/uploads/2017/08/gotthatch.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottgrassley.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/gottcaliffshar.pnghttps://timmermanreport.com/2017/08/adamas-wins-parkinsons-drug-approval-genmab-soars-amgen-defends-pcsk9-price/2017-08-25T15:42:21+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/genmab.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/darzalexsales.pnghttps://timmermanreport.com/2017/08/getting-precision-medicine-complicated/2017-08-28T16:39:16+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/wp-content/uploads/2017/08/cdxtable.jpghttps://timmermanreport.com/2017/08/gilead-can-play-win-car-t-next-decade/2017-08-31T23:26:23+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/rosenberg-steven-2.jpghttps://timmermanreport.com/2017/09/novartis-historic-car-t-approval-gilead-kite-megadeal-fda-crackdown-stem-cell-hucksters/2017-09-01T10:22:07+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2017/09/replimune-led-biovex-vets-snags-55m-new-oncolytic-viruses-cancer/2017-09-08T15:01:52+00:00https://timmermanreport.com/wp-content/uploads/2017/09/robcoffin.jpghttps://timmermanreport.com/2017/09/gritstone-grabs-93m-doubling-personalized-neoantigen-cancer-vaccines/2017-09-08T15:02:38+00:00https://timmermanreport.com/wp-content/uploads/2017/06/aallen.jpghttps://timmermanreport.com/wp-content/uploads/2015/06/disis.jpghttps://timmermanreport.com/2017/09/allergans-tribal-patent-switcheroo-cellectis-alnylam-see-trial-deaths-execs-defend-dreamers/2017-09-08T21:42:47+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/09/entreps.pnghttps://timmermanreport.com/2017/09/corporate-vcs-get-rewarded-rewarded/2017-09-12T01:08:34+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/06/BG-photo-Oct-2014.jpghttps://timmermanreport.com/wp-content/uploads/2017/03/JulieSunderland.jpghttps://timmermanreport.com/wp-content/uploads/2015/05/jpapanek.pnghttps://timmermanreport.com/2017/08/can-follow-charlottesville/2017-09-14T00:57:35+00:00https://timmermanreport.com/wp-content/uploads/2017/08/sgraham.jpghttps://timmermanreport.com/2017/09/boom-hows-going-big-pharma-vets-startups/2017-09-18T20:06:03+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2017/09/alnylam-gets-hump-venter-accused-running-boys-club-biosimilar-avastin-arrives/2017-09-22T16:14:52+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/09/biosims.pnghttps://timmermanreport.com/2017/09/socializing-hours-biotech-runs-open/2017-09-25T18:35:04+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/08/Bruce-Booth-Web-Bio.jpghttps://timmermanreport.com/wp-content/uploads/2017/09/struex.jpghttps://timmermanreport.com/wp-content/uploads/2017/09/hopkins.jpghttps://timmermanreport.com/wp-content/uploads/2017/09/rtb2017.jpghttps://timmermanreport.com/2017/09/long-run-ep-2-editas-medicine-ceo-katrine-bosley/2017-09-27T10:09:33+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/09/katrine-bosley.jpghttps://timmermanreport.com/2017/10/ksq-scores-76m-lures-meeker-crispr-dream-high-confidence-drug-development/2017-10-02T11:00:49+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/05/meeker.jpghttps://timmermanreport.com/2017/10/nimbus-rinses-repeats-entices-celgene-immunology-drug-candidates/2017-10-03T11:30:16+00:00https://timmermanreport.com/wp-content/uploads/2017/10/donnicholson.jpghttps://timmermanreport.com/2017/10/ipo-market-finds-rhythm-fda-huddles-ftc-pricing-praluent-gets-stay/2017-10-06T10:03:14+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/obamacidara.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/maraganoreprice.pnghttps://timmermanreport.com/2017/10/alzheimers-rd-go-now-plenty-directions/2017-10-09T17:05:41+00:00https://timmermanreport.com/wp-content/uploads/2017/10/Steven-Paul-1.jpghttps://timmermanreport.com/wp-content/uploads/2016/12/johnalam.pnghttps://timmermanreport.com/2017/10/spark-gene-therapy-sails-thru-adcomm-broad-institute-nuzzles-deerfield-pfizers-cancer-deal-africa/2017-10-13T15:43:01+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/oncemeg.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/frieden.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/maris.pnghttps://timmermanreport.com/2017/10/exclusive-illumina-ventures-rakes-230m-fund-declares-independence-parent-mostly/2017-10-16T10:21:01+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/naclerio.pnghttps://timmermanreport.com/2017/10/vc-briefs-geminis-42m-precision-dry-eye-mission-bios-10m-single-cell-analysis/2017-10-17T11:00:07+00:00https://timmermanreport.com/2017/10/vir-biotechnology-shock-awe-startup-bets-infectious-disease-500m/2017-10-18T18:20:51+00:00https://timmermanreport.com/wp-content/uploads/2017/10/GeorgeScangos.jpghttps://timmermanreport.com/wp-content/uploads/2015/04/robert\_nelsen2.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/CHubbert-e1498678944331.jpghttps://timmermanreport.com/2017/10/gileads-thrilling-car-t-victory-celgenes-agonizing-crohns-defeat-vir-goes-big/2017-10-20T17:04:49+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/boothcelg.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/armstrong.pnghttps://timmermanreport.com/2017/10/biomarin-history-contains-rare-insight-rare-disease-business/2017-10-23T19:53:07+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/rarebreed.jpghttps://timmermanreport.com/2017/10/abbvie-shells-205m-upfront-rights-two-alector-alzheimers-targets/2017-10-24T11:00:34+00:00https://timmermanreport.com/wp-content/uploads/2017/10/arnon.pnghttps://timmermanreport.com/2017/10/activist-fda-boss-zeroes-opioid-crisis-ptc-shot-crispr-2-0-buzz/2017-10-27T10:09:08+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/gottliebpassage.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/califfopioid.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/megmis.pnghttps://timmermanreport.com/2017/10/kymera-raises-30m-targeted-protein-degradation-new-modality-stir-imagination/2017-10-30T11:00:25+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/kymeralogo.jpghttps://timmermanreport.com/2017/11/understanding-polio-baseball-cancer-sometimes-vital/2017-11-02T20:26:18+00:00https://timmermanreport.com/wp-content/uploads/2017/11/Boxes-1-2-3.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/adaptive-landscape.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/pitchseq.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/YuDarvishGif.gifhttps://timmermanreport.com/wp-content/uploads/2017/11/missbats.pnghttps://timmermanreport.com/2017/11/amazon-prowling-drug-supply-chain-celgenes-ho-hum-bounceback-couple-ipos/2017-11-03T14:40:07+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/alnyions.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/junonov3.pnghttps://timmermanreport.com/2017/11/dark-underbelly-startup-fundraising-working-self-doubt-loneliness/2017-11-06T11:29:13+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/underbelly.pnghttps://timmermanreport.com/wp-content/uploads/2017/09/katrine-bosley.jpghttps://timmermanreport.com/wp-content/uploads/2015/04/mgilman1-e1428962932988.jpghttps://timmermanreport.com/2017/11/long-run-podcast-elias-zerhouni-role-immigrants-science/2017-11-09T19:10:51+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/15812\_Zerhouni\_100\_2016.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/biotechshowcasebanner.jpghttps://timmermanreport.com/2017/11/sages-salvo-postpartum-depression-sareptas-two-steps-ahead-barron-jumps-gsk/2017-11-10T11:13:14+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2017/11/oxygen-providing-high-autonomy-ma-model-sign-things-come/2017-11-13T11:19:13+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/aplump.jpghttps://timmermanreport.com/2017/11/former-lilly-exec-lead-hhs-flurry-fda-approvals-gates-bets-100m-alzheimers/2017-11-17T11:38:19+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/bradjack.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/andymaster.pnghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/2017-11-21T11:12:38+00:00https://timmermanreport.com/wp-content/uploads/2017/04/sblackman.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc1.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc11.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc11.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc3.tifhttps://timmermanreport.com/wp-content/uploads/2017/11/sitc4.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc5.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc6.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc7.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc8.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc9.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/sitc10.jpghttps://timmermanreport.com/2017/11/will-great-sex-predator-purge-alter-gender-dynamics-work/2017-11-20T15:12:01+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/nancysimonian.jpghttps://timmermanreport.com/2017/11/female-contraception-health-liberty/2017-11-27T11:28:45+00:00https://timmermanreport.com/wp-content/uploads/2017/04/sholtzman.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/jeremy-levin.pnghttps://timmermanreport.com/2017/11/codiak-aspiring-make-exosome-drugs-cancer-nabs-76m-march-clinic/2017-11-29T12:00:00+00:00https://timmermanreport.com/wp-content/uploads/2017/11/codiak\_Doug\_Williams-2.jpghttps://timmermanreport.com/2017/11/long-run-podcast-steve-holtzman-becoming-biotech-political-activist/2017-11-29T13:00:34+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/sholtzman.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/biotechshowcasebanner.jpghttps://timmermanreport.com/2017/12/foundation-medicine-wins-fda-cms-two-fer-azar-calls-high-drug-prices-biogen-buys-ms-challenger/2017-12-01T11:02:58+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/lisabubble.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/SANOFI\_empoweringLife\_logo\_H-CMJN-e1513400638167.jpghttps://timmermanreport.com/wp-content/uploads/2017/10/5AM-VenturesNew-e1511204213232.jpghttps://timmermanreport.com/wp-content/uploads/2017/10/Sofinnova-logo-2016-e1511024831616.jpghttps://timmermanreport.com/wp-content/uploads/2017/10/EBDsm-e1510070774128.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/2017-12-06T11:11:02+00:00https://timmermanreport.com/wp-content/uploads/2017/04/sblackman.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/samsitc1.tifhttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc1.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc2.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc4.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc5.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc6.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc7.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc8.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc9.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc10.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc11.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc12.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc13.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc14.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc15.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc16.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc17.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc18.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc19.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc20.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc21.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc22.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc23.tifhttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc24.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/blacksitc25.jpghttps://timmermanreport.com/2017/12/obsidian-therapeutics-gets-49-5m-bring-car-t-dosing-control/2017-12-06T11:15:07+00:00https://timmermanreport.com/wp-content/uploads/2015/04/mgilman1-e1428962932988.jpghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/2017-12-06T17:28:34+00:00https://timmermanreport.com/wp-content/uploads/2017/12/mitfig1.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/mitfig5.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/mitfig2.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/Figure-3-1.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/mitfig4.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/Ashvin-Bashyam-headshot.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/Jacob-Becraft-headshot.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/Yu-Ja-Huang-headshot.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/Annie-Yu-headshot.jpghttps://timmermanreport.com/2017/12/sage-crushes-depression-trial-sparks-hemophilia-tour-de-force-cvs-aetna-megadeal/2017-12-08T13:44:34+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/moresage.pnghttps://timmermanreport.com/2017/12/biotechs-test-root-tax-windfall-support-next-generation-scientists/2017-12-11T17:51:41+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/12/taxplan.pnghttps://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0083.jpghttps://timmermanreport.com/wp-content/uploads/2017/11/Ashvin-Bashyam-headshot.jpghttps://timmermanreport.com/2017/12/accelerator-backed-corporate-vcs-spreads-wings-not-boston-sf/2017-12-13T13:37:48+00:00https://timmermanreport.com/wp-content/uploads/2017/12/Funding\_Clusters\_Mar2017.jpghttps://timmermanreport.com/wp-content/uploads/2014/12/Thong-Le.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/mohler.pnghttps://timmermanreport.com/2017/12/a16z-rakes-new-450m-fund-bet-bringing-engineering-biology/2017-12-14T11:00:18+00:00https://timmermanreport.com/wp-content/uploads/2017/12/vijay\_pande3.jpghttps://timmermanreport.com/wp-content/uploads/2017/12/jorge-conde-e1506726522541.pnghttps://timmermanreport.com/2017/12/walk-talk-powell-street-everest-training-jpm18/2017-12-18T11:17:49+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2017/11/nancysimonian.jpghttps://timmermanreport.com/2017/12/five-things-think-know-happiness/2017-12-20T11:41:53+00:00https://timmermanreport.com/wp-content/uploads/2017/12/robperez1.pnghttps://timmermanreport.com/2017/12/biomarin-make-long-run-podcast-daniel-levine-dan-maher/2017-12-21T11:58:30+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/10/rarebreed.jpghttps://timmermanreport.com/2018/01/finding-path-biotech-vc-long-run-podcast-bob/2018-01-03T11:15:33+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/bobmore-e1497476431914.jpghttps://timmermanreport.com/2018/01/scholar-rock-year-pause-snags-47m-take-new-tack-sma/2018-01-03T19:24:36+00:00https://timmermanreport.com/wp-content/uploads/2017/07/Nagesh.jpghttps://timmermanreport.com/2018/01/microsoft-makes-nine-figure-bet-adaptives-tcr-antigen-map-biontech-hauls-270m-10-drug-cancer-pipeline/2018-01-04T13:00:04+00:00https://timmermanreport.com/wp-content/uploads/2015/01/harlan-robins\_2.jpghttps://timmermanreport.com/wp-content/uploads/2018/01/Sean-Marett\_web.jpghttps://timmermanreport.com/2018/01/spark-sets-850k-bar-microsofts-bet-ai-immune-mapping-ton-vc-deals/2018-01-05T20:50:44+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/megwells.pnghttps://timmermanreport.com/2018/01/celgene-buys-impact-1-1b-upfront-regeneron-rounds-60m-friends-uk-biobank-pfizer-drops-neuro-pre-jpm18-roundup/2018-01-08T13:40:02+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/grainger.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/nobhill1.jpghttps://timmermanreport.com/2018/01/getting-seat-table-long-run-podcast-abbie-celniker/2018-01-17T11:26:52+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/01/acelniker.jpghttps://timmermanreport.com/2018/01/reverse-engineering-o-bispecifics-autoimmunity-pandion-snags-58m/2018-01-18T12:00:19+00:00https://timmermanreport.com/wp-content/uploads/2018/01/acoyle.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/jviney.pnghttps://timmermanreport.com/2018/01/celgenes-rumored-juno-bid-hospitals-shoot-generic-drugmakers-keytruda-hits-phase-iii/2018-01-19T11:52:26+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/nikhil.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/crls.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/wilson.pnghttps://timmermanreport.com/2018/01/levering-junes-o-team-penn-tmunity-fetches-100m-gilead-parker-ping/2018-01-23T16:33:26+00:00https://timmermanreport.com/wp-content/uploads/2018/01/azam.jpghttps://timmermanreport.com/2018/01/celgene-pulls-trigger-juno-azar-confirmed-half-hearted-gene-editing/2018-01-26T11:16:33+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/herper.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/moregeneediting.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/adamsolid.jpghttps://timmermanreport.com/2018/01/state-laws-zero-rising-drug-costs/2018-01-30T11:30:18+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/wp-content/uploads/2018/01/leorat1.jpghttps://timmermanreport.com/wp-content/uploads/2018/01/leorat2-e1517260140606.jpghttps://timmermanreport.com/wp-content/uploads/2018/01/leorat3.jpghttps://timmermanreport.com/wp-content/uploads/2018/01/leorat4.jpghttps://timmermanreport.com/2018/02/amazon-sizes-healthcare-beast-vertex-raises-bar-cf-moderna-hauls-another-500m/2018-02-02T11:49:35+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/02/andygtx.pnghttps://timmermanreport.com/wp-content/uploads/2018/02/bradearnings.pnghttps://timmermanreport.com/2018/02/bms-makes-case-tmb-express-scripts-sees-drug-price-slowdown-theravance-pockets-100m/2018-02-09T11:18:35+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/02/karlin.pnghttps://timmermanreport.com/wp-content/uploads/2018/02/gildhcv.pnghttps://timmermanreport.com/wp-content/uploads/2018/02/suennen.pnghttps://timmermanreport.com/2018/02/looking-glass-phewas/2018-02-20T11:17:41+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2018/02/gileads-latest-car-t-domino-takedas-deal-spree-mercks-oncolytics-bet/2018-02-23T11:24:46+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2018/02/henri-termeer-tribute-uplifting-idea-tumultuous-time/2018-02-26T11:24:46+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2018/02/termeer.jpghttps://timmermanreport.com/2018/02/matching-technology-people-bruce-booth-long-run-podcast/2018-02-28T11:04:03+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/08/Bruce-Booth-Web-Bio.jpghttps://timmermanreport.com/wp-content/uploads/2018/02/BES18\_Banners\_msg2\_600x200.jpghttps://timmermanreport.com/2018/03/celgene-drops-ball-flurry-vc-deals-frontpoints/2018-03-02T11:53:10+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2018/02/genentech-celgene-orbimed-5am-dont-miss-seattle-cancer-summit-mar-5/2018-03-04T01:54:44+00:00https://timmermanreport.com/wp-content/uploads/2018/02/Rob-Hershberg\_202.jpghttps://timmermanreport.com/wp-content/uploads/2017/03/JulieSunderland.jpghttps://timmermanreport.com/wp-content/uploads/2018/02/shendure.jpghttps://timmermanreport.com/2018/03/getting-precision-medicine-io-combinations-even-complicated/2018-03-05T11:27:33+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2018/03/shkreli-goes-to-jail-holmes-gets-fined-gilead-cso-exits-with-barely-a-peep/2018-03-16T10:17:25+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/03/aveytweet.pnghttps://timmermanreport.com/wp-content/uploads/2018/03/tobaccotweet.jpghttps://timmermanreport.com/2018/03/rock-dj-scientist-entrepreneur-michael-gilman-long-run-podcast/2018-03-18T17:13:33+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2015/04/mgilman1-e1428962932988.jpghttps://timmermanreport.com/2018/03/tcr2-therapeutics-grabs-125m-to-take-tcr-therapies-sans-hla-screens-to-the-clinic/2018-03-21T12:00:59+00:00https://timmermanreport.com/wp-content/uploads/2018/03/garrymenzel.jpghttps://timmermanreport.com/2018/03/the-data-privacy-wake-up-abbvies-5-8b-whiff-and-a-regeneron-alnylam-alliance/2018-03-23T10:17:42+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2018/04/challenges-in-creating-and-distributing-mobile-health-tools-qa-with-dr-heather-evans-of-mpower/2018-04-06T10:17:49+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2018/04/heather-evans.jpghttps://timmermanreport.com/2018/04/the-immune-sequencing-frontier-harlan-and-chad-robins-on-the-long-run/2018-04-11T21:31:16+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2015/01/harlan-robins\_2.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/Chad\_Robins\_CEO\_2015a-e1459985386206.jpghttps://timmermanreport.com/2018/04/harnessing-what-was-there-all-along-book-review-of-a-cure-within/2018-04-20T10:17:59+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2018/03/curewithindiagram.pnghttps://timmermanreport.com/2018/04/kineta-and-genentech-team-up-to-combat-chronic-pain/2018-04-16T15:38:17+00:00https://timmermanreport.com/wp-content/uploads/2015/01/kyleserikawa.jpghttps://timmermanreport.com/2018/05/luna-dna-brings-blockchain-and-genomics-together/2018-05-04T10:17:16+00:00https://timmermanreport.com/wp-content/uploads/2018/03/timhay-pic.jpghttps://timmermanreport.com/wp-content/uploads/2018/05/Dawn-Barry-President-and-Co-founder-Luna-DNA-e1525421604375.pnghttps://timmermanreport.com/2018/05/charting-his-own-entrepreneurial-course-ethan-perlstein-on-the-long-run-podcast/2018-05-09T10:17:48+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/03/Ethan-Perlstein-1000x500px-v3.jpghttps://timmermanreport.com/2018/05/start-of-a-drug-a-fortuitous-collaboration-part-1-of-3/2018-05-25T05:37:09+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2018/05/cells-exploding.jpghttps://timmermanreport.com/2018/05/start-of-a-drug-blueprint-for-building-a-bridge-across-valley-of-death-part-2-of-3/2018-05-29T16:52:49+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2018/05/confocal-image.jpghttps://timmermanreport.com/wp-content/uploads/2018/05/compound-90.jpghttps://timmermanreport.com/2018/06/start-of-a-drug-square-pegs-round-indications/2018-06-01T15:37:37+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2018/06/blazing-a-trail-with-high-tech-treatments-of-the-future/2018-06-05T17:55:27+00:00https://timmermanreport.com/wp-content/uploads/2018/03/timhay-pic.jpghttps://timmermanreport.com/wp-content/uploads/2018/06/Corey-McCann-Color-Headshot.pnghttps://timmermanreport.com/2018/06/bio18-reflections-axovant-and-ophthotech-reboot-with-gene-therapy-more/2018-06-08T10:17:44+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/06/sibold.jpghttps://timmermanreport.com/wp-content/uploads/2018/06/tcells.pnghttps://timmermanreport.com/2018/06/eha18-preview-blood-drugs-to-watch-in-stockholm/2018-06-13T10:12:04+00:00https://timmermanreport.com/wp-content/uploads/2018/06/celg18stock.pnghttps://timmermanreport.com/2017/02/hiring-women-execs-biotech-vc-firms-moneyball-play-part-1-getting-better-returns/2018-06-13T19:18:35+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/frangraphs.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/femalefounders.pnghttps://timmermanreport.com/2018/06/bluebird-gene-therapy-holding-up-crispr-gyrations-and-a-clever-antibiotic-business-idea/2018-06-15T10:00:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/06/blue1.pnghttps://timmermanreport.com/wp-content/uploads/2018/06/blue2.pnghttps://timmermanreport.com/wp-content/uploads/2018/06/sage164.pnghttps://timmermanreport.com/wp-content/uploads/2018/06/lazarus.pnghttps://timmermanreport.com/2018/06/impact-on-the-world-in-more-ways-than-one-tony-coles-on-the-long-run-podcast/2018-06-21T17:06:58+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/06/tonycoles.jpghttps://timmermanreport.com/2018/06/sareptas-stunner-summer-ipo-wave-and-a-white-house-plan-to-clip-wings-at-fda/2018-06-22T10:17:47+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/06/maiztweet.pnghttps://timmermanreport.com/wp-content/uploads/2018/06/skortweet.pnghttps://timmermanreport.com/2018/06/how-are-biotechs-big-name-vcs-performing-not-as-well-as-you-may-think/2018-06-27T15:44:47+00:00https://timmermanreport.com/2015/07/even-in-a-boom-biotech-vcs-fail-to-deliver-positive-cash-returns/2018-06-27T22:41:14+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2018/06/how-are-biotech-vc-funds-performing-see-data-from-six-state-pension-funds/2018-06-28T10:17:11+00:00https://timmermanreport.com/2018/06/amazons-online-pharmacy-chess-move-and-the-pre-holiday-ipo-wave-continues/2018-06-29T10:17:20+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/06/bijanamzn.pnghttps://timmermanreport.com/2018/06/so-you-want-to-get-into-biotechpart-2-banana-peel-what-banana-peel/2018-07-02T21:41:33+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2018/06/chris\_larson-8449.jpghttps://timmermanreport.com/wp-content/uploads/2018/06/irenai.jpghttps://timmermanreport.com/wp-content/uploads/2018/06/C-Thut-headshot.jpghttps://timmermanreport.com/wp-content/uploads/2018/06/jeffreid.pnghttps://timmermanreport.com/2018/06/so-you-want-to-get-into-biotechpart-1-many-stories-many-paths/2018-07-02T22:04:07+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2018/03/Ethan-Perlstein-1000x500px-v3.jpghttps://timmermanreport.com/wp-content/uploads/2017/04/sblackman.jpghttps://timmermanreport.com/wp-content/uploads/2018/06/laura-strong.jpghttps://timmermanreport.com/2018/07/epipen-rival-gets-a-lift-summer-price-increases-bayer-doubles-down-on-broad/2018-07-06T10:17:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/07/brucebigelow.pnghttps://timmermanreport.com/2017/05/former-sarepta-ceo-gets-15m-hedge-fund-startup-incubator/2018-07-09T17:22:47+00:00https://timmermanreport.com/wp-content/uploads/2017/05/cgarabedian.jpghttps://timmermanreport.com/2018/07/novartis-bails-on-antibiotics-acceleron-goes-2-for-2-grail-ceo-assembles-her-team/2018-07-13T10:17:43+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/07/vrtxletter.pnghttps://timmermanreport.com/2018/07/hotspot-therapeutics-raises-45m-to-follow-in-nimbus-footsteps-creating-allosteric-binders/2018-07-17T11:00:35+00:00https://timmermanreport.com/wp-content/uploads/2018/07/jonathan-montagu.jpghttps://timmermanreport.com/wp-content/uploads/2018/07/geraldine-harriman.jpghttps://timmermanreport.com/2018/07/novartis-merck-back-off-on-prices-rubius-leads-ipo-charge-crispr-stocks-rattled/2018-07-20T10:17:00+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/07/azar.pnghttps://timmermanreport.com/2018/07/alector-staying-private-for-now-pulls-in-133m-for-alzheimers-rd/2018-07-25T11:00:02+00:00https://timmermanreport.com/wp-content/uploads/2018/07/sabahoney.jpghttps://timmermanreport.com/2018/07/an-alzheimers-hope-fest-gsk-cozies-up-to-23andme-a-gilead-legend-steps-aside/2018-07-27T10:17:11+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/07/andybiib.pnghttps://timmermanreport.com/2018/07/verana-backed-by-gv-brook-byers-grabs-30m-to-squeeze-meaning-out-of-emrs/2018-08-01T00:27:58+00:00https://timmermanreport.com/wp-content/uploads/2018/07/mikikapoor.jpghttps://timmermanreport.com/wp-content/uploads/2017/03/JulieSunderland.jpghttps://timmermanreport.com/2018/08/beigenes-cash-haul-illuminas-big-q2-startups-keep-hiring-pharma-vets/2018-08-03T10:17:03+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2018/08/5am-nea-lead-50m-bet-on-akouos-crafting-gene-therapy-for-the-ear/2018-08-07T11:00:51+00:00https://timmermanreport.com/wp-content/uploads/2018/02/Kush\_131444-cropped-2-175x197.jpghttps://timmermanreport.com/wp-content/uploads/2018/08/SimonsEJ\_Headshot.jpghttps://timmermanreport.com/2018/08/zigging-when-others-zag-speros-ankit-mahadevia-on-the-antibiotic-opportunity/2018-08-08T10:17:21+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2015/03/Ankit\_Mahadevia\_Small\_b-e1426115612339.jpghttps://timmermanreport.com/2018/08/alnylam-crosses-the-threshold-gileads-changing-of-the-guard-gene-therapy-financings-galore/2018-08-21T22:55:07+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/08/gilmangiddy.pnghttps://timmermanreport.com/wp-content/uploads/2018/08/andyshort.pnghttps://timmermanreport.com/2018/08/building-startups-with-pharma-needs-in-mind-thong-le-on-the-long-run-podcast/2018-08-22T10:17:57+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2014/12/Thong-Le.jpghttps://timmermanreport.com/2018/08/time-and-money-what-are-they-worth-to-a-young-scientist/2018-08-28T10:17:16+00:00https://timmermanreport.com/wp-content/uploads/2017/01/Boaz-Vilozny\_Headshot\_w500p.pnghttps://timmermanreport.com/wp-content/uploads/2018/08/bluelinechart.jpghttps://timmermanreport.com/wp-content/uploads/2018/08/retirementchart.jpghttps://timmermanreport.com/2018/08/exact-goes-from-madison-wis-to-madison-ave-a-couple-of-ipo-candidates-get-in-line/2018-08-24T10:17:28+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2018/09/telling-biotech-stories-on-tv-listen-to-meg-tirrell-on-the-long-run-podcast/2018-09-05T13:28:11+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/08/megtirrell.jpghttps://timmermanreport.com/2018/09/health-data-that-can-meet-pharma-standards-amy-abernethy-on-the-long-run/2018-09-19T10:17:38+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/09/Amy-headshot\_2018.jpghttps://timmermanreport.com/2018/10/overcoming-a-bad-job-market-finding-a-path-in-biotech-sabah-oney-on-the-long-run/2018-10-03T10:17:47+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/07/sabahoney.jpghttps://timmermanreport.com/2018/03/whats-better-curing-cancer-preventing/2018-10-15T20:49:34+00:00https://timmermanreport.com/wp-content/uploads/2018/03/slyman.jpghttps://timmermanreport.com/wp-content/uploads/2018/03/Stewart\_HPV-03-650.pnghttps://timmermanreport.com/2018/10/making-it-easy-to-share-biological-data-john-wilbanks-on-the-long-run-podcast/2018-10-17T10:17:45+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/10/wilbanks2018.jpghttps://timmermanreport.com/2015/11/pursuing-a-hard-cancer-target-qa-with-warp-drive-ceo-laurence-reid/2018-10-17T17:12:20+00:00https://timmermanreport.com/wp-content/uploads/2015/11/lreid.pnghttps://timmermanreport.com/2018/10/nine-vcs-who-matter-but-you-never-read-about/2018-10-30T10:17:46+00:00https://timmermanreport.com/wp-content/uploads/2018/10/BTS\_BANNER\_1080x300.jpghttps://timmermanreport.com/2018/11/investing-at-the-nexus-of-biology-technology-julie-sunderland-of-biomatics-on-the-long-run/2018-11-14T19:00:51+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/11/Julie-Sunderland-Headshot.jpghttps://timmermanreport.com/2018/11/china-biotech-six-things-to-watch-in-2019/2018-11-15T11:17:53+00:00https://timmermanreport.com/2018/09/fulcrum-gets-80m-to-test-small-molecules-against-rare-disorders-of-gene-expression/2018-11-21T14:20:37+00:00https://timmermanreport.com/wp-content/uploads/2018/09/gould.jpghttps://timmermanreport.com/2018/11/sage-postpartum-depression-drug-passes-scrutiny-blavatniks-200m-beneficence-a-novartis-pricing-trial-balloon/2018-11-21T14:22:24+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/11/alnylamchart.pnghttps://timmermanreport.com/wp-content/uploads/2018/11/pd1sales.pnghttps://timmermanreport.com/2018/11/illumina-takes-out-pacbio-abbvies-pre-emptive-price-cut-hhs-drug-pricing-go-to-guy-dies/2018-11-21T14:22:39+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/11/clive.pnghttps://timmermanreport.com/wp-content/uploads/2018/11/esperionchart.pnghttps://timmermanreport.com/2018/10/amgens-price-cut-biogen-eisai-alzheimers-whiff-a-new-osteoarthritis-drug/2018-11-21T14:22:53+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/10/diamond.pnghttps://timmermanreport.com/wp-content/uploads/2018/10/ban2401.jpghttps://timmermanreport.com/wp-content/uploads/2018/10/ban2401slide.jpghttps://timmermanreport.com/2018/10/novartis-2b-takeover-of-endocyte-revolution-warp-drive-amgens-foray-in-dna-sequencing/2018-11-21T14:23:05+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2015/11/lreid.pnghttps://timmermanreport.com/wp-content/uploads/2015/03/mgoldsmith.pnghttps://timmermanreport.com/2018/10/abbvie-plunks-down-100m-upfront-for-morphics-oral-integrin-inhibitors-for-fibrosis/2018-11-21T14:23:34+00:00https://timmermanreport.com/wp-content/uploads/2018/10/Praveen-crop-medium.jpghttps://timmermanreport.com/wp-content/uploads/2015/04/mgilman1-e1428962932988.jpghttps://timmermanreport.com/2018/10/allogenes-megabucks-ipo-cvs-aetna-muscling-through-consumer-genetics-in-the-mainstream/2018-11-21T14:23:57+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/10/generictrend.pnghttps://timmermanreport.com/wp-content/uploads/2018/10/andy1.pnghttps://timmermanreport.com/wp-content/uploads/2018/10/andy2.pnghttps://timmermanreport.com/wp-content/uploads/2018/10/andy3.pnghttps://timmermanreport.com/2018/10/the-mit-biotech-group-alumni-where-are-they-now/2018-11-21T14:24:09+00:00https://timmermanreport.com/wp-content/uploads/2018/10/jamesweis.jpghttps://timmermanreport.com/2018/09/jj-dumps-geron-roches-pd-l1-practice-changer-and-amarins-fish-oil-surprise/2018-11-21T14:24:35+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/09/west1.pnghttps://timmermanreport.com/wp-content/uploads/2018/09/west2.pnghttps://timmermanreport.com/wp-content/uploads/2018/09/amarin.pnghttps://timmermanreport.com/wp-content/uploads/2018/09/slavitt.pnghttps://timmermanreport.com/wp-content/uploads/2018/09/shaysarah.pnghttps://timmermanreport.com/2018/09/wuxi-eyes-a-fresh-1b-california-aims-at-abbvie-and-msks-industry-ties-in-the-spotlight/2018-11-21T14:25:05+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2018/09/baselga-brouhaha-a-shkreli-imitator-and-autoimmunity-strides-from-bms-and-gilead/2018-11-21T14:25:16+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2018/11/modernas-mega-ipo-plan-abbvie-nails-hcv-svb-takes-out-leerink/2018-11-21T14:28:38+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/11/tobacco.pnghttps://timmermanreport.com/wp-content/uploads/2018/11/morrison.pnghttps://timmermanreport.com/2018/10/nobel-highlights-and-lowlights-msk-fallout-continues-pfizer-ceo-stepping-down/2018-11-21T14:30:30+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/10/garthwaite.pnghttps://timmermanreport.com/wp-content/uploads/2018/10/chentweet.pnghttps://timmermanreport.com/wp-content/uploads/2018/10/boothpeople.pnghttps://timmermanreport.com/2018/11/extending-human-healthspan-ned-david-of-unity-biotech-on-the-long-run/2018-11-29T03:02:20+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/11/Nathaniel-David-color.jpghttps://timmermanreport.com/2018/11/crispr-babies-irelands-bold-genomics-move-and-a-flurry-of-fda-approvals/2018-11-30T11:03:03+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2018/12/23andme-the-burden-of-knowledge-and-the-real-value-of-money/2018-12-07T11:02:58+00:00https://timmermanreport.com/wp-content/uploads/2018/12/kyletweet1.pnghttps://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/kyletweet2.pnghttps://timmermanreport.com/2018/12/osi-veterans-and-versant-ventures-unveil-startup-to-fight-allosteric-resistance-mutations-in-cancer/2018-12-11T14:30:43+00:00https://timmermanreport.com/wp-content/uploads/2018/12/davidmepstein.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/alexmayweg.jpghttps://timmermanreport.com/2018/12/allens-125m-bet-on-immunology-gileads-new-ceo-insulin-price-gouging-scrutiny/2018-12-14T11:16:19+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/bumol.pnghttps://timmermanreport.com/2018/12/versant-ventures-reloads-with-700m-for-early-stage-biotech/2018-12-17T14:26:26+00:00https://timmermanreport.com/wp-content/uploads/2018/12/bolzon.jpghttps://timmermanreport.com/wp-content/uploads/2018/12/woiwode.jpghttps://timmermanreport.com/2018/12/abernethy-goes-to-fda-relays-monster-round-gileads-boston-shopping-spree/2018-12-21T13:00:54+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2019/01/hurricane-lantus-the-storm-that-will-finally-force-pharma-to-take-cost-effectiveness-and-budgetary-impact-seriously/2019-01-02T16:58:04+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2019/01/medicares-car-t-wreck/2019-01-03T13:37:21+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2019/01/bms-celgene-megamerger-verily-pockets-1b-and-abbvies-wager-on-cd39/2019-01-05T04:09:19+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/datweet.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/datweet2.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/datweet3.pnghttps://timmermanreport.com/2019/01/adaptive-genentechs-tcr-strategy-archs-new-cell-therapy-co-esperions-rich-eu-deal/2019-01-07T05:54:07+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2019/01/lilly-buys-loxo-baselga-resurfaces-and-bluebirds-gene-therapy-payment-plan/2019-01-11T11:02:57+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/azartweet.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/andysurvival.pnghttps://timmermanreport.com/2019/01/big-money-for-glaring-global-health-needs-george-scangos-on-the-long-run/2019-01-16T11:16:10+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/10/GeorgeScangos.jpghttps://timmermanreport.com/2019/01/house-dems-hunt-pharma-big-game-shutdown-woes-jpm-reflections/2019-01-18T11:14:32+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/steensma.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/steensma2.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/steensma3.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/steensma4.pnghttps://timmermanreport.com/2019/01/genentech-ceo-in-editas-ceo-out-the-shutdown-ipo/2019-01-25T11:19:46+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/01/kaplan.pnghttps://timmermanreport.com/2019/02/meet-the-full-kilimanjaro-climb-to-fight-cancer-team/2019-02-07T11:09:03+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Kili\_700x330.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_02.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_04.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_06.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_08.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_10.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_12.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_14.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_16.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_adamgridley2.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_18.jpghttps://timmermanreport.com/wp-content/gallery/testimonials/thumbs/thumbs\_testimonial\_20.jpghttps://timmermanreport.com/wp-content/gallery/shuksan2020/thumbs/thumbs\_IMG\_1197.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_billnewell.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_Bob-More1.pnghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_bradbury\_dan-57\_v0211.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_D.-Smith.pnghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_garrym.jpghttps://timmermanreport.com/wp-content/gallery/shuksan2020/thumbs/thumbs\_IMG\_1198.jpghttps://timmermanreport.com/wp-content/gallery/shuksan2020/thumbs/thumbs\_IMG\_1204.jpghttps://timmermanreport.com/wp-content/gallery/shuksan2020/thumbs/thumbs\_IMG\_1211.JPGhttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_Heidi\_Hagen\_2018\_v2-1.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_julia-owens-v4.pnghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_KBosley-headshot-2.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_KellyOBrien2.pnghttps://timmermanreport.com/wp-content/gallery/shuksan2020/thumbs/thumbs\_IMG\_1212.jpghttps://timmermanreport.com/wp-content/gallery/shuksan2020/thumbs/thumbs\_IMG\_1214.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_alice.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_artkrieg.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_KirstenAxelsen.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_Kristin-Anderson2.pnghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_LesleyStolz.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_lukeSquare2.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_nancymillerrich.JPGhttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_Dave-Melville\_02.pnghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_bowdish.PNGhttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_Nina-Kjellson.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_Praveen-crop-medium.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_Sanford-Zweifach.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_senthil.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_Erin\_Duffy.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_jebkeiper.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_huber.PNGhttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_Simba-Gill.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_Spencer-Guthrie-headshot.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_ucianescarlett.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_zbarry.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_johnalam.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_juliaowens.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_katrine.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_alecmore.pnghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_heatherb.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_peterfaroni.JPGhttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_nhong.jpghttps://timmermanreport.com/wp-content/gallery/kilifull/thumbs/thumbs\_kenbrunt.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_samtruex.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_fambrough2.PNGhttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_biondi1.PNGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_67441434\_10219962301752538\_228618648149819392\_n.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Team-Climb-to-Fight-Kili.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2143.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2146.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2175.JPGhttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_alex.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_art.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_chipclark.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2182.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2204.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2229.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2231.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2235.JPGhttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_bernatolle.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_amandabanks.pnghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_Dave-Melville\_02.pnghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2246.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2264.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2266.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2373.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2386.JPGhttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_dougfambrough.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_joshthornton.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_kandersen.pnghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC2387.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC02674.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC02684.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC02726.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_DSC02728.JPGhttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_lalo.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_Murcko-Mark-1.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_Nina-Kjellson.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_LT1.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_LT3.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_LT7.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_LT10.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_LT11.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_parag.pnghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_suehager.pnghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_UScarlett-2.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_mostafa.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_LT12.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Photo-Jul-24-4-54-35-AM.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Shira-Camp-Dance-Party-Day-1-8.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Shira-Camp-Dance-Party-Day-1-6.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Shira-Camp-Dance-Party-Day-1-7.JPGhttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_ginger.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_jens.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_jeff.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Shira-Camp-Dance-Party-Day-1-14.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Shira-Camp-Dance-Party-Day-1-16.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Shira-Camp-Dance-Party-Day-1-23.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Shira-Camp-Dance-Party-Day-1-24.JPGhttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Kili-Banner-1.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_joanne.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_kamal.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_laurie.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Photo-Jul-25-12-24-58-AM.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Above-the-Clouds.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Baranco-Wall-Kilimanjaro-July-2019.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_Kilimanjaro.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_IMG\_20190722\_135709703.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_nathan.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_nerissa.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_ram.jpghttps://timmermanreport.com/wp-content/gallery/kiligallery/thumbs/thumbs\_LT17.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_BW-Headshot\_French-Anna.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_abe-ceesay-45-cropped-768x768.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_deb-square-new-2.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_harding.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_katherineandersen.PNGhttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_ramani.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_saul.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_wendy.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_lukeSquare2.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2021/thumbs/thumbs\_VineetaAgarwala-400x400.jpghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_svb-logo-box-rgb.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_Faber-Logo.jpghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_5am\_RGB\_COLOR\_BLU-01.pnghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_brian.jpghttps://timmermanreport.com/wp-content/gallery/kili2023/thumbs/thumbs\_bharatt.pnghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_samtruex.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_UScarlett-2.jpghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_Atlas-Logo-2015-Icon-Type.jpghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_BainCapital\_Life-Sciences\_H\_rgb.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_cbre.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_Dicerna.jpghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_King-St.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_kandersen.pnghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_art.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_hamid.jpghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_MassBioLogo\_Color.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_Qiming.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_PRIMARY-CROPPED-e1617928610495.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_Browne-Consulting-Group-scaled.jpghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_Foley-Hoag.pnghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_kaye.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_kaja.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_ted.jpghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_lightstonepng.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_crlpng.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_RACap\_ID\_Blue\_NoTag.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_sr-one.pnghttps://timmermanreport.com/wp-content/gallery/traverse-sponsors/thumbs/thumbs\_1AB-Green-1.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_sandra.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_lydia.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_schenkein.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_IMG\_3189.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_IMG\_3277.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_IMG\_80941.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_IMG\_3278.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_IMG\_3377.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_heath.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_ben.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_june.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_IMG\_3360.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_IMG\_3252.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_IMG\_3226.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_IMG\_3148.jpghttps://timmermanreport.com/wp-content/gallery/ebc22/thumbs/thumbs\_ebc10.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_Tim-Springer.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_yael.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_andrea.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_bonnie-anderson-2021.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_Deb-Palestrant\_Final\_2021.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse2022/thumbs/thumbs\_Julie-Sunderland.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_raju.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_lalo.jpghttps://timmermanreport.com/wp-content/gallery/timmermantraverse23/thumbs/thumbs\_sheila.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5709.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5707.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5718.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5712.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5748.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5738.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5739.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5751.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5727.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5731.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5784.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5794.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5788.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5786.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5675.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5692.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5676.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5681.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_IMG\_5690.jpghttps://timmermanreport.com/wp-content/gallery/ttdrcrf24/thumbs/thumbs\_ShiraCamp2024.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_046.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_036.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_062.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_035.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_057.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_066.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_068.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_071.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_075.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_079.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_092.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_093.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_095.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_096.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_106.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_109.jpghttps://timmermanreport.com/wp-content/gallery/tr10east/thumbs/thumbs\_20250306\_TR10\_110.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-205.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-239.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-551.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_bwatts.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_lbain.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_ajohnston.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-226.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-263.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-315.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-370.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-379.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_bsundaresh.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_alaporte.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_bscruggs.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-390.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-483.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-525.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-529.jpghttps://timmermanreport.com/wp-content/gallery/tr10west/thumbs/thumbs\_tr10-west-coast-party-13mar25-550.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_coconnor.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_csabatospeyton.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_efischer.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_hturner.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_hwan.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_jcassidy.pnghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_kkamdar.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_lmifflin.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_malexander.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_mgutbrod.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_mlanger.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_swarren.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_sspencer.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_ttribble.jpghttps://timmermanreport.com/wp-content/gallery/kili26/thumbs/thumbs\_cgibson.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_zbarry.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_ucianescarlett.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_Simba-Gill.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_Sanford-Zweifach.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_Praveen-crop-medium.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_Nina-Kjellson.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_nancymillerrich.JPGhttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_lukeSquare2.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_LesleyStolz.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_Kristin-Anderson2.pnghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_KirstenAxelsen.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_KellyOBrien2.pnghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_Heidi\_Hagen\_2018\_v2-1.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_garrym.jpghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_Bob-More1.pnghttps://timmermanreport.com/wp-content/gallery/kiliteam19/thumbs/thumbs\_billnewell.jpghttps://timmermanreport.com/2019/02/azar-angles-for-a-deal-pharma-can-live-with-macrogenics-big-break-sanofi-scraps-38-rd-programs/2019-02-08T11:17:04+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/02/ReedAruba.jpghttps://timmermanreport.com/2019/02/the-immune-sequencing-frontier-take-2-harlan-and-chad-robins-on-the-long-run/2019-02-13T23:59:58+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2015/01/harlan-robins\_2.jpghttps://timmermanreport.com/wp-content/uploads/2016/04/Chad\_Robins\_CEO\_2015a-e1459985386206.jpghttps://timmermanreport.com/2019/02/the-pcsk9-price-cut-jj-depression-drug-passes-test-gileads-nash-strikeout/2019-02-15T11:24:37+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/02/jessica.pnghttps://timmermanreport.com/2019/02/staying-resilient-finding-a-way-forward-julia-owens-on-the-long-run/2019-02-27T19:48:41+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/team-j-owens-v4.pnghttps://timmermanreport.com/2019/03/the-biotech-industry-can-help-address-the-opioid-crisis-but-we-arent-doing-enough/2019-03-05T12:30:02+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2019/02/third-rock-arch-join-forces-lead-191m-bet-on-maze-and-gene-modifiers/2019-02-28T12:00:44+00:00https://timmermanreport.com/wp-content/uploads/2019/02/chomcy.jpghttps://timmermanreport.com/2019/03/pharma-dodges-senate-bullet-roche-pays-4-8b-for-spark-bms-celgene-deal-wobbles/2019-03-01T14:36:56+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/02/2281.pnghttps://timmermanreport.com/wp-content/uploads/2019/02/2282.pnghttps://timmermanreport.com/wp-content/uploads/2019/02/2283.pnghttps://timmermanreport.com/wp-content/uploads/2019/02/2284.pnghttps://timmermanreport.com/2019/03/beam-therapeutics-pushing-the-edges-in-base-editing-raises-135m/2019-03-06T12:00:33+00:00https://timmermanreport.com/wp-content/uploads/2019/03/john-evans.jpghttps://timmermanreport.com/2019/03/gottlieb-exits-biogens-big-gene-therapy-buy-and-lillys-pre-emptive-price-cut/2019-03-08T01:31:52+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2019/03/seeing-lots-of-single-cells-up-close-serge-saxonov-of-10x-genomics-on-the-long-run/2019-03-13T13:56:47+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/03/serge-saxonov-1.jpghttps://timmermanreport.com/2019/03/sharpless-in-the-saddle-nih-threatened-again-pbms-prep-for-senate-scrutiny/2019-03-15T01:09:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/03/front1.pnghttps://timmermanreport.com/wp-content/uploads/2019/03/front2.pnghttps://timmermanreport.com/wp-content/uploads/2019/03/front3.pnghttps://timmermanreport.com/2019/03/ai-drug-discovery-starts-to-come-of-age-as-it-aims-for-the-clinic/2019-03-19T02:20:15+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/03/aheifets.jpghttps://timmermanreport.com/wp-content/uploads/2019/03/barzilay.jpghttps://timmermanreport.com/2019/03/sages-depression-triumph-biogens-alzheimers-defeat-apple-watch-hype/2019-03-22T06:22:29+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2019/03/researchers-look-to-the-immune-system-after-relentless-alzheimers-failures/2019-03-25T10:14:39+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2018/07/sabahoney.jpghttps://timmermanreport.com/wp-content/uploads/2019/03/caseylynch.jpghttps://timmermanreport.com/2019/03/postmortem-5-lessons-learned-from-a-public-benefit-rare-disease-startup/2019-03-28T10:10:49+00:00https://timmermanreport.com/wp-content/uploads/2018/03/Ethan-Perlstein-1000x500px-v3.jpghttps://timmermanreport.com/2019/03/life-of-a-scientific-entrepreneur-bob-langer-of-mit-on-the-long-run/2019-03-27T02:26:00+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/03/Langer\_Photo\_courtesy.jpghttps://timmermanreport.com/2019/03/thermo-bets-on-viral-vector-manufacturing-precision-genfits-ipos-not-much-else/2019-03-28T23:20:43+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/03/bobmoretweet.pnghttps://timmermanreport.com/2019/04/the-abcs-and-ds-of-changing-medicare-drug-policy/2019-04-04T13:29:09+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2019/04/mit-project-alpha-aiming-to-give-early-biopharma-investors-better-odds/2019-04-16T11:01:37+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/04/andrewlo.jpghttps://timmermanreport.com/2019/04/foundation-flatiron-cross-the-genotype-phenotype-chasm-show-clinical-cancer-genome-database-at-work/2019-04-15T23:37:49+00:00https://timmermanreport.com/wp-content/uploads/2019/04/flatiron\_vineeta\_agarwala.jpghttps://timmermanreport.com/wp-content/uploads/2019/04/FMI\_GauravS\_portrait\_01v2\_dotcom.jpghttps://timmermanreport.com/2019/04/3-lessons-for-success-in-research-reflections-from-aacr-2019/2019-04-23T10:29:31+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Kristin-Anderson2.pnghttps://timmermanreport.com/wp-content/uploads/2019/04/phdcomics.jpghttps://timmermanreport.com/2019/04/the-gut-microbiome-modifies-immuno-oncology-response-suggesting-ways-to-accelerate-activity/2019-04-22T10:30:52+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/04/Chris\_S\_Final\_web.jpghttps://timmermanreport.com/wp-content/uploads/2019/04/bernat.jpghttps://timmermanreport.com/2019/04/membraneless-organelles-offer-new-drug-discovery-opportunities/2019-04-29T18:14:36+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AM-head-shot.jpghttps://timmermanreport.com/wp-content/uploads/2019/04/tonyhyman.jpghttps://timmermanreport.com/wp-content/uploads/2019/04/amir-nashat\_2017\_polaris.jpghttps://timmermanreport.com/2019/04/ifm-nails-second-big-deal-selling-nlrp3-inhibitors-to-novartis-for-310m-upfront/2019-05-01T02:07:26+00:00https://timmermanreport.com/wp-content/uploads/2019/03/Mar-07-2018-Genzyme-Cancer-Summit-0046.jpghttps://timmermanreport.com/wp-content/uploads/2019/03/garyglick.jpghttps://timmermanreport.com/2019/05/investing-from-the-heart-to-find-new-als-therapies/2019-05-06T10:43:26+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2019/05/thank-you-biotech-kili-climb-to-fight-has-crushed-its-1m-goal-for-cancer-research/2019-05-08T18:05:28+00:00https://timmermanreport.com/2019/05/an-elephant-for-immunology-drug-development-sheila-gujrathi-on-the-long-run/2019-05-09T00:57:25+00:00https://timmermanreport.com/wp-content/uploads/2019/05/shelia-gujrathi.jpghttps://timmermanreport.com/2019/05/livlyme-and-the-many-hats-of-patient-advocacy-organizations/2019-05-13T12:43:42+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2019/05/amgen-swings-for-the-ras-fence-gileads-grilling-on-price-agios-enlarges-the-pie/2019-05-16T23:50:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/05/sachs.jpghttps://timmermanreport.com/wp-content/uploads/2019/05/miller.pnghttps://timmermanreport.com/2019/05/pain-drug-development-flounders-in-the-opioid-crisis-but-novel-mechanisms-emerging/2019-05-20T16:28:26+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/05/ericelenko.jpghttps://timmermanreport.com/2019/05/baseball-comes-to-surprise-medical-billing/2019-05-28T11:30:54+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2019/05/organs-on-a-chip-organoids-start-to-deliver-results-as-an-alternative-preclinical-route/2019-05-31T11:30:47+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/05/doningber.jpghttps://timmermanreport.com/wp-content/uploads/2018/12/geraldine.jpghttps://timmermanreport.com/2019/05/third-rock-and-friends-bet-110m-on-thrive-a-hopkins-born-cancer-screening-startup/2019-06-01T14:02:48+00:00https://timmermanreport.com/wp-content/uploads/2019/05/clengauer.jpghttps://timmermanreport.com/wp-content/uploads/2019/05/skafka.jpghttps://timmermanreport.com/2019/06/predicting-who-will-benefit-from-cancer-drugs-liz-oday-on-the-long-run/2019-06-13T04:18:39+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/06/eoday.jpghttps://timmermanreport.com/2019/06/who-will-be-the-next-celgene-of-dealmaking-vcs-entrepreneurs-size-up-partners/2019-06-16T18:09:25+00:00https://timmermanreport.com/wp-content/uploads/2019/06/bpa19.jpghttps://timmermanreport.com/2019/06/pfizers-wager-on-small-molecules-summer-ipo-flurries-gileads-protein-degrader-play/2019-06-20T23:01:09+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2019/06/just-because-you-can-doesnt-mean-you-should-gene-therapy-is-not-the-solution-to-every-problem/2019-06-24T13:39:15+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2019/06/abbvie-allergan-mash-up-adaptive-headlines-ipo-rush-fda-cops-on-the-beat/2019-06-27T23:25:12+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2019/07/cancer-survivor-and-cancer-drug-developer-laura-shawver-on-the-long-run/2019-07-02T21:59:14+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/07/laura-shawver.jpghttps://timmermanreport.com/2019/07/biontech-snags-320m-roche-spark-delay-summer-job-switches/2019-07-11T21:04:24+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/07/midyearhikes.pnghttps://timmermanreport.com/2019/07/better-cancer-treatment-through-better-information-cindy-perettie-on-the-long-run/2019-07-11T21:12:40+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/07/cperettie.jpghttps://timmermanreport.com/2019/07/as-cancer-immunotherapy-booms-biomarkers-re-emerge-to-guide-treatment/2019-07-16T12:45:25+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/07/LaVallee\_Theresa\_2x2\_web.pnghttps://timmermanreport.com/wp-content/uploads/2019/07/johnwherry.pnghttps://timmermanreport.com/2019/07/crispr-boosts-animal-models-making-preclinical-research-more-efficient/2019-07-23T12:45:51+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/07/kalinichenko-vladimir.jpghttps://timmermanreport.com/wp-content/uploads/2019/07/Kevin-Holden-1.jpghttps://timmermanreport.com/2019/08/executive-shortages-pose-challenge-to-biotech-growth-prospects/2019-08-12T10:45:38+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AM-head-shot.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/toft\_robin-18TG245fxHi-1030x687.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/asherfig1.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/asherfig2.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/Formela\_WB640x536.jpghttps://timmermanreport.com/2019/08/novartis-no-no-bayer-buys-bluerock-and-job-switches-galore/2019-08-12T21:31:26+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/jacob.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/brad1.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/sharpless1.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/sharpless2.pnghttps://timmermanreport.com/2019/08/roche-genentechs-clever-ntkr-strategy-regenerons-ebola-win-pcr-pioneer-passes/2019-08-16T14:32:06+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/collins.jpghttps://timmermanreport.com/2019/08/autoimmunity-research-paves-the-way-for-new-ideas-in-halting-preventing-type-1-diabetes/2019-08-27T10:23:56+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/jessicadunne.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/Jeff-Bluestone\_2x2\_2017\_web.pnghttps://timmermanreport.com/2019/08/getting-in-on-the-ground-floor-of-the-biotech-boom-joel-marcus-on-the-long-run/2019-08-20T20:22:06+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/JoelMarcus.jpghttps://timmermanreport.com/2019/08/as-car-t-ranks-expand-industry-scrambles-to-solve-long-standing-manufacturing-challenges/2019-08-21T17:05:25+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/MitchFinal2large-v5-retinex-v1.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/Tim-Moore-768x815.jpghttps://timmermanreport.com/2019/08/bio-leaders-defend-immigrants-sareptas-smackdown-pfizer-bets-500m-on-nc/2019-08-22T22:37:48+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/chandra.pnghttps://timmermanreport.com/2019/08/amgen-antes-up-for-otezla-abbvie-does-the-obvious-an-sirna-nails-pcsk9/2019-08-29T21:56:34+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/sek1.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/sek2.pnghttps://timmermanreport.com/2019/09/hot-job-market-creates-challenges-for-companies-opens-doors-for-workers/2019-09-10T10:33:13+00:00https://timmermanreport.com/wp-content/uploads/2019/08/adamthomas.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/tomcarey.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/erinlanciati.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/ginger.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/robsurdel.jpghttps://timmermanreport.com/2019/09/dr-jekyll-and-mr-pharma-bro-coping-with-my-split-personality/2019-09-03T16:50:01+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2019/09/making-a-difference-for-sickle-cell-disease-ted-love-on-the-long-run/2019-09-04T10:28:59+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/09/tedlove-e1567531583823.jpghttps://timmermanreport.com/2019/09/vertexs-bet-on-type-1-diabetes-azs-type-2-diabetes-cv-outcomes-win-fda-commish-speculation/2019-09-06T03:06:17+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/09/billn.pnghttps://timmermanreport.com/wp-content/uploads/2019/09/charley.pnghttps://timmermanreport.com/2019/09/10x-pops-on-ipo-day-amgens-kras-drug-tantalizes-lillys-ret-drug-impresses/2019-09-14T21:53:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2019/09/a-nonprofit-that-carried-a-tb-drug-through-the-fda-bruce-carter-on-the-long-run/2019-09-18T02:58:36+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/09/BruceCarter.jpghttps://timmermanreport.com/2019/09/speaker-pelosis-envisioned-drug-price-clampdown-lundbecks-move-into-migraine-diabetes-drug-device-pairings/2019-09-19T23:39:07+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/09/boothtweet.pnghttps://timmermanreport.com/2019/09/big-ipo-week-on-deck-amazon-walmart-health-moves-akcea-exec-shakeup/2019-09-27T14:19:28+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/09/lisatweet.pnghttps://timmermanreport.com/2019/10/from-farm-field-to-mit-lab-phil-sharp-on-the-long-run/2019-10-01T19:22:36+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/10/PhilSharp.jpghttps://timmermanreport.com/wp-content/uploads/2019/09/PPD-Biotech-Logo.pnghttps://timmermanreport.com/2019/10/esmo-wrap-a-twitchy-ipo-market-novartis-picks-microsoft-for-ai-help/2019-10-03T23:48:22+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2019/10/12-vcs-who-matter-but-you-hardly-ever-read-about/2019-10-09T20:06:45+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Biotech-Showcase-January-13-15-2020-2.jpghttps://timmermanreport.com/2019/10/ucbs-2b-bet-on-rare-disease-biontechs-ipo-haircut-greenwood-eases-out-the-door/2019-10-11T15:38:58+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2019/10/turning-synthetic-biology-into-living-drugs-synlogics-aoife-brennan-on-the-long-run/2019-10-16T17:25:25+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/10/aoifebrennan.jpghttps://timmermanreport.com/wp-content/uploads/2019/09/PPD-Biotech-Logo.pnghttps://timmermanreport.com/2019/10/reata-booms-alexion-buys-achillion-teva-drops-the-ball-big-time/2019-10-18T02:08:06+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/10/reatashares.jpghttps://timmermanreport.com/wp-content/uploads/2019/10/mnk.jpghttps://timmermanreport.com/2019/10/biotechs-film-making-exec-behind-jim-allison-breakthrough/2019-10-21T19:33:45+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AM-head-shot.jpghttps://timmermanreport.com/wp-content/uploads/2019/10/billhaney.jpghttps://timmermanreport.com/2019/10/vertexs-watershed-for-cf-biogens-head-scratcher-and-seattle-genetics-nails-her2climb/2019-10-25T00:59:32+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/10/coughlin.pnghttps://timmermanreport.com/wp-content/uploads/2019/10/brad2.pnghttps://timmermanreport.com/2019/10/early-cancer-screening-is-proving-itself-in-the-clinic-but-what-will-it-mean-for-drug-developers/2019-10-28T22:48:52+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/10/helmy.jpghttps://timmermanreport.com/wp-content/uploads/2019/10/Paul\_600x600\_0.jpghttps://timmermanreport.com/2019/10/the-story-of-henri-termeer-john-hawkins-and-jim-geraghty-on-the-long-run/2019-10-29T21:01:18+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/10/John-Hawkins-final.jpghttps://timmermanreport.com/wp-content/uploads/2019/10/jimgeraghty.jpghttps://timmermanreport.com/wp-content/uploads/2019/09/PPD-Biotech-Logo.pnghttps://timmermanreport.com/2019/10/amgens-bet-on-beigene-david-hungs-megaround-zolgensma-speed-bump/2019-11-01T03:29:12+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/10/mrtx.pnghttps://timmermanreport.com/wp-content/uploads/2019/10/bradkey.pnghttps://timmermanreport.com/wp-content/uploads/2019/10/ali.pnghttps://timmermanreport.com/2019/11/newer-gene-editing-candidates-target-blood-disorders-as-gene-therapies-start-to-hit-the-market/2019-11-04T22:31:18+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/samkulkarni.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/jason-fontenot.jpghttps://timmermanreport.com/2019/11/takedas-busy-week-halozymes-stumble-and-new-fda-commish-on-deck/2019-11-08T01:42:14+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/regn.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/andyp.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/bobc.pnghttps://timmermanreport.com/2019/11/dont-pull-back-on-basic-biology-for-psychiatry-its-time-to-double-down/2019-11-12T11:25:06+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2019/11/mercks-ebola-vaccine-triumph-weills-106m-neurohub-tevas-reversal/2019-11-15T02:08:15+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/tevastatement.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/andyamarin.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/andyamarin2.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/davidnektar.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/sldbchart.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/daphnetweet.pnghttps://timmermanreport.com/2019/11/feeding-frenzy-the-ecosystem-is-growing-stronger/2019-11-19T14:58:04+00:00https://timmermanreport.com/wp-content/uploads/2019/11/claythorp.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/benscruggs.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/clay1.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/clay2.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/clay3.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/clay4.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/clay5.pnghttps://timmermanreport.com/wp-content/uploads/2019/11/clay6.pnghttps://timmermanreport.com/2019/11/running-the-kras-marathon-with-wellspring-and-visualizing-a-second-half-kick/2019-11-19T21:42:47+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AM-head-shot.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/troy\_wilson\_34v03.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/kevanshokat.jpghttps://timmermanreport.com/2019/11/tamping-down-inflammation-synaptic-dysfunction-in-alzheimers-john-alam-on-the-long-run/2019-11-27T00:06:12+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2016/12/johnalam.pnghttps://timmermanreport.com/wp-content/uploads/2019/09/PPD-Biotech-Logo.pnghttps://timmermanreport.com/2019/12/ifm-staying-small-raises-merely-55-5m-promotes-former-novartis-exec-to-ceo/2019-12-02T20:15:44+00:00https://timmermanreport.com/wp-content/uploads/2019/12/martinsiedel.jpghttps://timmermanreport.com/wp-content/uploads/2019/03/garyglick.jpghttps://timmermanreport.com/2020/01/hbv-curative-treatments-gear-up-in-the-clinic-as-hcv-combos-help-to-guide-the-way/2020-01-02T13:39:39+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/12/jamesmerson.jpghttps://timmermanreport.com/wp-content/uploads/2019/06/clarion\_navy-gray-logotag\_stacked\_hi-res-transparent.pnghttps://timmermanreport.com/wp-content/uploads/2019/12/PhilPang.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/zhihong.jpghttps://timmermanreport.com/2020/01/weve-been-neglecting-common-diseases-we-need-to-reverse-this-trend/2020-01-07T11:09:47+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2020/01/three-lessons-for-business-ahead-of-jpm-from-the-kilimanjaro-climb-to-fight-cancer/2020-01-06T19:17:33+00:00https://timmermanreport.com/wp-content/uploads/2017/06/team-j-owens-v4.pnghttps://timmermanreport.com/wp-content/uploads/2020/01/LT1.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/juliakili1.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/selfcare.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/juliakilisummit.jpghttps://timmermanreport.com/2019/12/biotechs-build-on-single-cell-analytics-for-drug-rd-as-human-cell-atlas-is-mapped/2020-01-08T16:27:14+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2019/12/AvivRegev.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/bio\_liangschweizer.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/ben-hindson-1.jpghttps://timmermanreport.com/2020/01/mrna-vaccines-impress-blueprint-wins-first-fda-ok-calif-gov-stares-down-biotech-on-the-eve-of-jpm20/2020-01-10T03:41:56+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2020/01/GOPR0032-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/GOPR0038-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/GOPR0084-scaled.jpghttps://timmermanreport.com/2020/01/eqrx-taps-zeitgeist-raises-200m-for-innovative-drugs-at-aggressive-low-prices/2020-01-13T01:20:20+00:00https://timmermanreport.com/wp-content/uploads/2020/01/Alexis-Borisy-EQRX-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/Melanie-Nallicheri-EQRX-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2017/07/krishna-yeshwant.jpghttps://timmermanreport.com/2020/01/a-new-cholesterol-lowering-drug-at-a-low-price-tim-mayleben-on-the-long-run/2020-01-14T02:14:44+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/Tim-Mayleben.jpghttps://timmermanreport.com/2020/01/lillys-half-measure-on-insulin-illuminas-up-market-play-the-little-deals-from-sf/2020-01-17T00:38:31+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2020/01/schenkeintweet.jpghttps://timmermanreport.com/2020/01/seeking-to-understand-dr-kings-vision-of-unity-at-our-divided-moment/2020-01-21T23:13:28+00:00https://timmermanreport.com/wp-content/uploads/2017/12/robperez1.pnghttps://timmermanreport.com/2018/12/relay-therapeutics-hauls-in-400m-to-push-frontier-in-computational-drug-discovery/2020-01-22T18:37:19+00:00https://timmermanreport.com/wp-content/uploads/2018/12/sanjiv-patel.jpghttps://timmermanreport.com/wp-content/uploads/2018/12/borisy.jpghttps://timmermanreport.com/wp-content/uploads/2015/01/oleg1.pnghttps://timmermanreport.com/2020/01/scientists-at-the-movies-relay-therapeutics-ceo-sanjiv-patel-on-the-long-run/2020-01-27T18:45:02+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/12/sanjiv-patel.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/precisionnanosystems.jpghttps://timmermanreport.com/2020/02/first-buy-then-invest-novartis-gilead-join-35m-bet-on-vinetis-software/2020-02-05T12:30:32+00:00https://timmermanreport.com/wp-content/uploads/2020/02/amyduross.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/Nina-Kjellson.jpghttps://timmermanreport.com/2020/02/car-t-for-autoimmunity-bluestone-joins-sonoma-biotherapeutics-a-40m-bet/2020-02-06T08:00:49+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Jeff-Bluestone\_2x2\_2017\_web.pnghttps://timmermanreport.com/2020/02/putting-the-pieces-together-for-programmable-cell-therapy-jane-grogan-on-the-long-run/2020-02-11T23:21:49+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/02/janegrogan.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/precisionnanosystems.jpghttps://timmermanreport.com/2020/02/automation-and-miniaturization-are-upon-us-gritstones-mission-to-make-personalized-medicines/2020-02-13T01:25:40+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/2020/02/lilly-genentech-alzheimers-drugs-fail-revolutions-big-ipo-an-obesity-drug-disappears/2020-02-14T00:24:32+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2020/02/crltweet.pnghttps://timmermanreport.com/2020/02/dissecting-biotechs-living-and-walking-dead/2020-02-24T18:59:58+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AM-head-shot.jpghttps://timmermanreport.com/wp-content/uploads/2020/02/paul-godfrey.jpghttps://timmermanreport.com/wp-content/uploads/2020/02/tania-bubela.img\_.-331395875.pnghttps://timmermanreport.com/wp-content/uploads/2020/02/asherdead1.pnghttps://timmermanreport.com/2020/02/facing-up-to-a-political-crisis-bio-chairman-jeremy-levin-on-the-long-run/2020-02-25T03:40:32+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/01/jeremy-levin.pnghttps://timmermanreport.com/2020/03/agbt-2020-recap-partying-like-its-1999-for-good-reason/2020-03-03T11:06:38+00:00https://timmermanreport.com/wp-content/uploads/2020/02/DeannaInscripta\_20190426123759-scaled.jpghttps://timmermanreport.com/2020/03/reconceiving-the-value-of-curative-therapies/2020-03-06T14:32:31+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2020/02/as-a-scientist-you-have-a-duty-to-speak-up-as-the-2020-election-nears/2020-03-12T19:26:15+00:00https://timmermanreport.com/wp-content/uploads/2020/02/JessicaSagers.pnghttps://timmermanreport.com/2020/03/solid-tumors-have-eluded-car-t-but-novel-targets-and-techniques-are-at-hand/2020-03-17T22:20:45+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/azam.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/RobertNew.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/xichen.jpghttps://timmermanreport.com/2020/03/knowledge-is-power-dont-give-up-on-diagnostic-tests-for-covid19/2020-03-29T15:33:07+00:00https://timmermanreport.com/wp-content/uploads/2020/03/mikepellinis32.pnghttps://timmermanreport.com/2020/03/as-covid19-comes-to-india-expect-drug-supplies-to-run-short/2020-03-30T12:32:35+00:00https://timmermanreport.com/wp-content/uploads/2019/09/BruceCarter.jpghttps://timmermanreport.com/2020/03/dos-and-donts-of-staying-connected-in-the-time-of-physical-distancing/2020-03-30T12:33:19+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Nina-Kjellson.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/rainbow.jpghttps://timmermanreport.com/2020/03/we-interrupt-this-nightmare-to-bring-you-a-few-giggles/2020-03-30T12:34:30+00:00https://timmermanreport.com/wp-content/uploads/2020/03/Lisa-Suennen-headshot-mts.jpeghttps://timmermanreport.com/2020/03/unsung-heroes-who-give-me-hope/2020-03-30T12:34:57+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Bob-More1-1.pnghttps://timmermanreport.com/2020/03/a-surge-of-gratitude-from-a-doctor-on-the-front-lines-of-covid-19-in-boston/2020-03-30T12:35:09+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2020/03/what-not-to-do-lessons-from-spains-cavalier-response-to-covid-19/2020-03-30T12:35:25+00:00https://timmermanreport.com/wp-content/uploads/2019/04/bernat.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/covid19curveMar24.pnghttps://timmermanreport.com/2020/03/staying-mentally-healthy-to-weather-the-covid19-crisis/2020-03-30T12:36:41+00:00https://timmermanreport.com/wp-content/uploads/2020/03/jefflieberman.jpeghttps://timmermanreport.com/wp-content/uploads/2020/03/lsmayer.jpghttps://timmermanreport.com/2020/03/love-in-the-time-of-coronavirus/2020-03-30T12:37:19+00:00https://timmermanreport.com/wp-content/uploads/2017/03/JulieSunderland.jpghttps://timmermanreport.com/2020/03/stay-home-keep-your-physical-distance-engage-with-partners-who-can-help/2020-03-30T12:37:48+00:00https://timmermanreport.com/wp-content/uploads/2020/03/robperez3.jpghttps://timmermanreport.com/2020/03/covid-19-response-the-roadmap-not-followed/2020-03-30T12:38:07+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2020/03/the-biopharmaceutical-counterattack/2020-03-30T12:38:28+00:00https://timmermanreport.com/wp-content/uploads/2020/03/jeremy\_levin\_005.jpghttps://timmermanreport.com/2020/03/the-big-story-right-this-second-columbia-pediatrician-and-nyc-nurse-see-catastrophic-shortage-of-ppe/2020-03-30T12:39:15+00:00https://timmermanreport.com/2020/03/cancer-drugmakers-seek-to-broaden-use-of-tissue-agnostic-therapies/2020-03-31T00:20:54+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/BrianAlexander\_portrait\_800x800\_1\_.jpghttps://timmermanreport.com/wp-content/uploads/2018/12/davidmepstein.pnghttps://timmermanreport.com/2020/03/learning-from-china-ramping-up-covid19-tests-to-meet-needs-around-the-world/2020-03-31T17:08:32+00:00https://timmermanreport.com/wp-content/uploads/2020/03/kheim1.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/group-photo-leaving-train-station-Wuhan.jpghttps://timmermanreport.com/2020/03/switzerland-what-went-right-and-how-to-better-prepare-for-the-second-wave/2020-03-31T17:48:13+00:00https://timmermanreport.com/wp-content/uploads/2020/03/alexm.jpghttps://timmermanreport.com/2020/03/the-strategy-of-stealth-mode-when-to-stay-hidden-when-to-de-cloak/2020-04-01T13:22:48+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AM-head-shot.jpghttps://timmermanreport.com/wp-content/uploads/2019/03/john-evans.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/avak.jpghttps://timmermanreport.com/2020/03/pharmacy-as-the-biomarker-of-biopharmas-strategic-change-after-coronavirus/2020-04-01T13:45:11+00:00https://timmermanreport.com/wp-content/uploads/2020/03/JeffBerkowitz-Headshot-e1585260062394.jpghttps://timmermanreport.com/2020/04/thinking-ahead-building-a-broad-arsenal-against-infectious-disease/2020-04-02T00:17:45+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ankit-mahadevia.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/treatmentdays.pnghttps://timmermanreport.com/2020/04/building-on-our-immunology-understanding-seeing-reasons-for-hope/2020-04-02T00:26:23+00:00https://timmermanreport.com/wp-content/uploads/2020/04/dougwilliams.jpghttps://timmermanreport.com/2020/04/covid-19s-unexpected-silver-lining-a-chance-at-redemption-for-us-healthcare/2020-04-02T16:17:47+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2020/04/loss-and-grief-in-the-time-of-covid-19/2020-04-06T20:35:41+00:00https://timmermanreport.com/wp-content/uploads/2020/04/shear-hr.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/lsmayer.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/jefflieberman.jpeghttps://timmermanreport.com/2020/04/where-the-puck-is-going-serologic-testing-for-sars-cov-2-immunity/2020-04-06T21:45:16+00:00https://timmermanreport.com/wp-content/uploads/2020/04/Mike-Koeris-fave1\_small.jpeghttps://timmermanreport.com/2020/04/ive-got-a-fund-full-of-toilet-paper-and-im-ready-to-deal/2020-04-06T22:39:47+00:00https://timmermanreport.com/wp-content/uploads/2020/03/Lisa-Suennen-headshot-mts.jpeghttps://timmermanreport.com/2020/04/rationale-for-testing-anticoagulants-against-covid19/2020-04-07T23:51:20+00:00https://timmermanreport.com/wp-content/uploads/2020/04/eweiss1.jpghttps://timmermanreport.com/2020/04/facing-the-consequences-of-a-misinformation-pandemic/2020-04-08T20:51:00+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/wp-content/uploads/2020/04/fordtweet.pnghttps://timmermanreport.com/2020/04/the-pandemic-an-african-american-point-of-view-on-covid-19/2020-04-14T17:29:40+00:00https://timmermanreport.com/wp-content/uploads/2017/08/stevegraham.jpghttps://timmermanreport.com/2020/04/a-typical-day-for-a-healthcare-investor-and-doctor-peering-into-the-fog/2020-04-15T15:30:49+00:00https://timmermanreport.com/wp-content/uploads/2020/04/davidsable-e1586902485803.jpeghttps://timmermanreport.com/2020/04/drug-repurposing-to-keep-covid19-patients-out-of-the-icu/2020-04-15T19:54:25+00:00https://timmermanreport.com/wp-content/uploads/2020/04/rplenge.pnghttps://timmermanreport.com/2020/04/dont-waste-this-crisis-solving-the-patient-cost-share-problem/2020-04-15T20:45:33+00:00https://timmermanreport.com/wp-content/uploads/2020/03/JeffBerkowitz-Headshot-e1585260062394.jpghttps://timmermanreport.com/2020/04/serology-testing-keep-an-eye-out-for-quick-and-dirty-tests/2020-04-16T23:03:39+00:00https://timmermanreport.com/wp-content/uploads/2020/04/Mike-Koeris-fave1\_small.jpeghttps://timmermanreport.com/wp-content/uploads/2020/04/viralload.jpghttps://timmermanreport.com/2020/04/scaling-up-biotech-drugs-and-vaccines-against-covid19/2020-04-16T23:17:38+00:00https://timmermanreport.com/wp-content/uploads/2020/04/JIm-Thomas.jpghttps://timmermanreport.com/2020/04/cultivating-a-tolerance-for-adversity-in-our-teams-and-our-communities/2020-04-20T13:01:34+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ericmurphy.pnghttps://timmermanreport.com/wp-content/uploads/2020/04/j22-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/LT1.jpghttps://timmermanreport.com/2020/04/massachusetts-biotechs-consider-how-to-return-safely-and-create-a-new-normal/2020-04-23T00:26:08+00:00https://timmermanreport.com/wp-content/uploads/2019/08/adamthomas.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/Kelley\_Boucher.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/erinlanciati.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/Andy\_Dawson\_headshot.jpghttps://timmermanreport.com/2020/04/capturing-family-history-while-we-have-time/2020-04-27T22:36:58+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2020/04/we-didnt-become-the-world-biotech-leader-by-sealing-ourselves-off/2020-04-28T10:24:30+00:00https://timmermanreport.com/wp-content/uploads/2019/04/bernat.jpghttps://timmermanreport.com/2020/04/juggling-all-the-balls-of-an-academic-lab-in-a-pandemic/2020-04-28T13:57:15+00:00https://timmermanreport.com/wp-content/uploads/2020/04/james-olson.jpghttps://timmermanreport.com/2020/05/if-were-smart-covid19-will-strengthen-our-defense-against-drug-resistant-bugs/2020-05-04T19:33:26+00:00https://timmermanreport.com/wp-content/uploads/2020/05/vidya-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/Pottinger\_Paul-scaled.jpghttps://timmermanreport.com/2020/05/beyond-car-t-new-engineered-immune-cell-types-head-to-the-clinic/2020-05-05T10:39:27+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2020/05/klichinsky.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/hastings.jpghttps://timmermanreport.com/2020/05/the-spirit-of-giving-is-more-powerful-than-ever/2020-05-05T10:53:23+00:00https://timmermanreport.com/wp-content/uploads/2020/05/kellypraveen.jpghttps://timmermanreport.com/wp-content/uploads/2018/12/KellyOBrien2.pnghttps://timmermanreport.com/2020/05/extending-an-immune-sequencing-platform-against-the-common-foe/2020-05-06T22:57:43+00:00https://timmermanreport.com/wp-content/uploads/2020/05/crobins\_301\_2019-171x171-1.pnghttps://timmermanreport.com/2020/05/a-master-class-in-science-education-for-the-pandemic/2020-05-11T23:25:54+00:00https://timmermanreport.com/wp-content/uploads/2016/05/krieg.jpghttps://timmermanreport.com/2020/05/biopharma-gets-serious-in-a-hurry-about-virtual-clinical-trials/2020-05-18T10:08:25+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2020/05/aholland.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/breeburks.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/dforman.jpghttps://timmermanreport.com/2020/05/stepping-up-ones-game-pandemic-style/2020-05-19T10:13:12+00:00https://timmermanreport.com/wp-content/uploads/2020/03/Lisa-Suennen-headshot-mts.jpeghttps://timmermanreport.com/wp-content/uploads/2020/05/ccbingo.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/crue.pnghttps://timmermanreport.com/2020/05/creating-leaner-and-meaner-clinical-trials-for-the-long-run/2020-05-21T23:22:51+00:00https://timmermanreport.com/wp-content/uploads/2020/05/CTTI\_Pam\_Tenaerts\_PREFERRED-scaled.jpghttps://timmermanreport.com/2020/05/the-recovery-a-long-road-ahead-for-patients-healthcare-workers-and-hospitals/2020-05-27T10:21:28+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2020/05/we-need-biopharma-to-dig-deep-and-fight-hard-on-inequality-heres-how/2020-06-03T12:55:06+00:00https://timmermanreport.com/wp-content/uploads/2020/03/robperez3.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/mlksilenceoffriends.jpghttps://timmermanreport.com/2020/06/accent-ceo-shakti-narayan-on-targeting-rna-modifying-proteins-for-cancer/2020-06-08T10:06:14+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/shakti.pnghttps://timmermanreport.com/2020/06/complexity-in-motion-multi-omics-tools-make-moves-to-unravel-path-from-genotype-to-phenotype/2020-06-09T10:58:53+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/Richard-Terry-Leadership-1000x1024-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/ben-hindson-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/dr\_parag-mallick-bio-pic-500x500-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/Anup-Parikh-r2.jpghttps://timmermanreport.com/2020/06/atlas-venture-closes-fund-xii-at-400-million-promotes-gladstone-to-partner/2020-06-08T13:05:32+00:00https://timmermanreport.com/wp-content/uploads/2020/06/KJmulam.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/gladstone.jpghttps://timmermanreport.com/2020/06/versant-bets-50m-on-lycia-to-make-protein-degraders-against-extracellular-targets/2020-06-09T12:00:06+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/carolyn\_bio.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/aetna.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/clareozawa.jpghttps://timmermanreport.com/2020/06/making-drugs-at-the-edge-of-reason/2020-06-10T10:03:46+00:00https://timmermanreport.com/wp-content/uploads/2020/06/vickisato.jpghttps://timmermanreport.com/2020/06/a-busy-ipo-calendar-forma-repare-progenity-genetron/2020-06-17T00:28:12+00:00https://timmermanreport.com/wp-content/uploads/2020/06/franklee.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/Lloyd-1-768x768-1.jpghttps://timmermanreport.com/2020/06/dna-sequencing-startups-aim-to-reduce-cost-increase-meaning-in-the-data/2020-06-17T14:46:25+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/roswell.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/jessesalk.jpghttps://timmermanreport.com/2020/06/codiak-scales-up-exosome-capabilities-snags-72-5m-from-sarepta/2020-06-22T12:00:37+00:00https://timmermanreport.com/wp-content/uploads/2020/04/dougwilliams.jpghttps://timmermanreport.com/2020/06/bit-bio-cellular-reprogramming-startup-seeks-to-revamp-ipscs-with-50m/2020-06-24T13:08:44+00:00https://timmermanreport.com/wp-content/uploads/2020/06/kj1.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/Elpis\_MarkK\_500-1.jpghttps://timmermanreport.com/2020/06/lassen-therapeutics-emerges-from-stealth-with-antibody-to-il-11-receptor/2020-06-29T10:12:38+00:00https://timmermanreport.com/wp-content/uploads/2020/06/kj1.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/MarkBarret2.jpghttps://timmermanreport.com/2020/07/simcha-therapeutics-locks-in-25-million-in-series-a-renews-interest-in-il-18/2020-07-02T00:21:13+00:00https://timmermanreport.com/wp-content/uploads/2020/06/kj1.pnghttps://timmermanreport.com/wp-content/uploads/2020/07/ARing-HS.pnghttps://timmermanreport.com/2020/07/the-vintage-of-2020-how-covid-19-is-molding-biotech-startups/2020-07-08T18:50:05+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2020/07/ovid-therapeutics-finds-european-partner-to-advance-treatment-for-rare-neurological-disease/2020-07-13T11:00:41+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/jeremy\_levin\_005.jpghttps://timmermanreport.com/2020/07/next-gen-synthetic-biology-pushes-further-into-drug-discovery-mrna-and-dna-on-the-desktop/2020-07-15T22:07:34+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2020/07/sri.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/tim-brears.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/becraft.jpghttps://timmermanreport.com/2020/06/qa-with-regeneron-svp-david-weinreich-on-therapeutic-neutralizing-antibodies/2020-07-17T15:57:00+00:00https://timmermanreport.com/wp-content/uploads/2020/06/kj1.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/David-Weinreich.jpghttps://timmermanreport.com/2020/07/karuna-therapeutics-innovates-in-schizophrenia-treatment-with-hybrid-drug/2020-07-20T10:26:09+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2017/10/Steven-Paul-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/Breier\_headshot.jpghttps://timmermanreport.com/2020/07/adaptive-trials-pioneered-in-the-us-successfully-implemented-in-the-uk-for-covid-19/2020-07-22T22:00:13+00:00https://timmermanreport.com/wp-content/uploads/2018/12/ucianescarlett.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/ucianefig1.pnghttps://timmermanreport.com/wp-content/uploads/2020/07/ucianefig5.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/ucianefig3.pnghttps://timmermanreport.com/2020/07/seer-raises-55-million-introduces-novel-proteomic-technology/2020-07-24T00:09:09+00:00https://timmermanreport.com/wp-content/uploads/2020/06/kj1.pnghttps://timmermanreport.com/wp-content/uploads/2020/07/omid-forkhzad.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/omeado.jpghttps://timmermanreport.com/2020/08/versant-ventures-wagers-35m-on-cytokine-engineering-with-bright-peak/2020-08-04T09:54:17+00:00https://timmermanreport.com/wp-content/uploads/2020/06/kj1.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/alexm.jpghttps://timmermanreport.com/2020/08/ohana-biosciences-and-sperm-biology-the-other-half-of-the-fertility-equation/2020-08-03T10:15:03+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/amber.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/kathleen-gray.jpghttps://timmermanreport.com/2020/08/akili-interactive-delivers-prescription-level-treatment-via-video-games/2020-08-04T09:27:44+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/EddieMartucci.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/AdamGazzaley.jpghttps://timmermanreport.com/2020/08/generation-bio-blazes-new-trail-in-gene-therapy-with-non-viral-approach/2020-08-06T00:24:25+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/mcdonough.jpghttps://timmermanreport.com/2020/08/gsks-bcma-antibody-gets-ok-biogen-teams-with-denali-a-telemedicine-megadeal/2020-08-07T03:21:31+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/08/springworks-faces-key-readout-for-gamma-secretase-eyes-bcma-combo-for-cancer/2020-08-13T20:45:33+00:00https://timmermanreport.com/wp-content/uploads/2020/06/kj1.pnghttps://timmermanreport.com/wp-content/uploads/2020/08/saqib-islam.pnghttps://timmermanreport.com/2020/08/a-microbiome-turnaround-novavax-gears-up-moderna-commits-to-100m-doses/2020-08-14T01:00:33+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/08/antibiotic-resistance-looms-large-in-pandemic-crispr-phages-show-promise/2020-08-18T20:31:56+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2020/08/Erin\_Duffy.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/LocusBioTeamHeadshots-21-2-e1546367110402.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/Christian\_Groendahl.jpghttps://timmermanreport.com/2020/09/mood-disorder-rd-lacking-innovation-turns-to-psychedelics/2020-09-01T10:09:51+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2020/08/berra\_yazar-klosinski.pnghttps://timmermanreport.com/wp-content/uploads/2020/08/srini.pnghttps://timmermanreport.com/2020/09/beyond-aav-avrobio-and-orchard-take-ex-vivo-approach-to-gene-therapy/2020-09-02T15:55:40+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/bobbygaspar.pnghttps://timmermanreport.com/wp-content/uploads/2020/08/geoff-macKay\_1.pnghttps://timmermanreport.com/2019/01/schrodinger-backed-by-gates-and-wuxi-grabs-85m-for-computational-drug-discovery-qa-with-ceo-ramy-farid/2020-09-08T22:08:53+00:00https://timmermanreport.com/wp-content/uploads/2019/01/farid\_140x140.pnghttps://timmermanreport.com/2020/09/recursion-pulls-in-239m-for-ai-drug-discovery-bayer-bets-on-fibrosis/2020-09-09T11:00:54+00:00https://timmermanreport.com/wp-content/uploads/2020/09/juergen.pnghttps://timmermanreport.com/wp-content/uploads/2020/09/gibson.pnghttps://timmermanreport.com/2020/09/attralus-secures-25m-series-a-to-diagnose-and-treat-amyloidosis/2020-09-14T16:13:33+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/S\_Guthrie-headshot-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/richard-scaled.jpghttps://timmermanreport.com/2017/02/cant-rna-can-arrakis-tests-small-molecules-new-way/2020-09-14T16:39:17+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/04/mgilman1-e1428962932988.jpghttps://timmermanreport.com/2020/09/graphite-bio-secures-45m-series-a-to-advance-targeted-gene-editing-therapy/2020-09-16T12:00:56+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/joshlehrer.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/Porteus\_Matthew.jpghttps://timmermanreport.com/2020/09/designing-hyperstable-minibinders-against-sars-cov-2-qa-with-david-baker/2020-09-22T10:45:53+00:00https://timmermanreport.com/wp-content/uploads/2019/12/david-baker.pnghttps://timmermanreport.com/2020/07/cygnal-therapeutics-zeroes-in-on-unorthodox-peripheral-nervous-system-approach-to-cancer/2020-09-29T23:01:47+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/pearl.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/tcwang.jpghttps://timmermanreport.com/2020/10/rayzebio-snags-45m-to-reimagine-targeted-radiotherapies-for-cancer/2020-10-14T12:00:32+00:00https://timmermanreport.com/wp-content/uploads/2020/10/song.jpghttps://timmermanreport.com/wp-content/uploads/2020/10/Versant\_Team\_Jerrel.jpghttps://timmermanreport.com/2020/10/getting-ready-for-the-next-pandemic-with-a-comprehensive-response/2020-10-20T16:19:09+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ankit-mahadevia.jpghttps://timmermanreport.com/2020/10/corporate-leaders-face-pressure-from-investors-regulators-to-act-on-diversity/2020-10-21T18:21:21+00:00https://timmermanreport.com/wp-content/uploads/2020/06/Karl-Simpson-BIO-headshot2.jpghttps://timmermanreport.com/wp-content/uploads/2020/10/cambriaallen.pnghttps://timmermanreport.com/2020/10/an-especially-inspiring-nobel-prize-and-a-sign-of-more-work-to-do/2020-10-21T18:28:42+00:00https://timmermanreport.com/wp-content/uploads/2020/10/jenadair-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/Barbara\_McClintock\_1902-1992\_shown\_in\_her\_laboratory\_in\_1947.jpghttps://timmermanreport.com/2020/10/learning-from-covid-19-the-lessons-for-real-world-data/2020-10-21T18:29:29+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/09/tech-impact-requires-deep-engagement-with-biopharma-lead-users/2020-10-21T18:30:13+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/Barbara\_McClintock\_1902-1992\_shown\_in\_her\_laboratory\_in\_1947.jpghttps://timmermanreport.com/wp-content/uploads/2017/08/Bruce-Booth-Web-Bio.jpghttps://timmermanreport.com/2020/08/an-underappreciated-aspect-of-power-listening/2020-10-21T18:31:23+00:00https://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/pathtopowerbookshot-e1553888803110.pnghttps://timmermanreport.com/2020/09/how-lunch-with-bill-gates-sr-changed-my-life/2020-10-21T18:32:15+00:00https://timmermanreport.com/wp-content/uploads/2014/12/Thong-Le.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/gatessr.jpghttps://timmermanreport.com/2020/07/closing-medicines-feedback-gap-can-tech-help-integrate-clinical-care-and-clinical-research/2020-10-21T18:36:43+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/mcclellan.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/esserman.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/adlermilstein.jpghttps://timmermanreport.com/2020/07/jill-hagenkords-rags-to-riches-story-reminds-us-why-we-still-admire-entrepreneurs/2020-10-21T18:37:28+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/jillhagenkord.jpghttps://timmermanreport.com/2020/07/clinical-trials-high-value-attack-surface-for-pharmatech-entrepreneurs/2020-10-21T18:38:23+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/07/can-novartis-digitally-transform-clinical-development/2020-10-21T18:39:02+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/vas-narasimhan.jpghttps://timmermanreport.com/2020/06/astrazeneca-opens-its-digital-komono/2020-10-21T18:40:23+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/06/tech-integration-into-pharma-a-report-from-the-front-line/2020-10-21T18:41:08+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/06/digital-natives-and-skilled-operators-weaving-data-science-into-pharma-rd/2020-10-21T18:41:57+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/05/adtech-data-for-health-time-to-get-past-the-ick-factor/2020-10-21T18:42:44+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/05/pharmas-digital-champions-should-focus-on-solving-one-problem-well/2020-10-21T18:43:29+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/05/covid-doctors-navigate-tension-between-individual-autonomy-and-systematized-care/2020-10-21T18:44:47+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/05/randomized-controlled-trials-for-healthcare-delivery-work-now-lets-do-more-at-scale/2020-10-21T18:45:36+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/2020/04/build-back-better/2020-10-21T18:46:20+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/buildbetter.pnghttps://timmermanreport.com/2020/04/george-yancopoulos-that-rarest-of-species-a-physician-scientist-still-in-charge-of-a-pharma/2020-10-21T18:47:07+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/giamatti-scaled.jpghttps://timmermanreport.com/2020/09/covid-19-diagnostic-testing-needs-to-be-open-not-closed/2020-10-21T18:47:38+00:00https://timmermanreport.com/wp-content/uploads/2020/09/Alex-Dickinson.jpghttps://timmermanreport.com/2020/09/america-the-engine-of-biomedical-discovery-should-be-trumps-most-favored-nation/2020-10-21T18:49:29+00:00https://timmermanreport.com/wp-content/uploads/2020/09/TomCulman.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/JFKWHP-ST-387-19-62.jpghttps://timmermanreport.com/2020/03/diagnostic-test-developer-points-to-academic-blind-spot-that-hampers-translation/2020-10-21T18:50:17+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/03/adjusting-to-telemedicine-a-first-hand-account/2020-10-21T18:50:58+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/jonathanshaywitz-scaled.jpghttps://timmermanreport.com/2020/03/digital-tools-in-clinical-trials-find-opportunity-during-pandemic/2020-10-21T18:51:34+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/03/why-telehealth-champions-are-worried-about-trust/2020-10-21T18:52:12+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2019/04/life-after-twitter/2020-10-21T18:53:03+00:00https://timmermanreport.com/wp-content/uploads/2015/01/dshaywitz.jpghttps://timmermanreport.com/2020/03/the-value-and-necessity-of-tinkering/2020-10-21T18:53:46+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/03/our-tightly-networked-world-blessing-and-curse/2020-10-21T18:54:40+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/02/techlash-offers-health-and-tech-opportunity-to-reset-relationship-rediscover-mutual-respect/2020-10-21T18:55:42+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/02/davidandamy.pnghttps://timmermanreport.com/2020/01/challenging-core-assumptions-tech-backlash-paves-the-way-for-more-thoughtful-healthtech/2020-10-21T18:56:31+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/taleb.pnghttps://timmermanreport.com/2020/01/incrementalism-is-the-new-disruption-trust-is-the-new-black-and-positive-change-for-now-at-fda-takeaways-from-the-2020-precision-medicine-world-conference/2020-10-21T18:57:23+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2019/04/flatiron\_vineeta\_agarwala.jpghttps://timmermanreport.com/wp-content/uploads/2015/02/Atul-Butte2\_0.jpghttps://timmermanreport.com/wp-content/uploads/2015/07/michael-pellini.jpghttps://timmermanreport.com/2020/01/understanding-the-ideology-of-digital-transformation/2020-10-21T18:58:20+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/01/atomwise-and-eqrx-two-contrasting-strategies-for-the-rd-inefficiency-problem/2020-10-21T18:59:12+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/2020/01/entering-jpm20-with-a-grounded-yet-hopeful-view-of-health-tech/2020-10-21T19:00:08+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/2020/01/sanofis-new-ceo-captures-pharmas-grounded-view-of-health-tech/2020-10-21T19:01:33+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/paulhudson-e1578514452262.jpghttps://timmermanreport.com/2020/01/new-job-same-thesis-aligning-tech-pharma-to-elicit-best-of-both/2020-10-21T19:03:37+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/2019/11/ai-can-help-with-repeatable-processes-but-dont-expect-thunderbolts-for-drug-discovery/2020-10-21T19:04:29+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/manzi\_hires-white-background.jpghttps://timmermanreport.com/2019/12/losing-80-lbs-was-hard-keeping-it-off-was-so-much-harder/2020-10-21T19:05:19+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/weightloss.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/ketones.jpghttps://timmermanreport.com/2019/12/aural-pleasures-2019-edition/2020-10-21T19:06:06+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/2019/11/disruption-fast-and-slow/2020-10-21T19:06:48+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/davidshaywitz.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/janelle.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/bkocher\_detail.jpghttps://timmermanreport.com/2019/11/tech-vcs-and-biotech-vcs-talking-past-each-other-on-ai-drug-discovery/2020-10-21T19:07:28+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/davidshaywitz.jpghttps://timmermanreport.com/wp-content/uploads/2019/11/davidweitz.jpghttps://timmermanreport.com/2020/07/race-and-life-sciences-where-is-the-healing/2020-10-21T19:10:59+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/wp-content/uploads/2020/07/jamesbaldwin.jpghttps://timmermanreport.com/2020/08/the-data-are-telling-us-to-prepare-for-a-difficult-fall/2020-10-21T19:11:49+00:00https://timmermanreport.com/wp-content/uploads/2020/08/AML-21697\_9099266\_mutable\_color.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/tracker.pnghttps://timmermanreport.com/wp-content/uploads/2020/08/projections.pnghttps://timmermanreport.com/wp-content/uploads/2020/08/masks.pnghttps://timmermanreport.com/wp-content/uploads/2020/08/australia.pnghttps://timmermanreport.com/2020/06/leadership-strategy-and-capabilities-how-we-are-losing-the-fight-against-the-virus/2020-10-21T19:12:38+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/jhuCOVIDcases06.26.20.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/ourworlddataJune26-scaled.jpghttps://timmermanreport.com/2020/05/miscommunications-misapplied-policy-misunderstood-liberty-why-the-us-pandemic-response-is-in-trouble/2020-10-21T19:13:58+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/2020/04/the-real-question-is-how-to-restart/2020-10-21T19:17:24+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/2020/04/whats-the-real-risk-of-death-from-covid19-its-can-be-deceiving/2020-10-21T19:18:05+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/2020/03/let-it-rip-or-shelter-at-home-how-to-choose-between-two-unpalatable-options/2020-10-21T19:21:23+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/2020/03/8-days-later-italy-vs-us/2020-10-21T19:23:28+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/otello3.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/otello4.jpghttps://timmermanreport.com/2020/03/lessons-from-italy-how-the-us-can-respond-to-the-urgent-coronavirus-threat/2020-10-21T19:24:55+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/caseschina.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/curve.jpghttps://timmermanreport.com/2020/08/insurance-reform-not-executive-orders-is-the-best-tool-to-protect-u-s-patients-and-u-s-pharmaceutical-innovation/2020-10-21T20:22:27+00:00https://timmermanreport.com/wp-content/uploads/2020/01/PeterKolchinsky\_RECTANGLE.jpghttps://timmermanreport.com/2020/07/the-remdesivir-pricing-letter-gilead-should-have-written/2020-10-21T20:24:03+00:00https://timmermanreport.com/wp-content/uploads/2020/01/PeterKolchinsky\_RECTANGLE.jpghttps://timmermanreport.com/2020/07/when-raising-drug-prices-helps-patients/2020-10-21T20:24:45+00:00https://timmermanreport.com/wp-content/uploads/2020/07/chrismorrison.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/PeterKolchinsky\_RECTANGLE.jpghttps://timmermanreport.com/wp-content/uploads/2016/03/kenfrazier-e1457218843995.jpghttps://timmermanreport.com/2020/03/covid-19-teaches-us-the-real-definition-of-a-novel-drug/2020-10-21T20:25:28+00:00https://timmermanreport.com/wp-content/uploads/2020/01/PeterKolchinsky\_RECTANGLE.jpghttps://timmermanreport.com/2020/01/false-heroes-pharmacy-benefit-managers-and-the-patients-they-prey-on/2020-10-21T20:26:16+00:00https://timmermanreport.com/wp-content/uploads/2020/01/PeterKolchinsky\_RECTANGLE.jpghttps://timmermanreport.com/2020/05/getting-the-numbers-wrong/2020-10-21T20:47:20+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2020/05/giving-models-and-modelers-a-bad-name/2020-10-21T20:48:07+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2020/04/how-to-navigate-the-coming-blizzard-of-covid-19-antibody-studies/2020-10-21T20:51:22+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2020/04/getting-it-right-walking-the-diagnostic-and-serologic-testing-tightrope/2020-10-21T20:52:04+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2020/04/why-covid-19-cant-be-directly-compared-with-the-flu/2020-10-21T20:52:39+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2020/04/covid-19-models-what-makes-them-tick/2020-10-21T20:55:39+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2020/10/looking-at-cancer-from-a-different-angle-pearl-huang-on-the-long-run/2020-10-21T23:03:42+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/pearl.jpghttps://timmermanreport.com/2020/10/seeing-covid-19-in-context-applying-spatial-biology-to-the-lungs/2020-10-21T23:04:32+00:00https://timmermanreport.com/wp-content/uploads/2020/10/sarahwarrensquare.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/Jason-Reeves-Headshot-1.jpghttps://timmermanreport.com/2020/09/small-molecules-against-rna-targets-jennifer-petter-on-the-long-run/2020-10-21T23:05:03+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/jpetter-scaled.jpghttps://timmermanreport.com/2020/09/becoming-a-biotech-vc-otello-stampacchia-on-the-long-run/2020-10-21T23:06:03+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/Global-Partnering-Virtual-Passpport-EBD-Group.pnghttps://timmermanreport.com/2020/08/a-swing-and-a-miss-from-the-cdc/2020-10-21T23:52:18+00:00https://timmermanreport.com/wp-content/uploads/2020/03/mikepellinis32.pnghttps://timmermanreport.com/2020/08/spiritual-renewal-in-the-north-cascades-and-facing-homelessness/2020-10-21T23:53:05+00:00https://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1212-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/facinghomelessness.pnghttps://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1198-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1197-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1211-scaled-e1597953164283.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1212-1-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1214-scaled-e1597953252945.jpghttps://timmermanreport.com/2020/08/from-rio-to-rome-rosana-kapeller-on-the-long-run/2020-10-21T23:53:56+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/kapeller.pnghttps://timmermanreport.com/2020/08/covid-19-is-driving-a-shift-in-how-we-value-diagnostic-tests/2020-10-21T23:54:48+00:00https://timmermanreport.com/wp-content/uploads/2019/01/Bonnie\_Cropped-e1596736764296.jpghttps://timmermanreport.com/2020/07/barring-foreign-talent-is-an-assault-on-biotech-innovation/2020-10-21T23:55:57+00:00https://timmermanreport.com/wp-content/uploads/2020/07/John\_Maraganore.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/jeremy\_levin\_005.jpghttps://timmermanreport.com/2020/07/playing-the-long-game-for-antibiotic-rd/2020-10-22T00:00:08+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ankit-mahadevia.jpghttps://timmermanreport.com/2020/06/from-heart-to-head-corporations-can-step-up-against-systemic-racism/2020-10-22T00:00:46+00:00https://timmermanreport.com/wp-content/uploads/2020/06/Karl-Simpson-BIO-headshot2.jpghttps://timmermanreport.com/2020/10/machine-learning-for-drug-discovery-daphne-koller-on-the-long-run/2020-10-26T23:21:43+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/10/insitro-daphne-koller2x.jpghttps://timmermanreport.com/2020/10/how-many-covid-19-deaths-could-have-been-avoided-more-than-150000/2020-10-27T15:54:53+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2020/10/the-battle-for-the-soul-of-biopharma-peter-kolchinsky-on-the-long-run/2020-10-28T17:11:59+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/PeterKolchinsky\_RECTANGLE.jpghttps://timmermanreport.com/2020/10/what-happened-in-switzerland/2020-10-29T09:00:53+00:00https://timmermanreport.com/wp-content/uploads/2020/03/alexm.jpghttps://timmermanreport.com/wp-content/uploads/2020/10/swiss1.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/swiss2.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/swiss3.pnghttps://timmermanreport.com/2020/11/rebuffed-as-overlords-ai-experts-return-in-peace-seeking-partnership-with-clinicians/2020-11-03T01:17:44+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/Saria\_photo-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/zak-091817\_data\_science\_040-300x350-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/marz.pnghttps://timmermanreport.com/wp-content/uploads/2020/11/rudin.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/Ken\_Ehlert.pnghttps://timmermanreport.com/wp-content/uploads/2020/11/PeteLee-0618\_07.jpeg.jpghttps://timmermanreport.com/2020/11/targeted-protein-degraders-pull-in-millions-of-dollars-in-the-wake-of-new-hope/2020-11-04T07:21:48+00:00https://timmermanreport.com/wp-content/uploads/2020/11/theresagaffney-scaled-e1604441689266.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/markrolfe.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/carolyn\_bio.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/markuswarmuth.pnghttps://timmermanreport.com/2019/07/has-the-time-come-for-a-us-nice/2020-11-04T19:05:58+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2020/05/if-trikafta-isnt-good-enough-for-icer-what-drug-is/2020-11-04T19:07:42+00:00https://timmermanreport.com/wp-content/uploads/2020/02/JessicaSagers.pnghttps://timmermanreport.com/2020/11/why-learning-from-electronic-health-records-is-so-appealing-and-so-hard/2020-11-05T02:34:35+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/11/biotech-companies-acting-on-promises-to-increase-racial-diversity/2020-11-10T14:31:36+00:00https://timmermanreport.com/wp-content/uploads/2020/06/Karl-Simpson-BIO-headshot2.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/minita.jpghttps://timmermanreport.com/wp-content/uploads/2018/12/billnewell.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/rene-russo-color.pnghttps://timmermanreport.com/wp-content/uploads/2018/05/Chip-Clark-Genocea.jpghttps://timmermanreport.com/2020/11/so-you-have-a-cool-platform-the-next-decision-will-make-or-break-your-company/2020-11-11T08:58:12+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2020/11/creating-the-future-of-microbiome-based-therapies-simba-gill-on-the-long-run/2020-11-12T00:31:15+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/Simba-Gill.jpghttps://timmermanreport.com/2019/02/the-boston-cancer-summit-and-sf-cancer-summit-see-the-agenda-get-your-tickets/2020-11-13T22:14:35+00:00https://timmermanreport.com/wp-content/uploads/2019/02/Registration\_Form\_Header\_830x224-1-e1550689310437.jpghttps://timmermanreport.com/2019/02/get-tickets-now-the-cancer-summit-series-is-coming-to-boston-sf-seattle/2020-11-13T22:20:54+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Kili\_700x330.jpghttps://timmermanreport.com/wp-content/uploads/2019/02/Registration\_Form\_Header\_830x224.jpghttps://timmermanreport.com/wp-content/uploads/2019/02/Registration\_Form\_Header\_830x224.jpghttps://timmermanreport.com/wp-content/uploads/2019/02/Registration\_Form\_Header\_830x224.jpghttps://timmermanreport.com/2020/11/the-mrna-vaccine-news-is-good-but-lets-keep-the-masks-for-now/2020-11-19T04:11:09+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2020/11/why-the-operation-warp-speed-vaccine-studies-arent-limited-to-severe-disease/2020-11-20T22:09:58+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2020/11/a-new-model-for-vaccine-communications-grounded-in-science-and-empathy/2020-11-23T19:41:20+00:00https://timmermanreport.com/wp-content/uploads/2020/11/MK\_headshot\_2019.pnghttps://timmermanreport.com/wp-content/uploads/2020/11/Head\_Shot\_High\_Res\_328229.jpghttps://timmermanreport.com/2020/11/medicines-based-on-unusual-genetic-traits-andrew-farnum-on-the-long-run/2020-11-24T01:06:07+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/farnum-e1606176095863.pnghttps://timmermanreport.com/2020/11/i-used-to-report-on-clinical-trials-now-im-in-one-heres-why-i-volunteered/2020-11-25T16:52:35+00:00https://timmermanreport.com/wp-content/uploads/2020/11/mikehuckman1.pnghttps://timmermanreport.com/wp-content/uploads/2020/11/firstshot-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/secondshot-scaled.jpghttps://timmermanreport.com/2020/11/pfizer-biontechs-watershed-moment-lilly-antibody-gets-eua-the-rebuilding-begins/2020-11-27T16:04:58+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/wedding.pnghttps://timmermanreport.com/wp-content/uploads/2020/11/atul.pnghttps://timmermanreport.com/2020/11/5am-atlas-join-40m-bet-on-kinaset-a-pan-jak-inhibitor-for-severe-asthma/2020-11-30T12:00:01+00:00https://timmermanreport.com/wp-content/uploads/2020/11/clarke.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/Jamil-square-e1522187161557.jpghttps://timmermanreport.com/2020/11/the-weather-outside-is-frightful-and-thats-just-the-half-of-it/2020-11-30T20:32:09+00:00https://timmermanreport.com/wp-content/uploads/2020/03/Lisa-Suennen-headshot-mts.jpeghttps://timmermanreport.com/wp-content/uploads/2020/11/mascara.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/fomo.pnghttps://timmermanreport.com/wp-content/uploads/2020/11/stomp.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/dembones.pnghttps://timmermanreport.com/2020/04/a-san-francisco-doctor-answering-the-call-to-new-york/2020-11-30T22:25:16+00:00https://timmermanreport.com/wp-content/uploads/2020/04/eweiss1.jpghttps://timmermanreport.com/2018/01/big-idea-big-money-big-skepticism-long-run-podcast-stephane-bancel/2020-12-01T21:44:24+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2015/05/SBancel-moderna-2.jpghttps://timmermanreport.com/2020/12/genesis-technology-stanford-spinout-for-ai-drug-discovery-captures-52m-series-a/2020-12-02T11:00:39+00:00https://timmermanreport.com/wp-content/uploads/2020/12/evan-p-500-e1606884134151.pnghttps://timmermanreport.com/wp-content/uploads/2020/12/peppi\_prasit.jpghttps://timmermanreport.com/2020/12/vaccine-scarcity-buckle-up-for-debate-in-the-coming-months/2020-12-02T04:55:25+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/acip.pnghttps://timmermanreport.com/2020/11/merck-buys-velosbio-biogens-alzheimers-surprise-a-reflection-from-wisconsin/2020-12-04T19:35:16+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/biib.pnghttps://timmermanreport.com/2020/06/making-a-difference-on-race-ted-love-on-the-long-run/2020-12-04T21:48:27+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/tedlove2020.jpghttps://timmermanreport.com/2017/12/long-run-podcast-steve-graham-racism-corporate-america/2020-12-04T21:49:17+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/08/stevegraham.jpghttps://timmermanreport.com/2020/12/this-covid-19-long-hauler-is-still-trying-to-recover/2020-12-07T16:06:44+00:00https://timmermanreport.com/wp-content/uploads/2020/12/blairschoeb.pnghttps://timmermanreport.com/2020/12/vaccine-trials-as-a-band-of-brothers-and-sisters/2020-12-08T01:50:27+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2020/12/14834/2020-12-08T13:00:46+00:00https://timmermanreport.com/wp-content/uploads/2020/10/song.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/liebisch-2019.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/Pete-Smith-1-scaled.jpghttps://timmermanreport.com/2020/12/vaccine-communication-another-opportunity-for-biopharma-to-lead/2020-12-11T20:19:22+00:00https://timmermanreport.com/wp-content/uploads/2020/12/kyle1.pnghttps://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2020/12/the-vaccine-is-coming-and-scientists-need-to-keep-the-focus-on-equity/2020-12-11T20:35:45+00:00https://timmermanreport.com/wp-content/uploads/2020/12/michele-andrsik.jpghttps://timmermanreport.com/2020/12/the-us-is-teeming-with-spacs-why-is-the-uk-at-zero/2020-12-14T02:02:45+00:00https://timmermanreport.com/wp-content/uploads/2018/12/ucianescarlett.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/uciane1.pnghttps://timmermanreport.com/2020/12/seeking-impact-serviers-david-lee-on-the-long-run-podcast/2020-12-14T22:52:40+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/davidlee.jpghttps://timmermanreport.com/2020/12/startup-profiles-exosite-drug-discovery-efficient-gene-therapy-for-the-eye/2020-12-16T12:30:02+00:00https://timmermanreport.com/wp-content/uploads/2020/12/liu\_1.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/bruce.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/Jackie-Grant\_large\_52425c438f53f4d02eb7eba32b8b5077.jpghttps://timmermanreport.com/2020/12/round-2-whats-changed-and-what-hasnt-in-caring-for-outpatients-with-covid-19/2020-12-17T11:03:54+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2020/03/doctor-mother-ceo-balancing-competing-needs-and-opting-for-the-front-lines/2020-12-17T15:40:42+00:00https://timmermanreport.com/wp-content/uploads/2020/03/achristini.pnghttps://timmermanreport.com/2020/12/a-grateful-physician-reflects-on-getting-the-covid-19-vaccine/2020-12-17T21:30:40+00:00https://timmermanreport.com/wp-content/uploads/2020/03/achristini.pnghttps://timmermanreport.com/2020/12/more-than-words-taking-steps-together-towards-greater-health-equity/2020-12-21T10:46:25+00:00https://timmermanreport.com/wp-content/uploads/2020/05/nkjellson.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/nina1.pnghttps://timmermanreport.com/wp-content/uploads/2020/12/healthequity1.jpghttps://timmermanreport.com/2020/12/science-in-the-face-of-fear-vaccine-hesitancy-and-public-trust/2020-12-20T22:44:10+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/kmcurves.pnghttps://timmermanreport.com/2020/12/listening-through-the-noise-and-talking-to-those-who-will-listen/2020-12-22T10:51:31+00:00https://timmermanreport.com/wp-content/uploads/2020/12/samblackman.pnghttps://timmermanreport.com/2020/12/celsius-servier-forge-single-cell-analysis-partnership-for-colorectal-cancer/2020-12-21T23:15:09+00:00https://timmermanreport.com/wp-content/uploads/2020/12/Tariq-Kassum-Celsius.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/AvivRegev.jpghttps://timmermanreport.com/2020/12/priority-for-next-administration-tech-ready-health-leadership/2020-12-22T00:06:23+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/12/covid-19-drives-new-push-for-crispr-based-home-diagnostics/2020-12-22T13:50:43+00:00https://timmermanreport.com/wp-content/uploads/2020/11/fvinluan\_headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/rahul-480v4.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/janicechen.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/Gerald-J.-Kost.jpghttps://timmermanreport.com/2020/12/a-triumph-of-the-scientific-enterprise-industry-academia-and-government/2020-12-22T17:39:03+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/modernatweet.pnghttps://timmermanreport.com/2020/12/pfizer-biontech-vaccine-gets-fda-advisory-ok-now-comes-more-hard-work/2020-12-22T17:43:17+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/nurse.pnghttps://timmermanreport.com/2020/12/azs-muddy-result-regeneron-cocktail-okd-and-biogen-sage-bet-big-on-depression/2020-12-22T17:46:27+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/dec3.1.pnghttps://timmermanreport.com/wp-content/uploads/2020/12/dec3.2.pnghttps://timmermanreport.com/wp-content/uploads/2020/12/dec3.3.pnghttps://timmermanreport.com/wp-content/uploads/2020/12/dec3.4.pnghttps://timmermanreport.com/wp-content/uploads/2020/12/dec3.5.pnghttps://timmermanreport.com/2020/11/moderna-pfizer-nail-covid-19-vaccines-now-comes-the-hard-part/2020-12-22T17:50:06+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/10/jj-az-back-in-the-saddle-regeneron-moves-the-ball-downfield-and-a-flurry-of-deals/2020-12-22T17:51:03+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/10/remdesivirs-fda-approval-moderna-fully-enrolls-fda-wrestles-with-trust/2020-12-22T17:59:45+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/10/bach.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/distrust1.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/distrust2.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/distrust3.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/distrust4.pnghttps://timmermanreport.com/2020/10/jj-vaccine-study-paused-lilly-antibody-paused-and-regenerons-ebola-fda-approval/2020-12-22T18:35:12+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/12/creative-new-treatments-for-mental-health-steve-paul-on-the-long-run/2020-12-22T19:41:36+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/10/Steven-Paul-1.jpghttps://timmermanreport.com/2020/10/a-historic-nobel-for-crispr-pfizer-sticks-up-for-fda-a-cdc-legend-speaks/2020-12-22T22:47:35+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/10/front1.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/front2.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/front3.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/front4.pnghttps://timmermanreport.com/2020/10/fda-commissioners-speak-out-an-antibiotic-incentive-proposal-and-a-drug-price-grilling/2020-12-22T22:50:27+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/10/porter1.pnghttps://timmermanreport.com/wp-content/uploads/2020/10/porter2.pnghttps://timmermanreport.com/2020/09/illuminas-bet-on-early-cancer-detection-esmo-highlights/2020-12-22T22:52:22+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2020/09/industry-and-academia-take-a-stand-for-science/2020-12-22T22:54:11+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/fauci-advisory-council.jpghttps://timmermanreport.com/2020/09/fda-and-cdc-credibility-tarnished-pfizer-sprints-ahead-with-covid19-vaccine/2020-12-22T22:55:32+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/worldsept3.pnghttps://timmermanreport.com/2020/07/pfizer-secures-2b-for-covid-19-vaccine-biontech-raises-500m-our-test/2020-12-22T22:56:59+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/alit.pnghttps://timmermanreport.com/wp-content/uploads/2020/07/pfevaccine.pnghttps://timmermanreport.com/2020/07/standing-with-fauci-positive-moderna-vaccine-data-and-blueprints-megadeal/2020-12-22T22:57:48+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/megken.pnghttps://timmermanreport.com/2020/07/novavax-nabs-1-6b-bd-secures-fast-antigen-test-ok-a-tribute-to-tony-fauci/2020-12-22T22:58:31+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/07/pfizer-biontech-vaccine-shows-life-but-cases-surge-testing-falters-prices-haunt/2020-12-22T23:14:22+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/JUly1snapshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/mitchell.pnghttps://timmermanreport.com/2020/06/the-exponential-curves-re-emerge/2020-12-22T23:14:53+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/cdcJune25.jpghttps://timmermanreport.com/2020/06/merck-wins-2-big-approvals-a-surprise-from-old-dex-and-a-digital-therapeutics-first/2020-12-22T23:15:20+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/06/inconvenient-truths-and-rays-of-light/2020-12-22T23:15:50+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/06/anger-pain-and-even-some-hope/2020-12-22T23:16:17+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/frazier.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/ned.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/jha.pnghttps://timmermanreport.com/2020/05/the-infodemic-summer/2020-12-22T23:17:01+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/postman-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/haydon.pnghttps://timmermanreport.com/2020/05/a-glimmer-of-hope-and-a-premature-victory-dance/2020-12-22T23:17:41+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2014/12/lukeSquare4.jpghttps://timmermanreport.com/2020/05/meet-my-friend-who-supported-trump-in-2016/2020-12-22T23:18:44+00:00https://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/megtweet.pnghttps://timmermanreport.com/wp-content/uploads/2020/05/millerdragon.pnghttps://timmermanreport.com/2020/05/keeping-the-faith-and-bracing-for-the-long-slog/2020-12-22T23:19:20+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/pearl.pnghttps://timmermanreport.com/2020/05/a-time-for-empathy/2020-12-22T23:20:03+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/carolyn.pnghttps://timmermanreport.com/wp-content/uploads/2020/05/schenkein.pnghttps://timmermanreport.com/2020/04/a-sad-week-of-reckless-leadership/2020-12-22T23:21:23+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/Jeff-Duchin-bio-page.pnghttps://timmermanreport.com/wp-content/uploads/2020/04/nejmfarce.pnghttps://timmermanreport.com/wp-content/uploads/2020/04/someexperts.pnghttps://timmermanreport.com/wp-content/uploads/2020/04/drwoodcock.pnghttps://timmermanreport.com/2020/04/gsk-partners-with-vir-on-antibodies-pfizer-with-biontech-on-vaccines-the-testing-fiasco-continues/2020-12-22T23:22:19+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/covidlyapr9.pnghttps://timmermanreport.com/wp-content/uploads/2020/04/megthemedia.pnghttps://timmermanreport.com/wp-content/uploads/2020/04/andybillmitchell.pnghttps://timmermanreport.com/2020/04/coronavirus-synthesis-arch-flagship-reload-merck-passes-2-phase-iiis/2020-12-22T23:22:53+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/covid19dashapr2.pnghttps://timmermanreport.com/2020/03/the-coronavirus-tsunami-lyells-492m-megaround-some-deals-you-missed/2020-12-22T23:23:28+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/oecd1.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/oecd2.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/oecd3.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/healthcareworkforce.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/craigs.jpghttps://timmermanreport.com/2020/03/covid-19-collective-problem-solving-time/2020-12-22T23:24:03+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/uw1.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/notflu.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/flattencurve.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/andyitaly.pnghttps://timmermanreport.com/2020/03/covid-19-spreads-in-seattle-gileads-4-9b-cancer-bet-thermo-grabs-qiagen/2020-12-22T23:24:43+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/nurse1.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/nurse2.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/bloom.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/levitt.pnghttps://timmermanreport.com/2020/01/coronavirus-fear-spreads-cvs-feels-the-heat-black-diamonds-sizzling-ipo/2020-12-22T23:25:40+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/02/sanofis-intriguing-ms-drug-mercks-big-spinoff-a-new-peanut-allergy-drug/2020-12-22T23:26:07+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/02/gilead-moderna-rise-to-the-occasion-esperion-goes-back-to-back-sangamos-big-neurology-deal/2020-12-22T23:26:38+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/02/andycorona.pnghttps://timmermanreport.com/2020/01/much-ado-about-coronavirus-and-23andme-hits-the-wall/2020-12-22T23:27:25+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/coronavirus.pnghttps://timmermanreport.com/2020/07/writing-in-the-language-of-dna-kevin-ness-on-the-long-run/2020-12-23T21:52:44+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/kevinness.jpghttps://timmermanreport.com/2020/05/finding-a-path-in-biotech-venture-capital-nina-kjellson-on-the-long-run/2020-12-23T21:53:26+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/nkjellson.jpghttps://timmermanreport.com/2020/06/fighting-covid-19-racism-andy-plump-on-the-long-run/2020-12-23T21:53:36+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/plump.jpghttps://timmermanreport.com/2020/04/real-time-tracking-of-viral-outbreaks-emma-hodcroft-on-the-long-run/2020-12-23T21:54:08+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/Emma-Hodcroft6363\_2x3-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/RareCyte\_Logo\_DarkGray-1.pnghttps://timmermanreport.com/2020/05/coronavirus-vaccine-strategy-larry-corey-on-the-long-run/2020-12-23T21:54:19+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/RareCyte\_Logo\_DarkGray-1.pnghttps://timmermanreport.com/2020/04/diagnostic-dysfunction-for-covid19-mike-pellini-on-the-long-run/2020-12-23T21:54:52+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/mikepellinis32.pnghttps://timmermanreport.com/2020/04/hunting-for-antibodies-against-covid19-george-scangos-on-the-long-run/2020-12-23T21:55:02+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/10/GeorgeScangos.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/RareCyte\_Logo\_DarkGray.pnghttps://timmermanreport.com/2020/03/new-drugs-at-low-prices-alexis-borisy-and-melanie-nallicheri-of-eqrx-on-the-long-run/2020-12-23T21:55:27+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/Alexis-Borisy-EQRX-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/Melanie-Nallicheri-EQRX-scaled.jpghttps://timmermanreport.com/2020/03/living-life-fully-with-stage-4-lung-cancer-isabella-de-le-houssaye-on-the-long-run/2020-12-23T21:55:34+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/isabella-scaled.jpghttps://timmermanreport.com/2020/12/there-is-light-at-the-end-of-the-tunnel-yes-but-its-a-long-tunnel/2020-12-26T13:14:10+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/xkcd.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/xkcd1.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/xkcd2.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/xkcd3.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/xkcd4.jpghttps://timmermanreport.com/2020/08/convalescent-plasma-look-before-you-leap/2021-01-01T18:07:15+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2020/07/do-we-need-models-anymore/2021-01-01T18:07:34+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2021/01/the-vaccine-rollout-could-prompt-real-reform-to-the-us-health-system/2021-01-05T21:41:15+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2021/01/startup-profiles-senti-and-myeloid-raise-cash-to-push-cell-therapy-frontiers/2021-01-06T14:11:29+00:00https://timmermanreport.com/wp-content/uploads/2021/01/timlu.pnghttps://timmermanreport.com/wp-content/uploads/2021/01/sidmukherjee.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/getts.jpghttps://timmermanreport.com/2021/01/mrna-vaccines-inspire-hope-for-emerging-technologies-is-digital-pharma-next/2021-01-07T01:00:49+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2015/05/SBancel-moderna-2.jpghttps://timmermanreport.com/2021/01/fungus-based-startup-lifemine-fetches-50m-arsenal-attracts-bms-cell-therapy/2021-01-07T12:00:13+00:00https://timmermanreport.com/wp-content/uploads/2021/01/verdine.pnghttps://timmermanreport.com/wp-content/uploads/2021/01/drazan.pnghttps://timmermanreport.com/2021/01/a-moment-of-truth/2021-01-12T17:33:29+00:00https://timmermanreport.com/wp-content/uploads/2020/03/jeremy\_levin\_005.jpghttps://timmermanreport.com/2021/01/cell-gene-therapy-boom-sparks-investment-in-biologics-manufacturing/2021-01-13T10:49:33+00:00https://timmermanreport.com/wp-content/uploads/2020/11/fvinluan\_headshot.jpghttps://timmermanreport.com/wp-content/uploads/2017/06/aallen.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/rasession.pnghttps://timmermanreport.com/wp-content/uploads/2021/01/pcagnoni.pnghttps://timmermanreport.com/wp-content/uploads/2021/01/fabian.pnghttps://timmermanreport.com/wp-content/uploads/2021/01/armon.jpghttps://timmermanreport.com/2021/01/the-politics-of-speaking-up/2021-01-13T13:59:34+00:00https://timmermanreport.com/wp-content/uploads/2021/01/phastings.jpghttps://timmermanreport.com/2021/01/how-worried-should-we-be-about-emerging-strains-of-sars-cov-2/2021-01-14T10:11:03+00:00https://timmermanreport.com/wp-content/uploads/2021/01/maraaspinall.pnghttps://timmermanreport.com/wp-content/uploads/2021/01/viralspike.pnghttps://timmermanreport.com/wp-content/uploads/2021/01/newvariant.pnghttps://timmermanreport.com/2021/01/a-vision-for-an-mhealth-driven-biopharma-future/2021-01-19T10:01:28+00:00https://timmermanreport.com/wp-content/uploads/2021/01/overell.jpghttps://timmermanreport.com/2021/01/two-doses-or-one-lets-stick-to-the-data/2021-01-17T21:10:57+00:00https://timmermanreport.com/wp-content/uploads/2021/01/beyrer.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2021/01/gene-editing-for-transplants-and-cell-therapy-luhan-yang-on-the-long-run/2021-01-20T00:16:20+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/luhanyang.jpghttps://timmermanreport.com/2021/01/restoring-local-journalism-in-america/2021-01-22T18:29:36+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2021/01/whats-your-deq-why-data-empathy-is-essential-for-health-data-impact/2021-01-25T13:43:13+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2021/01/ideas-for-an-fda-reboot/2021-01-29T18:24:50+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2018/09/Amy-headshot\_2018.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/virbio.pnghttps://timmermanreport.com/2021/01/the-evolving-virus-against-the-vaccines-an-insiders-perspective/2021-02-01T17:04:34+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2021/02/2021-the-rise-of-the-variants/2021-02-02T18:45:24+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/otellofeb1.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/otellofeb1.2.jpghttps://timmermanreport.com/2021/02/the-insurrectionist-and-the-visionary/2021-02-05T13:37:32+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/confederate-flag.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/morrillactmap.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/porter-1.pnghttps://timmermanreport.com/2021/02/scientists-love-data-and-data-reveal-most-people-prefer-anecdotes/2021-02-05T22:33:46+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2021/02/the-urgency-has-never-been-greater-as-variants-ratchet-up-the-pressure/2021-02-08T13:45:10+00:00https://timmermanreport.com/wp-content/uploads/2021/01/maraaspinall.pnghttps://timmermanreport.com/2021/02/a-single-shot-for-heart-disease-sekar-kathiresan-on-the-long-run/2021-02-09T01:25:15+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/sek.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/synthego-e1612816479377.jpghttps://timmermanreport.com/2021/02/a-2b-ipo-bonanza-fda-clears-juno-car-t-and-avrobio-gene-therapy-dazzles/2021-02-09T01:34:42+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/bobjuno.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/katie.pnghttps://timmermanreport.com/2021/02/no-longer-an-afterthought-day-one-raises-130m-for-childhood-cancer-therapies/2021-02-10T11:30:35+00:00https://timmermanreport.com/wp-content/uploads/2021/02/DayOneTherapeutics\_Jeremy-1.jpghttps://timmermanreport.com/2021/02/ensoma-gets-70m-to-enable-off-the-shelf-accessible-cell-therapies/2021-02-11T14:19:37+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Sarah-de-Crescenzo.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/hans-peter-kiem.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/paula.jpghttps://timmermanreport.com/2021/02/long-covids-insidious-toll-novos-victory-against-obesity-gileads-stumble-in-ipf/2021-02-12T01:15:16+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/12/blairschoeb.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/kff1.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/kff2.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/sek2.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/cdc3.pnghttps://timmermanreport.com/2021/01/biotech-has-never-been-more-radiant-even-in-this-dark-moment/2021-02-12T15:42:38+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/megjan7.pnghttps://timmermanreport.com/wp-content/uploads/2021/01/trevortweet.pnghttps://timmermanreport.com/wp-content/uploads/2021/01/pavitra.pnghttps://timmermanreport.com/2017/03/grails-900m-haul-kites-car-t-stands-6-months-icahn-returns/2021-02-12T15:48:01+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2021/02/centessa-rolls-up-10-medicxi-startups-gets-250m-to-scale-up-virtual-model/2021-02-16T11:30:44+00:00https://timmermanreport.com/wp-content/uploads/2021/02/untitled-9522-49-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/ES-Slaoui-02.jpeghttps://timmermanreport.com/2021/02/genentechs-new-amd-contender-takedas-win-against-cmv-and-the-ipos-continue/2021-02-16T10:30:40+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2021/02/increasing-vaccine-confidence-with-the-tools-that-got-us-this-far/2021-02-17T01:43:36+00:00https://timmermanreport.com/wp-content/uploads/2020/12/michele-andrsik.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/covpnteam.jpghttps://timmermanreport.com/2021/02/public-health-focused-adjuvant-capital-backed-by-merck-gates-raises-300m/2021-02-18T10:00:47+00:00https://timmermanreport.com/wp-content/uploads/2021/02/anikagupta.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/adjuvant.jpghttps://timmermanreport.com/2021/02/biotechs-blue-collar-needs-centessas-roll-up-and-adjuvants-fund-for-public-health/2021-02-20T01:26:00+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/bluebirdstock.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/pavitra.pnghttps://timmermanreport.com/2021/02/big-news-for-obesity-and-heart-failure-thats-been-underappreciated/2021-02-22T10:23:36+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/alex1.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/alex2.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/alex3.pnghttps://timmermanreport.com/2021/02/alta-reloads-astrazeneca-loses-cancer-indication-sanofi-gsk-vaccine-reboots/2021-02-23T02:24:14+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/celine1.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/andy2.pnghttps://timmermanreport.com/2021/01/ukko-gets-bayers-backing-for-an-ai-approach-to-food-allergies/2021-02-23T22:46:34+00:00https://timmermanreport.com/wp-content/uploads/2020/11/fvinluan\_headshot.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/Ukko-Chairman-and-Co-Founder-Yanay-Ofran.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/Ukko-CEO-Anat-Binur.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/juergen.pnghttps://timmermanreport.com/2021/02/no-more-waiting-for-central-lab-results-truvian-raises-105m/2021-02-24T12:00:29+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Headshot-Samuel-Kitara.jpeghttps://timmermanreport.com/wp-content/uploads/2021/02/hawkins.jpghttps://timmermanreport.com/2021/02/orna-therapeutics-a-circular-rna-bet-raises-80m-to-overcome-classic-rna-challenges/2021-02-24T23:34:25+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Sarah-de-Crescenzo.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/Tom-v2-284-384-1.jpghttps://timmermanreport.com/2021/02/comprehensive-policy-for-infection-there-has-never-been-a-better-time/2021-02-25T01:41:21+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ankit-mahadevia.jpghttps://timmermanreport.com/2020/04/how-a-simple-gesture-morphed-into-a-full-time-effort-to-feed-the-frontline/2021-02-25T21:35:18+00:00https://timmermanreport.com/wp-content/uploads/2020/04/KuwanaHeadshot\_cropped.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/FOBPoke\_KPURgentCare\_19April2020-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/Midnight-Cookie\_HBV-RN3.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/Midnight-Cookie\_HBV-Staff-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/SAMIRS\_COLLAGE-2020-03-28-00.36-copy.pnghttps://timmermanreport.com/wp-content/uploads/2020/04/UWMC-Starbucks\_TopPot\_27Mar2020.jpghttps://timmermanreport.com/2020/03/look-for-the-helpers-in-the-seattle-scientific-community-and-the-wider-world/2021-02-25T21:35:57+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Kristin-Anderson2.pnghttps://timmermanreport.com/wp-content/uploads/2020/03/helen-chu.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/Keith\_Jerome.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/uwvirology.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/Roychoudhury\_Pavitraresize.jpghttps://timmermanreport.com/2021/02/pfizer-biontech-ace-real-world-test-jj-faces-fda-scrutiny-merck-pays-up/2021-02-26T06:07:10+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/02/sek3.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/carl.pnghttps://timmermanreport.com/2021/02/digital-tools-helped-enable-covid-19-vaccine-trials-what-are-the-lessons-learned/2021-02-28T14:08:31+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2021/02/ai-in-healthcare-harvards-zak-kohane-on-what-innovators-are-missing/2021-02-28T14:09:09+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/zak-091817\_data\_science\_040-300x350-1.jpghttps://timmermanreport.com/2019/08/from-pharma-vc-to-cell-therapy-startup-janelle-anderson-on-the-long-run/2021-03-01T20:09:33+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/08/janelle.jpghttps://timmermanreport.com/2021/03/tenaya-grabs-106m-for-gene-therapy-regenerative-medicines-for-the-heart/2021-03-01T22:52:52+00:00https://timmermanreport.com/wp-content/uploads/2021/02/faraz-ali.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/Goeddel1.jpghttps://timmermanreport.com/2021/03/investing-in-manufacturing-mental-health-more-bob-nelsen-on-the-long-run/2021-03-01T23:07:33+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/nelsen.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/synthego-e1612816479377.jpghttps://timmermanreport.com/2021/03/bring-on-the-ai-derived-antibodies-aulos-envisions-way-to-seize-il-2-opportunity/2021-03-03T10:23:20+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AM-head-shot.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/ehlers.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/Ukko-Chairman-and-Co-Founder-Yanay-Ofran.jpghttps://timmermanreport.com/2021/03/jj-vaccine-okd-morphic-nails-integrin-target-az-grabs-1b-for-moderna-shares/2021-03-02T23:29:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/brad.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/griffin.pnghttps://timmermanreport.com/2021/03/jj-vaccine-one-dose-delivers-strong-immune-response-and-protection/2021-03-03T17:15:14+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/jj1.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/jj2.pnghttps://timmermanreport.com/2021/03/what-pharma-data-scientists-can-learn-from-spacex-health-system-barriers-the-fda/2021-03-04T15:27:57+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2021/03/mental-health-a-new-frontier-for-biotech/2021-03-05T13:01:59+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/DA-Wallach-Headshot.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/jonathanshaywitz-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/harmit.pnghttps://timmermanreport.com/2021/03/science-policy-chat-join-rep-jake-auchincloss-and-me-on-clubhouse-mar-10/2021-03-09T19:49:58+00:00https://timmermanreport.com/wp-content/uploads/2021/03/330px-Jake\_Auchincloss\_117th\_Congress\_portrait.jpghttps://timmermanreport.com/2021/03/once-vaccinated-what-to-do-with-masks/2021-03-10T14:47:11+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/fludeaths.pnghttps://timmermanreport.com/2020/07/the-road-less-traveled-in-biotech-abe-ceesay-on-the-long-run/2021-03-11T14:20:13+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/abe-ceesay-45-cropped-scaled.jpghttps://timmermanreport.com/2021/03/signs-of-life-merck-ridgeback-covid-19-antiviral-and-sanofi-universal-flu-vaccine/2021-03-12T00:21:51+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2021/03/novavax-shines-vir-antibody-stays-in-the-game-and-cdc-lightens-up/2021-03-12T12:58:40+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/topolmar11.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/bradonblue.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/quench.pnghttps://timmermanreport.com/2021/03/one-vaccine-dose-or-two-we-need-our-best-defenses-against-the-variants/2021-03-14T15:26:36+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2021/03/software-for-the-cell-gene-therapy-wave-vinetis-amy-duross-on-the-long-run/2021-03-15T20:09:36+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/02/amyduross.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/synthego-e1612816479377.jpghttps://timmermanreport.com/2021/03/why-digital-fitness-companies-like-peloton-and-tonal-are-exciting-for-healthcare/2021-03-16T13:25:47+00:00https://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2021/03/azs-vaccine-mess-rubius-infiltrates-solid-tumors-insitros-400m-haul/2021-03-16T16:23:22+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/rubius.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/ourworld.pnghttps://timmermanreport.com/2021/03/the-rise-in-asian-american-hate-crimes-a-biopharma-perspective-and-call-for-action/2021-03-17T23:38:06+00:00https://timmermanreport.com/wp-content/uploads/2021/03/kwok.jpghttps://timmermanreport.com/2021/03/enticing-some-with-social-cues-others-with-health-exercise-rewards-body-and-mind/2021-03-20T17:26:18+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2021/03/burnout-alarms-are-ringing-people-need-a-break/2021-03-22T21:03:23+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/08/kapeller.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/rosanapaintings.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/angie\_you2.jpghttps://timmermanreport.com/wp-content/uploads/2015/09/bijan-salehizadeh@2x.jpghttps://timmermanreport.com/2020/06/scientists-focus-on-the-long-term-lung-complications-in-covid-19-survivors/2021-03-23T15:09:50+00:00https://timmermanreport.com/wp-content/uploads/2020/06/KJmulam.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/dausiello.jpghttps://timmermanreport.com/wp-content/uploads/2019/05/ericelenko.jpghttps://timmermanreport.com/2021/03/crossing-the-blood-brain-barrier-interview-with-denalis-ryan-watts/2021-03-24T19:58:00+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Headshot-Samuel-Kitara.jpeghttps://timmermanreport.com/wp-content/uploads/2021/03/ryanwatts.pnghttps://timmermanreport.com/2021/03/az-says-its-vaccine-is-ok-rebuilding-trust-will-take-a-while/2021-03-25T13:25:17+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/sek.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/outbreak.pnghttps://timmermanreport.com/2021/03/eliem-therapeutics-debuts-with-80m-to-tackle-chronic-pain-depression/2021-03-25T23:30:10+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Sarah-de-Crescenzo.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/Bob-Azelby.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/Valerie-Morisset.jpghttps://timmermanreport.com/2021/03/can-digital-fitness-extend-beyond-hardy-base-to-reach-those-who-may-benefit-most/2021-03-26T15:31:55+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2021/03/a-glimpse-into-a-price-controlled-future/2021-03-26T16:21:13+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/PeterKolchinsky\_RECTANGLE.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/JebKeiper-web.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/sara.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/brad-1.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/bruce.pnghttps://timmermanreport.com/2021/03/digital-health-from-pharma-tofitness/2021-03-27T20:36:25+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/erik\_compressed-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/Weber.jpghttps://timmermanreport.com/2021/03/needed-planet-fitness-for-the-digital-world/2021-03-28T18:03:28+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/pete.pnghttps://timmermanreport.com/2021/03/better-faster-cheaper-dna-synthesis-at-scale-emily-leproust-the-long-run/2021-03-30T13:28:07+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/Emily-Leproust-HZ-scaled.jpghttps://timmermanreport.com/2021/03/flying-blind-on-the-origin-of-a-pandemic/2021-03-30T14:14:59+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2021/03/asian-americans-in-biotech-breaking-the-silence/2021-03-31T20:39:16+00:00https://timmermanreport.com/wp-content/uploads/2021/03/NancyH\_31r-website.jpghttps://timmermanreport.com/2021/03/amgen-acquires-rodeo-lean-startup-with-dual-mechanism-for-crohns-colitis/2021-04-01T13:08:38+00:00https://timmermanreport.com/wp-content/uploads/2021/03/raymond-deshaies-desktop.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/Thong-7609-cropped.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/Markowitz.jpghttps://timmermanreport.com/2021/04/pfizers-vaccine-passes-kid-test-jjs-costly-error-and-ftc-challenges-illumina-grail/2021-04-02T00:41:50+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/crotty.pnghttps://timmermanreport.com/wp-content/uploads/2021/04/juurlink.pnghttps://timmermanreport.com/wp-content/uploads/2021/04/norbert.pnghttps://timmermanreport.com/wp-content/uploads/2021/04/mina.pnghttps://timmermanreport.com/wp-content/uploads/2021/04/frank.pnghttps://timmermanreport.com/2021/04/building-an-easy-on-ramp-for-consumer-fitness/2021-04-03T03:07:07+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/Headshot-Avatar-Wharton-Web-Page-129x133-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/mehta.pnghttps://timmermanreport.com/2021/04/covid-19-testing-going-to-the-dogs/2021-04-05T20:39:15+00:00https://timmermanreport.com/wp-content/uploads/2021/01/maraaspinall.pnghttps://timmermanreport.com/wp-content/uploads/2021/04/genie-joseph-headshot-cropped.jpghttps://timmermanreport.com/2021/04/compassionate-use-policy-has-everything-we-need-except-policy-and-compassion/2021-04-05T23:58:53+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Daniel-McIntyre.jpghttps://timmermanreport.com/2021/04/the-glory-of-john-martin-an-understated-leader-who-built-a-biotech-powerhouse/2021-04-06T00:58:43+00:00https://timmermanreport.com/wp-content/uploads/2021/04/chris-g-final-400px.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/john-martin.pnghttps://timmermanreport.com/2021/04/the-long-run-mentality-for-diversity-and-inclusion-in-biotech/2021-04-08T00:32:33+00:00https://timmermanreport.com/wp-content/uploads/2018/12/billnewell.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/frazier.pnghttps://timmermanreport.com/2021/04/diversity-in-clinical-trials-is-in-everyones-interest/2021-04-15T16:52:42+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2020/04/bridging-the-social-divide-in-the-pandemic/2021-04-15T17:07:35+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2020/09/what-we-know-about-covid-19-infection-and-what-we-dont/2021-04-15T17:08:19+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2021/04/partnering-in-a-world-of-biotech-abundance-james-sabry-on-the-long-run/2021-04-19T14:04:09+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/ec-sabry-2018\_370px.jpghttps://timmermanreport.com/2021/04/versant-ventures-sticking-with-the-knitting-raises-950m-for-early-stage-biotechs/2021-04-21T10:00:31+00:00https://timmermanreport.com/wp-content/uploads/2018/12/bolzon.jpghttps://timmermanreport.com/2021/04/liberating-founders-and-investors-from-narrative-bias/2021-04-26T15:42:47+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/alit.pnghttps://timmermanreport.com/2021/04/quantified-self-redux/2021-04-27T22:12:08+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2021/04/boundless-bio-pushing-frontiers-with-ecdna-cancer-therapy-raises-105m/2021-04-28T11:30:38+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Sarah-de-Crescenzo.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/Zachary-Hornby.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/jason.jpghttps://timmermanreport.com/2021/04/rare-side-effects-of-adenovirus-vaccines-call-for-careful-surveillance/2021-04-28T13:47:28+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2021/04/abbvie-bets-90m-on-capsida-approach-to-aav-gene-therapy-delivery/2021-04-29T09:15:40+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Headshot-Samuel-Kitara.jpeghttps://timmermanreport.com/wp-content/uploads/2020/06/clareozawa-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/beth-wlb-web.jpghttps://timmermanreport.com/2021/04/jj-back-after-pause-sanofi-aids-moderna-and-a-flood-of-women-join-biotech-boards/2021-04-29T23:58:13+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/brad1.pnghttps://timmermanreport.com/wp-content/uploads/2021/04/brad2-1.pnghttps://timmermanreport.com/wp-content/uploads/2021/04/BrightAngelApr24small.jpghttps://timmermanreport.com/2021/05/single-cell-analysis-comes-of-age-lighting-the-way-for-precision-therapies/2021-05-03T09:27:21+00:00https://timmermanreport.com/wp-content/uploads/2021/02/anikagupta.pnghttps://timmermanreport.com/wp-content/uploads/2019/05/clengauer.jpghttps://timmermanreport.com/wp-content/uploads/2020/02/DeannaInscripta\_20190426123759-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2021/04/APhilippakis-1\_134715-1.jpghttps://timmermanreport.com/wp-content/uploads/2020/10/sarahwarrensquare.pnghttps://timmermanreport.com/wp-content/uploads/2021/04/kamkolkar.pnghttps://timmermanreport.com/wp-content/uploads/2021/04/joevictor.jpghttps://timmermanreport.com/2021/05/rt-pcr-tests-for-covid-19-have-quantitative-power-lets-start-using-it/2021-05-03T23:04:29+00:00https://timmermanreport.com/wp-content/uploads/2021/01/maraaspinall.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/mara1-1.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/mara2.pnghttps://timmermanreport.com/2021/05/spotting-trends-and-starting-edgy-companies-daphne-zohar-on-the-long-run/2021-05-05T03:30:06+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/daphne.pnghttps://timmermanreport.com/2021/05/startup-profiles-perlmutter-bets-on-super-microscopy-foresites-precision-immunology/2021-05-05T11:30:21+00:00https://timmermanreport.com/wp-content/uploads/2021/05/Perlmutter1.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/tjian.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/june.jpghttps://timmermanreport.com/2021/05/motivating-fitness-with-immersive-experience-rather-than-competition/2021-05-06T04:27:14+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/danliebermanheadshot.pnghttps://timmermanreport.com/2018/03/mt-everest-its-time/2021-05-06T22:26:40+00:00https://timmermanreport.com/2018/02/cavemans-guide-to-productivity-entrepreneur-family-everest/2021-05-06T22:27:16+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2015/09/praveen.pnghttps://timmermanreport.com/wp-content/uploads/2018/02/badass.jpghttps://timmermanreport.com/2018/01/training-update-everest-climb-fight-cancer-fred-hutch-january/2021-05-06T22:27:49+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/sam.pnghttps://timmermanreport.com/wp-content/uploads/2018/01/sijan20.jpghttps://timmermanreport.com/2019/01/finding-a-way-in-genomic-diagnostics-bonnie-anderson-of-veracyte-on-the-long-run/2021-05-10T22:25:39+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/01/Bonnie\_Cropped-e1596736764296.jpghttps://timmermanreport.com/2021/05/appia-bio-seeks-off-the-shelf-cancer-therapy-with-rare-inkt-cells/2021-05-11T14:58:05+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/Kang1.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/Baltimore\_1\_crwBQpg.9a2d6c69.fill-310x412-c100.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/YangL.jpghttps://timmermanreport.com/2021/05/aducanumab-the-alzheimers-moonshot-what-would-it-be-worth-to-keep-your-mind/2021-05-13T13:16:28+00:00https://timmermanreport.com/wp-content/uploads/2020/02/JessicaSagers.pnghttps://timmermanreport.com/wp-content/uploads/2020/01/PeterKolchinsky\_RECTANGLE.jpghttps://timmermanreport.com/2018/07/finding-the-middle-market-of-biotech-vc-chris-garabedian-on-the-long-run-podcast/2021-05-13T17:45:36+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2017/05/cgarabedian.jpghttps://timmermanreport.com/2021/05/learning-from-post-it-your-solution-is-not-my-problem-except-when-it-is/2021-05-15T16:30:46+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2021/05/biden-threatens-patents-vaccines-shine-biogens-pricing-predicament/2021-05-15T18:31:03+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/trade.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/raj.pnghttps://timmermanreport.com/2021/05/pfizer-advances-to-adolescents-xontogenys-new-fund-rekindling-curiosity/2021-05-15T18:31:33+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/Goldstein1.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/Baltimore\_1\_crwBQpg.9a2d6c69.fill-310x412-c100.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/rajsingapore.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/economist.pnghttps://timmermanreport.com/2020/11/getting-married-in-2020-one-of-many-difficult-family-decisions-in-the-pandemic/2021-05-17T21:20:36+00:00https://timmermanreport.com/wp-content/uploads/2020/03/carolynng.jpghttps://timmermanreport.com/wp-content/uploads/2020/11/Carolyn-and-Matt.jpghttps://timmermanreport.com/2020/04/singapores-covid19-crisis-forgetting-to-check-the-blind-spot/2021-05-17T21:27:41+00:00https://timmermanreport.com/wp-content/uploads/2020/03/carolynng.jpghttps://timmermanreport.com/2020/03/singapore-braving-the-second-wave-of-covid19/2021-05-17T21:28:13+00:00https://timmermanreport.com/wp-content/uploads/2020/03/carolynng.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/straittimes.jpghttps://timmermanreport.com/2020/03/singapore-what-we-can-learn-from-a-high-risk-countrys-response-to-covid19/2021-05-17T21:28:49+00:00https://timmermanreport.com/wp-content/uploads/2020/03/carolynng.jpghttps://timmermanreport.com/2021/05/vedere-ii-after-novartis-acquisition-snags-77m-for-gene-therapy-to-restore-vision/2021-05-18T13:34:16+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/cyrus.pnghttps://timmermanreport.com/2021/05/sqz-biotech-shortens-cell-therapy-manufacturing-time-demonstrates-safety/2021-05-19T21:00:22+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/sharei.pnghttps://timmermanreport.com/2021/05/gsk-persists-with-vaccines-asco-abstracts-biogen-gene-therapy-fizzles/2021-05-21T00:44:13+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/katie.pnghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/2021-05-27T13:29:24+00:00https://timmermanreport.com/wp-content/uploads/2021/05/jingyiliu.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/eridai-1.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/dchang.pnghttps://timmermanreport.com/wp-content/uploads/2020/07/pearl.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/ahuang.pnghttps://timmermanreport.com/wp-content/uploads/2021/02/sek.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/reshma.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/samk.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/neilk.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/deanli.pnghttps://timmermanreport.com/wp-content/uploads/2021/05/vasn.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/vickisato.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/tachiy.pnghttps://timmermanreport.com/2021/05/from-fitness-to-flourish-expanding-the-scope-of-digital-exercise/2021-05-27T20:05:55+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/wellbeing.pnghttps://timmermanreport.com/2021/05/gsk-vir-win-antibody-ok-sanofi-gsk-moves-to-phase-iii-a-day-one-ipo/2021-05-28T02:43:36+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/suesutter.pnghttps://timmermanreport.com/2021/06/learning-from-mistakes-in-a-pandemic-aspiring-to-make-better-decisions-each-day/2021-06-01T10:55:35+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2021/06/the-promise-and-challenge-of-deriving-meaningful-clinical-insights-from-wearables/2021-06-01T10:44:55+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/mike-snyder\_web300.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/jessilynn-dunn.jpghttps://timmermanreport.com/2021/06/spatial-biology-to-map-the-universe-brad-gray-on-the-long-run/2021-06-02T13:35:47+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2016/02/bgray.jpghttps://timmermanreport.com/2019/12/sticking-with-epigenetics-during-lean-times-jigar-raythatha-on-the-long-run/2021-06-02T13:45:41+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/Jigar.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/precisionnanosystems.jpghttps://timmermanreport.com/2021/06/stablix-seeking-to-stabilize-instead-of-degrade-proteins-raises-63m/2021-06-03T12:00:57+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/Versant\_Team\_Carlo.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/colecraft.jpghttps://timmermanreport.com/2021/06/amgens-kras-triumph-eric-lander-in-the-saddle-and-eqrx-takes-aim-at-pd-l1/2021-06-04T00:48:16+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/dwb.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/boothmorph.pnghttps://timmermanreport.com/2021/06/bright-peak-therapeutics-raises-107m-to-advance-cytokine-engineering/2021-06-10T12:00:24+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/fredwiklund1.pnghttps://timmermanreport.com/wp-content/uploads/2017/01/mayweg.jpghttps://timmermanreport.com/2021/06/t-cell-diagnostic-tests-covid-19-pushed-us-and-we-can-see-where-this-leads/2021-06-10T10:34:52+00:00https://timmermanreport.com/wp-content/uploads/2021/06/chadrobins.pnghttps://timmermanreport.com/wp-content/uploads/2020/11/PeteLee-0618\_07.jpeg.jpghttps://timmermanreport.com/2021/06/biogens-alzheimers-controversy-cytokine-startups-reload-and-vaccines-beat-variants/2021-06-11T04:07:30+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/collinsbio.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/makris.pnghttps://timmermanreport.com/2019/05/from-open-biology-to-pharma-leadership-jay-bradner-of-novartis-on-the-long-run/2021-06-14T19:51:05+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/03/Mar-07-2018-Genzyme-Cancer-Summit-0046.jpghttps://timmermanreport.com/2021/06/mentoring-young-scientists-jay-bradner-and-andy-plump-on-the-long-run/2021-06-15T10:15:34+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/02/jbradner.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/plump.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/2021-06-14T23:43:58+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Isabel-Aznarez.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/carolyn.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/david-square-2-e1524497396520.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/Mira-square-site-e1522357939332.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/laurent.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/leone.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/funnell.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/fust-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/jesusgomez.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/phastings.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/moore.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/paolo.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/Corinne-Le-Goff.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/erichuang.jpghttps://timmermanreport.com/wp-content/uploads/2020/09/jpetter-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/LauraShawNew.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/paul.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/torres.jpghttps://timmermanreport.com/2021/06/after-devastating-new-study-is-there-a-future-for-workplace-wellness-and-has-peloton-figured-it-out/2021-06-15T16:40:11+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/Profiles\_MAPP\_Faculty\_MartySeligman.jpghttps://timmermanreport.com/2019/01/from-merck-fast-track-to-computer-chem-frontier-karen-akinsanya-on-the-long-run/2021-06-15T19:17:02+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/01/karen\_akinsanya\_headshot.pnghttps://timmermanreport.com/2018/05/re-starting-a-company-keeping-hope-alive-chip-clark-on-the-long-run/2021-06-15T19:20:50+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/05/Chip-Clark-Genocea.jpghttps://timmermanreport.com/2020/06/lets-turn-the-black-nod-into-a-collective-nod/2021-06-15T21:54:00+00:00https://timmermanreport.com/wp-content/uploads/2018/12/ucianescarlett.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/ucianefig1.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/ucianefig2.jpghttps://timmermanreport.com/2021/06/versant-ra-bet-47m-on-lenz-therapeutics-to-restore-near-vision-in-middle-age/2021-06-17T12:00:09+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/2021/06/novavax-nails-vaccine-trial-curevac-fails-flagship-sails-on-with-3-4b/2021-06-18T00:18:32+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2021/06/biopharmas-racial-justice-work-is-a-start-but-more-needs-to-happen/2021-06-23T10:07:59+00:00https://timmermanreport.com/wp-content/uploads/2018/03/slyman.jpghttps://timmermanreport.com/2021/01/is-pan-cancer-testing-a-pandoras-box/2021-06-22T23:01:06+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/2021/06/f-prime-leads-60m-bet-on-adela-scanning-the-methylome-for-early-signs-of-cancer/2021-06-23T12:00:39+00:00https://timmermanreport.com/wp-content/uploads/2021/06/baldoni.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/decarvalho.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/bratman.jpghttps://timmermanreport.com/2021/06/third-rock-led-abata-secures-95m-for-t-reg-cell-therapy-against-ms/2021-06-23T11:00:32+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/Samantha-Singer\_Abata-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/Richard-Ransohoff\_Abata.jpghttps://timmermanreport.com/2021/01/eqrx-fetches-500m-to-hit-the-gas-on-high-quality-low-cost-drug-model/2021-06-23T16:54:59+00:00https://timmermanreport.com/wp-content/uploads/2020/01/Alexis-Borisy-EQRX-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/Melanie-Nallicheri-EQRX-scaled.jpghttps://timmermanreport.com/2021/06/eqrx-exscientia-team-up-to-accelerate-rd-for-lower-priced-better-drugs/2021-06-24T11:00:41+00:00https://timmermanreport.com/wp-content/uploads/2020/01/Alexis-Borisy-EQRX-scaled.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/Andrew-Hopkins.jpghttps://timmermanreport.com/2021/06/the-other-half-decentralized-research-is-the-path-to-all-inclusive-medicine/2021-06-24T19:34:02+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Sanskriti-Thakur-Medable-CGO-2021.jpghttps://timmermanreport.com/2021/06/lander-pushes-arpa-h-lilly-follows-fast-in-alzheimers-wyden-moderates-on-price/2021-06-25T16:51:09+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/eric-lander-commerce-committee-hearing-crop.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/skorneybrian.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/llybiib.pnghttps://timmermanreport.com/2021/06/immunocompromised-people-are-vulnerable-to-covid-19-we-owe-them-some-answers/2021-06-29T10:44:16+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2021/06/lab-supply-shortages-persist-slowing-down-everyday-experiments/2021-06-29T14:37:14+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/eppendorf.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/manabe.jpghttps://timmermanreport.com/wp-content/uploads/2021/06/suzieruskin.pnghttps://timmermanreport.com/wp-content/uploads/2021/06/jcheah.pnghttps://timmermanreport.com/2020/05/day-one-taking-a-page-from-rare-disease-playbook-raises-60m-for-kids-with-cancer/2021-07-02T14:35:58+00:00https://timmermanreport.com/wp-content/uploads/2020/05/DayOneTherapeutics\_Leadership\_julie.jpghttps://timmermanreport.com/wp-content/uploads/2020/05/DayOneTherapeutics\_Leadership\_sam.jpghttps://timmermanreport.com/2021/07/verge-genomics-secures-25m-from-lilly-to-validate-new-als-drug-targets/2021-07-08T10:30:09+00:00https://timmermanreport.com/wp-content/uploads/2021/07/jane-e1625691740287.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/Alice-Zhang-Headshot-high-res-e1625691792560.pnghttps://timmermanreport.com/2021/07/one-and-done-gene-editing-a-feature-or-flaw/2021-07-12T19:08:57+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/simeon.pnghttps://timmermanreport.com/2021/07/payers-revolt-against-biogens-aduhelm-fda-credibility-crisis-and-a-prime-financing/2021-07-16T05:00:46+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/JebKeiper-web.pnghttps://timmermanreport.com/wp-content/uploads/2017/10/arnon.pnghttps://timmermanreport.com/wp-content/uploads/2021/07/rnjuly13.pnghttps://timmermanreport.com/wp-content/uploads/2021/07/brilliant.pnghttps://timmermanreport.com/wp-content/uploads/2021/07/jodie.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/cdc.pnghttps://timmermanreport.com/2021/07/from-deltato-omega/2021-07-19T15:59:28+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/OtelloJuly192021.pnghttps://timmermanreport.com/2021/07/investing-at-the-nexus-of-biology-technology-jenny-rooke-on-the-long-run/2021-07-19T20:55:13+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/Jenny.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/DNA-Script-Logo.pnghttps://timmermanreport.com/2021/07/why-we-need-mrna-vaccines-in-africa-and-for-all-who-are-immunocompromised/2021-07-20T13:39:20+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2021/07/biogens-bumbling-defense-delta-on-the-move-pacbios-power-play/2021-07-23T01:01:00+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/sekvaccine.pnghttps://timmermanreport.com/wp-content/uploads/2021/07/dickinson.pnghttps://timmermanreport.com/2021/07/an-industry-that-depends-on-diversity-should-defend-it/2021-07-27T10:19:24+00:00https://timmermanreport.com/wp-content/uploads/2021/01/phastings.jpghttps://timmermanreport.com/2021/07/career-arc-of-a-biotech-leader-sue-desmond-hellmann-on-the-long-run/2021-07-26T22:28:39+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/sue-desmond-hellmann.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/DNA-Script-Logo.pnghttps://timmermanreport.com/2021/07/biogens-perilous-path-intellias-in-vivo-milestone-holiday-financings/2021-07-29T16:48:42+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/secretary-xavier-becerra.jpghttps://timmermanreport.com/wp-content/uploads/2020/03/jeremy\_levin\_005.jpghttps://timmermanreport.com/wp-content/uploads/2018/06/tonycoles.jpghttps://timmermanreport.com/wp-content/uploads/2020/04/ankit-mahadevia.jpghttps://timmermanreport.com/2021/07/fda-rejections-midsummer-ipos-amgens-bispecific-buy/2021-07-30T00:08:51+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2019/12/david-baker.pnghttps://timmermanreport.com/wp-content/uploads/2021/03/nelsen.pnghttps://timmermanreport.com/wp-content/uploads/2021/07/hill.pnghttps://timmermanreport.com/2021/08/all-inclusive-medicine-needs-more-diverse-genomic-data/2021-08-04T10:19:37+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/wp-content/uploads/2021/07/varmus-1014x487-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/onlunye.jpghttps://timmermanreport.com/2018/12/messenger-rna-therapies-that-you-may-not-have-heard-of-ron-renaud-on-the-long-run/2021-08-03T15:36:30+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2018/12/renaud.jpghttps://timmermanreport.com/2021/08/sonoma-bio-engineering-t-cell-therapies-for-autoimmunity-nabs-265m-series-b/2021-08-04T11:00:03+00:00https://timmermanreport.com/wp-content/uploads/2021/06/baldoni.pnghttps://timmermanreport.com/wp-content/uploads/2019/08/Jeff-Bluestone\_2x2\_2017\_web.pnghttps://timmermanreport.com/2021/08/kidney-companies-taking-pages-from-the-oncology-playbook-with-precision-medicine/2021-08-04T21:52:00+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/wp-content/uploads/2021/07/eric-e1680045131907.jpghttps://timmermanreport.com/wp-content/uploads/2021/07/Tony\_558x392.pnghttps://timmermanreport.com/wp-content/uploads/2021/07/blaine.pnghttps://timmermanreport.com/2021/08/tachi-yamada-physician-scientist-biopharma-industry-leader-dies-at-76/2021-08-05T03:29:58+00:00https://timmermanreport.com/wp-content/uploads/2021/05/tachiy.pnghttps://timmermanreport.com/wp-content/uploads/2020/06/plump.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/Thong-7609-cropped.jpghttps://timmermanreport.com/wp-content/uploads/2021/08/topper.jpghttps://timmermanreport.com/wp-content/uploads/2021/08/goldsmith-image\_3x.pnghttps://timmermanreport.com/2021/08/bayer-snaps-up-vividion-sanofi-grabs-translate-bio-and-rip-tachi-yamada/2021-08-06T01:20:03+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/05/tachiy.pnghttps://timmermanreport.com/wp-content/uploads/2021/08/topol.pnghttps://timmermanreport.com/2021/08/better-cancer-drugs-for-kids-julie-grant-and-sam-blackman-on-the-long-run/2021-08-10T03:12:22+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/08/juliegrant.pnghttps://timmermanreport.com/wp-content/uploads/2020/12/samblackman.pnghttps://timmermanreport.com/wp-content/uploads/2021/08/TFS-LOGO.pnghttps://timmermanreport.com/2021/08/is-eqrx-an-existential-threat-to-the-biopharma-industry/2021-08-12T10:28:53+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2021/08/vaccination-and-the-delta-variant-four-steps-forward-two-steps-back/2021-08-16T10:22:32+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2021/08/spiritual-renewal-through-giving-back-and-experiencing-nature/2021-08-20T18:00:51+00:00https://timmermanreport.com/wp-content/uploads/2021/08/bakerglacier.pnghttps://timmermanreport.com/wp-content/uploads/2021/08/bakerglacier-1.pnghttps://timmermanreport.com/wp-content/uploads/2021/08/bakersummit.pnghttps://timmermanreport.com/wp-content/uploads/2021/08/bakersmall.jpghttps://timmermanreport.com/2021/08/pfizer-biontech-vaccine-approved-lilly-works-with-lycia-we-wait-for-jj/2021-08-26T23:43:02+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/08/tests.pnghttps://timmermanreport.com/wp-content/uploads/2021/08/chinaresearch.pnghttps://timmermanreport.com/wp-content/uploads/2021/08/cohen.pnghttps://timmermanreport.com/2021/08/atlas-medicxi-invest-70m-in-antibody-for-obesity-licensed-from-novartis/2021-08-31T13:48:46+00:00https://timmermanreport.com/wp-content/uploads/2021/08/klickstein.jpghttps://timmermanreport.com/wp-content/uploads/2020/06/gladstone.jpghttps://timmermanreport.com/2021/08/meet-the-climb-to-fight-cancer-postdoctoral-fellow-aleena-arakaki/2021-08-31T18:23:58+00:00https://timmermanreport.com/wp-content/uploads/2021/08/aleenaarakaki.jpghttps://timmermanreport.com/wp-content/uploads/2021/08/kili.pnghttps://timmermanreport.com/2021/09/uk-gamechanger-for-heart-disease-jj-hiv-vaccine-fails-purdue-goes-kaput/2021-09-03T12:49:51+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2020/07/John\_Maraganore.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/onno.pnghttps://timmermanreport.com/2021/09/base-editing-for-therapeutics-john-evans-on-the-long-run/2021-09-07T18:50:35+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2019/03/john-evans.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/TFS-LOGO.pnghttps://timmermanreport.com/wp-content/uploads/2021/07/DNA-Script-Logo.pnghttps://timmermanreport.com/2021/09/versant-orbimed-invest-50m-in-startup-inserting-genes-in-the-liver/2021-09-09T11:00:35+00:00https://timmermanreport.com/wp-content/uploads/2018/12/woiwode.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/wilson.jpghttps://timmermanreport.com/2021/09/knowledge-is-power-the-covid-testing-opportunity-mara-aspinall-on-the-long-run/2021-09-13T01:15:44+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/01/maraaspinall.pnghttps://timmermanreport.com/wp-content/uploads/2021/09/ANSR-logo-no-tag-1900px-PNG-1.pnghttps://timmermanreport.com/2021/09/hero-narratives-inspire-entrepreneurs-but-obscure-uncomfortable-trade-offs/2021-09-16T02:06:09+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/reid107823-600x801-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/03/SGSB-0349-Jeffrey\_PfefferRT.jpghttps://timmermanreport.com/2021/09/a-magical-time-in-the-presidential-range-giving-back-to-community/2021-09-21T00:57:19+00:00https://timmermanreport.com/wp-content/uploads/2021/09/madisonhut.pnghttps://timmermanreport.com/wp-content/uploads/2019/04/flatiron\_vineeta\_agarwala.jpghttps://timmermanreport.com/wp-content/uploads/2016/05/krieg.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/katherine.pnghttps://timmermanreport.com/wp-content/uploads/2021/09/reidhuber.pnghttps://timmermanreport.com/wp-content/uploads/2021/09/ALICE.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/traversemontage.pnghttps://timmermanreport.com/2021/09/what-should-i-read-a-few-suggestions-for-biotech-pros/2021-09-21T01:05:21+00:00https://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/brian-christian-photo-by-eileen-meny-crop-3.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/scott\_gottlieb\_2.pnghttps://timmermanreport.com/2021/09/jj-bounces-back-illumina-grail-scrutiny-azs-her-2-adc-triumph/2021-09-24T14:29:06+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/attnbiogen.pnghttps://timmermanreport.com/wp-content/uploads/2021/09/alex.pnghttps://timmermanreport.com/2021/09/sequencing-genomes-of-indigenous-populations-keolu-fox-on-the-long-run/2021-09-27T17:09:02+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner-1.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/keolufox1.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/ANSR-logo-no-tag-1900px-PNG-1-1.pnghttps://timmermanreport.com/wp-content/uploads/2021/09/TFS-LOGO-1.pnghttps://timmermanreport.com/2021/09/expansion-snags-80m-to-make-small-molecules-against-rna-targets/2021-09-29T11:00:08+00:00https://timmermanreport.com/wp-content/uploads/2021/09/300x300\_matthew\_disney.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/renato.pnghttps://timmermanreport.com/2021/09/merck-buys-acceleron-regeneron-antibody-saves-lives-moderna-invests-in-cambridge/2021-09-30T23:35:48+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/wp-content/uploads/2021/09/maccheever.jpeg